#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Disrupted resting-state brain functional network in methamphetamine abusers: A brain source space study by EEG
#Text=This study aimed to examine the effects of chronic methamphetamine use on the topological organization of whole-brain functional connectivity network (FCN) by reconstruction of neural-activity time series at resting-state.
1-1	0-9	Disrupted	_	
1-2	10-23	resting-state	_	
1-3	24-29	brain	_	
1-4	30-40	functional	_	
1-5	41-48	network	_	
1-6	49-51	in	_	
1-7	52-67	methamphetamine	_	
1-8	68-75	abusers	_	
1-9	75-76	:	_	
1-10	77-78	A	_	
1-11	79-84	brain	_	
1-12	85-91	source	_	
1-13	92-97	space	_	
1-14	98-103	study	_	
1-15	104-106	by	_	
1-16	107-110	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
1-17	111-115	This	_	
1-18	116-121	study	_	
1-19	122-127	aimed	_	
1-20	128-130	to	_	
1-21	131-138	examine	_	
1-22	139-142	the	_	
1-23	143-150	effects	_	
1-24	151-153	of	_	
1-25	154-161	chronic	_	
1-26	162-177	methamphetamine	_	
1-27	178-181	use	_	
1-28	182-184	on	_	
1-29	185-188	the	_	
1-30	189-200	topological	_	
1-31	201-213	organization	_	
1-32	214-216	of	_	
1-33	217-228	whole-brain	_	
1-34	229-239	functional	_	
1-35	240-252	connectivity	_	
1-36	253-260	network	_	
1-37	261-262	(	_	
1-38	262-265	FCN	_	
1-39	265-266	)	_	
1-40	267-269	by	_	
1-41	270-284	reconstruction	_	
1-42	285-287	of	_	
1-43	288-303	neural-activity	_	
1-44	304-308	time	_	
1-45	309-315	series	_	
1-46	316-318	at	_	
1-47	319-332	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
1-48	332-333	.	_	

#Text=The EEG of 36 individuals with methamphetamine use disorder (IWMUD) and 24 normal controls (NCs) were recorded, pre-processed and source-reconstructed using standardized low-resolution tomography (sLORETA).
2-1	334-337	The	_	
2-2	338-341	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
2-3	342-344	of	_	
2-4	345-347	36	_	
2-5	348-359	individuals	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-6	360-364	with	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-7	365-380	methamphetamine	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-8	381-384	use	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-9	385-393	disorder	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-10	394-395	(	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-11	395-400	IWMUD	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[1]	
2-12	400-401	)	_	
2-13	402-405	and	_	
2-14	406-408	24	_	
2-15	409-415	normal	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-16	416-424	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-17	425-426	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-18	426-429	NCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-19	429-430	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-20	431-435	were	_	
2-21	436-444	recorded	_	
2-22	444-445	,	_	
2-23	446-459	pre-processed	_	
2-24	460-463	and	_	
2-25	464-484	source-reconstructed	_	
2-26	485-490	using	_	
2-27	491-503	standardized	_	
2-28	504-518	low-resolution	_	
2-29	519-529	tomography	_	
2-30	530-531	(	_	
2-31	531-538	sLORETA	_	
2-32	538-539	)	_	
2-33	539-540	.	_	

#Text=The brain FCNs of participants were constructed and between-group differences in network topological properties were investigated using graph theoretical analysis.
3-1	541-544	The	_	
3-2	545-550	brain	_	
3-3	551-555	FCNs	_	
3-4	556-558	of	_	
3-5	559-571	participants	_	
3-6	572-576	were	_	
3-7	577-588	constructed	_	
3-8	589-592	and	_	
3-9	593-606	between-group	_	
3-10	607-618	differences	_	
3-11	619-621	in	_	
3-12	622-629	network	_	
3-13	630-641	topological	_	
3-14	642-652	properties	_	
3-15	653-657	were	_	
3-16	658-670	investigated	_	
3-17	671-676	using	_	
3-18	677-682	graph	_	
3-19	683-694	theoretical	_	
3-20	695-703	analysis	_	
3-21	703-704	.	_	

#Text=IWMUD showed decreased characteristic path length, increased clustering coefficient and small-world index at delta and gamma frequency bands compared to NCs.
4-1	705-710	IWMUD	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence	
4-2	711-717	showed	_	
4-3	718-727	decreased	_	
4-4	728-742	characteristic	_	
4-5	743-747	path	_	
4-6	748-754	length	_	
4-7	754-755	,	_	
4-8	756-765	increased	_	
4-9	766-776	clustering	_	
4-10	777-788	coefficient	_	
4-11	789-792	and	_	
4-12	793-804	small-world	_	
4-13	805-810	index	_	
4-14	811-813	at	_	
4-15	814-819	delta	_	
4-16	820-823	and	_	
4-17	824-829	gamma	_	
4-18	830-839	frequency	_	
4-19	840-845	bands	_	
4-20	846-854	compared	_	
4-21	855-857	to	_	
4-22	858-861	NCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
4-23	861-862	.	_	

#Text=Moreover, abnormal changes in inter-regional connectivity and network hubs were observed in all the frequency bands.
5-1	863-871	Moreover	_	
5-2	871-872	,	_	
5-3	873-881	abnormal	_	
5-4	882-889	changes	_	
5-5	890-892	in	_	
5-6	893-907	inter-regional	_	
5-7	908-920	connectivity	_	
5-8	921-924	and	_	
5-9	925-932	network	_	
5-10	933-937	hubs	_	
5-11	938-942	were	_	
5-12	943-951	observed	_	
5-13	952-954	in	_	
5-14	955-958	all	_	
5-15	959-962	the	_	
5-16	963-972	frequency	_	
5-17	973-978	bands	_	
5-18	978-979	.	_	

#Text=The results suggest that the IWMUD and NCs have distinct FCNs at all the frequency bands, particularly at the delta and gamma bands, in which deviated small-world brain topology was found in IWMUD.
#Text=1.
6-1	980-983	The	_	
6-2	984-991	results	_	
6-3	992-999	suggest	_	
6-4	1000-1004	that	_	
6-5	1005-1008	the	_	
6-6	1009-1014	IWMUD	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence	
6-7	1015-1018	and	_	
6-8	1019-1022	NCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
6-9	1023-1027	have	_	
6-10	1028-1036	distinct	_	
6-11	1037-1041	FCNs	_	
6-12	1042-1044	at	_	
6-13	1045-1048	all	_	
6-14	1049-1052	the	_	
6-15	1053-1062	frequency	_	
6-16	1063-1068	bands	_	
6-17	1068-1069	,	_	
6-18	1070-1082	particularly	_	
6-19	1083-1085	at	_	
6-20	1086-1089	the	_	
6-21	1090-1095	delta	_	
6-22	1096-1099	and	_	
6-23	1100-1105	gamma	_	
6-24	1106-1111	bands	_	
6-25	1111-1112	,	_	
6-26	1113-1115	in	_	
6-27	1116-1121	which	_	
6-28	1122-1130	deviated	_	
6-29	1131-1142	small-world	_	
6-30	1143-1148	brain	_	
6-31	1149-1157	topology	_	
6-32	1158-1161	was	_	
6-33	1162-1167	found	_	
6-34	1168-1170	in	_	
6-35	1171-1176	IWMUD	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence	
6-36	1176-1177	.	_	
6-37	1178-1179	1	_	
6-38	1179-1180	.	_	

#Text=Introduction
#Text=Methamphetamine (MA) is a highly addictive drug that its consumption is associated with increased feeling of awareness, energy, vigilance, and exhilaration.
7-1	1181-1193	Introduction	_	
7-2	1194-1209	Methamphetamine	_	
7-3	1210-1211	(	_	
7-4	1211-1213	MA	_	
7-5	1213-1214	)	_	
7-6	1215-1217	is	_	
7-7	1218-1219	a	_	
7-8	1220-1226	highly	_	
7-9	1227-1236	addictive	_	
7-10	1237-1241	drug	_	
7-11	1242-1246	that	_	
7-12	1247-1250	its	_	
7-13	1251-1262	consumption	_	
7-14	1263-1265	is	_	
7-15	1266-1276	associated	_	
7-16	1277-1281	with	_	
7-17	1282-1291	increased	_	
7-18	1292-1299	feeling	_	
7-19	1300-1302	of	_	
7-20	1303-1312	awareness	_	
7-21	1312-1313	,	_	
7-22	1314-1320	energy	_	
7-23	1320-1321	,	_	
7-24	1322-1331	vigilance	_	
7-25	1331-1332	,	_	
7-26	1333-1336	and	_	
7-27	1337-1349	exhilaration	_	
7-28	1349-1350	.	_	

#Text=These psychological effects and relatively easy access have made it a very popular drug among young adults.
8-1	1351-1356	These	_	
8-2	1357-1370	psychological	_	
8-3	1371-1378	effects	_	
8-4	1379-1382	and	_	
8-5	1383-1393	relatively	_	
8-6	1394-1398	easy	_	
8-7	1399-1405	access	_	
8-8	1406-1410	have	_	
8-9	1411-1415	made	_	
8-10	1416-1418	it	_	
8-11	1419-1420	a	_	
8-12	1421-1425	very	_	
8-13	1426-1433	popular	_	
8-14	1434-1438	drug	_	
8-15	1439-1444	among	_	
8-16	1445-1450	young	_	
8-17	1451-1457	adults	_	
8-18	1457-1458	.	_	

#Text=World Drug Report 2016 reported that there are around 14 to 54 million users of MA worldwide.
9-1	1459-1464	World	_	
9-2	1465-1469	Drug	_	
9-3	1470-1476	Report	_	
9-4	1477-1481	2016	_	
9-5	1482-1490	reported	_	
9-6	1491-1495	that	_	
9-7	1496-1501	there	_	
9-8	1502-1505	are	_	
9-9	1506-1512	around	_	
9-10	1513-1515	14	_	
9-11	1516-1518	to	_	
9-12	1519-1521	54	_	
9-13	1522-1529	million	_	
9-14	1530-1535	users	_	
9-15	1536-1538	of	_	
9-16	1539-1541	MA	_	
9-17	1542-1551	worldwide	_	
9-18	1551-1552	.	_	

#Text=MA use disorder imposes a large burden on the society; hence, it is important to increase the knowledge about it in the physiological and neurological terms, in order to improve associated diagnosis and treatments.
10-1	1553-1555	MA	_	
10-2	1556-1559	use	_	
10-3	1560-1568	disorder	_	
10-4	1569-1576	imposes	_	
10-5	1577-1578	a	_	
10-6	1579-1584	large	_	
10-7	1585-1591	burden	_	
10-8	1592-1594	on	_	
10-9	1595-1598	the	_	
10-10	1599-1606	society	_	
10-11	1606-1607	;	_	
10-12	1608-1613	hence	_	
10-13	1613-1614	,	_	
10-14	1615-1617	it	_	
10-15	1618-1620	is	_	
10-16	1621-1630	important	_	
10-17	1631-1633	to	_	
10-18	1634-1642	increase	_	
10-19	1643-1646	the	_	
10-20	1647-1656	knowledge	_	
10-21	1657-1662	about	_	
10-22	1663-1665	it	_	
10-23	1666-1668	in	_	
10-24	1669-1672	the	_	
10-25	1673-1686	physiological	_	
10-26	1687-1690	and	_	
10-27	1691-1703	neurological	_	
10-28	1704-1709	terms	_	
10-29	1709-1710	,	_	
10-30	1711-1713	in	_	
10-31	1714-1719	order	_	
10-32	1720-1722	to	_	
10-33	1723-1730	improve	_	
10-34	1731-1741	associated	_	
10-35	1742-1751	diagnosis	_	
10-36	1752-1755	and	_	
10-37	1756-1766	treatments	_	
10-38	1766-1767	.	_	

#Text=Functional magnetic resonance imaging (fMRI) and EEG data have been widely used to acquire knowledge about brain disorders such as schizophrenia, Alzheimer’s disease, tinnitus and addiction.
11-1	1768-1778	Functional	_	
11-2	1779-1787	magnetic	_	
11-3	1788-1797	resonance	_	
11-4	1798-1805	imaging	_	
11-5	1806-1807	(	_	
11-6	1807-1811	fMRI	_	
11-7	1811-1812	)	_	
11-8	1813-1816	and	_	
11-9	1817-1820	EEG	_	
11-10	1821-1825	data	_	
11-11	1826-1830	have	_	
11-12	1831-1835	been	_	
11-13	1836-1842	widely	_	
11-14	1843-1847	used	_	
11-15	1848-1850	to	_	
11-16	1851-1858	acquire	_	
11-17	1859-1868	knowledge	_	
11-18	1869-1874	about	_	
11-19	1875-1880	brain	_	
11-20	1881-1890	disorders	_	
11-21	1891-1895	such	_	
11-22	1896-1898	as	_	
11-23	1899-1912	schizophrenia	_	
11-24	1912-1913	,	_	
11-25	1914-1923	Alzheimer	_	
11-26	1923-1924	’	_	
11-27	1924-1925	s	_	
11-28	1926-1933	disease	_	
11-29	1933-1934	,	_	
11-30	1935-1943	tinnitus	_	
11-31	1944-1947	and	_	
11-32	1948-1957	addiction	_	
11-33	1957-1958	.	_	

#Text=EEG is portable and less expensive than fMRI.
12-1	1959-1962	EEG	_	
12-2	1963-1965	is	_	
12-3	1966-1974	portable	_	
12-4	1975-1978	and	_	
12-5	1979-1983	less	_	
12-6	1984-1993	expensive	_	
12-7	1994-1998	than	_	
12-8	1999-2003	fMRI	_	
12-9	2003-2004	.	_	

#Text=Furthermore, it has a high temporal resolution, which makes it a good instrument to study electrophysiology of the brain in different frequency bands.
13-1	2005-2016	Furthermore	_	
13-2	2016-2017	,	_	
13-3	2018-2020	it	_	
13-4	2021-2024	has	_	
13-5	2025-2026	a	_	
13-6	2027-2031	high	_	
13-7	2032-2040	temporal	_	
13-8	2041-2051	resolution	_	
13-9	2051-2052	,	_	
13-10	2053-2058	which	_	
13-11	2059-2064	makes	_	
13-12	2065-2067	it	_	
13-13	2068-2069	a	_	
13-14	2070-2074	good	_	
13-15	2075-2085	instrument	_	
13-16	2086-2088	to	_	
13-17	2089-2094	study	_	
13-18	2095-2112	electrophysiology	_	
13-19	2113-2115	of	_	
13-20	2116-2119	the	_	
13-21	2120-2125	brain	_	
13-22	2126-2128	in	_	
13-23	2129-2138	different	_	
13-24	2139-2148	frequency	_	
13-25	2149-2154	bands	_	
13-26	2154-2155	.	_	

#Text=So far, few studies have explored the effects of MA use on the brain activity, using resting-state EEG (rEEG).
14-1	2156-2158	So	_	
14-2	2159-2162	far	_	
14-3	2162-2163	,	_	
14-4	2164-2167	few	_	
14-5	2168-2175	studies	_	
14-6	2176-2180	have	_	
14-7	2181-2189	explored	_	
14-8	2190-2193	the	_	
14-9	2194-2201	effects	_	
14-10	2202-2204	of	_	
14-11	2205-2207	MA	_	
14-12	2208-2211	use	_	
14-13	2212-2214	on	_	
14-14	2215-2218	the	_	
14-15	2219-2224	brain	_	
14-16	2225-2233	activity	_	
14-17	2233-2234	,	_	
14-18	2235-2240	using	_	
14-19	2241-2254	resting-state	_	
14-20	2255-2258	EEG	_	
14-21	2259-2260	(	_	
14-22	2260-2264	rEEG	_	
14-23	2264-2265	)	_	
14-24	2265-2266	.	_	

#Text=Newton et al. found increased power at delta and theta oscillatory rhythms in IWMUD compared to the normal NCs and Ahmadlou et al. reported disrupted functional brain organization of IWMUD compared to that of NCs.The human brain is a small-world topology which supports both segregation and integration in information processing.
15-1	2267-2273	Newton	_	
15-2	2274-2276	et	_	
15-3	2277-2279	al	_	
15-4	2279-2280	.	_	
15-5	2281-2286	found	_	
15-6	2287-2296	increased	_	
15-7	2297-2302	power	_	
15-8	2303-2305	at	_	
15-9	2306-2311	delta	_	
15-10	2312-2315	and	_	
15-11	2316-2321	theta	_	
15-12	2322-2333	oscillatory	_	
15-13	2334-2341	rhythms	_	
15-14	2342-2344	in	_	
15-15	2345-2350	IWMUD	_	
15-16	2351-2359	compared	_	
15-17	2360-2362	to	_	
15-18	2363-2366	the	_	
15-19	2367-2373	normal	_	
15-20	2374-2377	NCs	_	
15-21	2378-2381	and	_	
15-22	2382-2390	Ahmadlou	_	
15-23	2391-2393	et	_	
15-24	2394-2396	al	_	
15-25	2396-2397	.	_	
15-26	2398-2406	reported	_	
15-27	2407-2416	disrupted	_	
15-28	2417-2427	functional	_	
15-29	2428-2433	brain	_	
15-30	2434-2446	organization	_	
15-31	2447-2449	of	_	
15-32	2450-2455	IWMUD	_	
15-33	2456-2464	compared	_	
15-34	2465-2467	to	_	
15-35	2468-2472	that	_	
15-36	2473-2475	of	_	
15-37	2476-2483	NCs.The	_	
15-38	2484-2489	human	_	
15-39	2490-2495	brain	_	
15-40	2496-2498	is	_	
15-41	2499-2500	a	_	
15-42	2501-2512	small-world	_	
15-43	2513-2521	topology	_	
15-44	2522-2527	which	_	
15-45	2528-2536	supports	_	
15-46	2537-2541	both	_	
15-47	2542-2553	segregation	_	
15-48	2554-2557	and	_	
15-49	2558-2569	integration	_	
15-50	2570-2572	in	_	
15-51	2573-2584	information	_	
15-52	2585-2595	processing	_	
15-53	2595-2596	.	_	

#Text=The network is segregated when containing a large number of connected clusters and integrated when including short path lengths among its units.
16-1	2597-2600	The	_	
16-2	2601-2608	network	_	
16-3	2609-2611	is	_	
16-4	2612-2622	segregated	_	
16-5	2623-2627	when	_	
16-6	2628-2638	containing	_	
16-7	2639-2640	a	_	
16-8	2641-2646	large	_	
16-9	2647-2653	number	_	
16-10	2654-2656	of	_	
16-11	2657-2666	connected	_	
16-12	2667-2675	clusters	_	
16-13	2676-2679	and	_	
16-14	2680-2690	integrated	_	
16-15	2691-2695	when	_	
16-16	2696-2705	including	_	
16-17	2706-2711	short	_	
16-18	2712-2716	path	_	
16-19	2717-2724	lengths	_	
16-20	2725-2730	among	_	
16-21	2731-2734	its	_	
16-22	2735-2740	units	_	
16-23	2740-2741	.	_	

#Text=These characteristics make the network efficient in information transfer with low wiring costs.
17-1	2742-2747	These	_	
17-2	2748-2763	characteristics	_	
17-3	2764-2768	make	_	
17-4	2769-2772	the	_	
17-5	2773-2780	network	_	
17-6	2781-2790	efficient	_	
17-7	2791-2793	in	_	
17-8	2794-2805	information	_	
17-9	2806-2814	transfer	_	
17-10	2815-2819	with	_	
17-11	2820-2823	low	_	
17-12	2824-2830	wiring	_	
17-13	2831-2836	costs	_	
17-14	2836-2837	.	_	

#Text=Previous studies reported that the small-world topology abnormally alters in many disease e.g. major depressive disorder, Parkinson's disease, Alzheimer’s disease, schizophrenia and tinnitus, opioids (heroin) and methamphetamine abuse, Cirrhosis, cognitive disorders related to aging.
18-1	2838-2846	Previous	_	
18-2	2847-2854	studies	_	
18-3	2855-2863	reported	_	
18-4	2864-2868	that	_	
18-5	2869-2872	the	_	
18-6	2873-2884	small-world	_	
18-7	2885-2893	topology	_	
18-8	2894-2904	abnormally	_	
18-9	2905-2911	alters	_	
18-10	2912-2914	in	_	
18-11	2915-2919	many	_	
18-12	2920-2927	disease	_	
18-13	2928-2931	e.g	_	
18-14	2931-2932	.	_	
18-15	2933-2938	major	_	
18-16	2939-2949	depressive	_	
18-17	2950-2958	disorder	_	
18-18	2958-2959	,	_	
18-19	2960-2971	Parkinson's	_	
18-20	2972-2979	disease	_	
18-21	2979-2980	,	_	
18-22	2981-2990	Alzheimer	_	
18-23	2990-2991	’	_	
18-24	2991-2992	s	_	
18-25	2993-3000	disease	_	
18-26	3000-3001	,	_	
18-27	3002-3015	schizophrenia	_	
18-28	3016-3019	and	_	
18-29	3020-3028	tinnitus	_	
18-30	3028-3029	,	_	
18-31	3030-3037	opioids	_	
18-32	3038-3039	(	_	
18-33	3039-3045	heroin	_	
18-34	3045-3046	)	_	
18-35	3047-3050	and	_	
18-36	3051-3066	methamphetamine	_	
18-37	3067-3072	abuse	_	
18-38	3072-3073	,	_	
18-39	3074-3083	Cirrhosis	_	
18-40	3083-3084	,	_	
18-41	3085-3094	cognitive	_	
18-42	3095-3104	disorders	_	
18-43	3105-3112	related	_	
18-44	3113-3115	to	_	
18-45	3116-3121	aging	_	
18-46	3121-3122	.	_	

#Text=Ahmadlou et al. have investigated the brain functional organization of IWMUD in early withdrawal stage using functional connectivity network (FCN) and graph theory.
19-1	3123-3131	Ahmadlou	_	
19-2	3132-3134	et	_	
19-3	3135-3137	al	_	
19-4	3137-3138	.	_	
19-5	3139-3143	have	_	
19-6	3144-3156	investigated	_	
19-7	3157-3160	the	_	
19-8	3161-3166	brain	_	
19-9	3167-3177	functional	_	
19-10	3178-3190	organization	_	
19-11	3191-3193	of	_	
19-12	3194-3199	IWMUD	_	
19-13	3200-3202	in	_	
19-14	3203-3208	early	_	
19-15	3209-3219	withdrawal	_	
19-16	3220-3225	stage	_	
19-17	3226-3231	using	_	
19-18	3232-3242	functional	_	
19-19	3243-3255	connectivity	_	
19-20	3256-3263	network	_	
19-21	3264-3265	(	_	
19-22	3265-3268	FCN	_	
19-23	3268-3269	)	_	
19-24	3270-3273	and	_	
19-25	3274-3279	graph	_	
19-26	3280-3286	theory	_	
19-27	3286-3287	.	_	

#Text=They reported increased gamma band small-world index (SWI) in IWMUD using rEEG and constructing the FCN at sensor level.
20-1	3288-3292	They	_	
20-2	3293-3301	reported	_	
20-3	3302-3311	increased	_	
20-4	3312-3317	gamma	_	
20-5	3318-3322	band	_	
20-6	3323-3334	small-world	_	
20-7	3335-3340	index	_	
20-8	3341-3342	(	_	
20-9	3342-3345	SWI	_	
20-10	3345-3346	)	_	
20-11	3347-3349	in	_	
20-12	3350-3355	IWMUD	_	
20-13	3356-3361	using	_	
20-14	3362-3366	rEEG	_	
20-15	3367-3370	and	_	
20-16	3371-3383	constructing	_	
20-17	3384-3387	the	_	
20-18	3388-3391	FCN	_	
20-19	3392-3394	at	_	
20-20	3395-3401	sensor	_	
20-21	3402-3407	level	_	
20-22	3407-3408	.	_	

#Text=To date, no study has examined the differences in the brain FCN of IWMUD by rEEG at neuronal source level compared to that of NCs.
21-1	3409-3411	To	_	
21-2	3412-3416	date	_	
21-3	3416-3417	,	_	
21-4	3418-3420	no	_	
21-5	3421-3426	study	_	
21-6	3427-3430	has	_	
21-7	3431-3439	examined	_	
21-8	3440-3443	the	_	
21-9	3444-3455	differences	_	
21-10	3456-3458	in	_	
21-11	3459-3462	the	_	
21-12	3463-3468	brain	_	
21-13	3469-3472	FCN	_	
21-14	3473-3475	of	_	
21-15	3476-3481	IWMUD	_	
21-16	3482-3484	by	_	
21-17	3485-3489	rEEG	_	
21-18	3490-3492	at	_	
21-19	3493-3501	neuronal	_	
21-20	3502-3508	source	_	
21-21	3509-3514	level	_	
21-22	3515-3523	compared	_	
21-23	3524-3526	to	_	
21-24	3527-3531	that	_	
21-25	3532-3534	of	_	
21-26	3535-3538	NCs	_	
21-27	3538-3539	.	_	

#Text=High-resolution EEG recording combined with source localization methods can provide better spatial resolution for EEG-based connectivity analysis.
22-1	3540-3555	High-resolution	_	
22-2	3556-3559	EEG	_	
22-3	3560-3569	recording	_	
22-4	3570-3578	combined	_	
22-5	3579-3583	with	_	
22-6	3584-3590	source	_	
22-7	3591-3603	localization	_	
22-8	3604-3611	methods	_	
22-9	3612-3615	can	_	
22-10	3616-3623	provide	_	
22-11	3624-3630	better	_	
22-12	3631-3638	spatial	_	
22-13	3639-3649	resolution	_	
22-14	3650-3653	for	_	
22-15	3654-3663	EEG-based	_	
22-16	3664-3676	connectivity	_	
22-17	3677-3685	analysis	_	
22-18	3685-3686	.	_	

#Text=In the current study, we constructed and compared whole-brain FCN for a group of IWMUD and a group of NCs using rEEG.
#Text=2.
23-1	3687-3689	In	_	
23-2	3690-3693	the	_	
23-3	3694-3701	current	_	
23-4	3702-3707	study	_	
23-5	3707-3708	,	_	
23-6	3709-3711	we	_	
23-7	3712-3723	constructed	_	
23-8	3724-3727	and	_	
23-9	3728-3736	compared	_	
23-10	3737-3748	whole-brain	_	
23-11	3749-3752	FCN	_	
23-12	3753-3756	for	_	
23-13	3757-3758	a	_	
23-14	3759-3764	group	_	
23-15	3765-3767	of	_	
23-16	3768-3773	IWMUD	_	
23-17	3774-3777	and	_	
23-18	3778-3779	a	_	
23-19	3780-3785	group	_	
23-20	3786-3788	of	_	
23-21	3789-3792	NCs	_	
23-22	3793-3798	using	_	
23-23	3799-3803	rEEG	_	
23-24	3803-3804	.	_	
23-25	3805-3806	2	_	
23-26	3806-3807	.	_	

#Text=Materials and methods
#Text=2.1 Participants
#Text=Thirty-six IWMUD, with a minimum of 1 and maximum of 6 months of abstinence, were recruited from "Peyrovan Hemmat Harm Reduction Institute" and "Iranian National Center for Addiction Studies (INCAS) Academic Clinic" located in Tehran. 24 age-matched NCs were also recruited in our research.
24-1	3808-3817	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
24-2	3818-3821	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
24-3	3822-3829	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
24-4	3830-3833	2.1	_	
24-5	3834-3846	Participants	_	
24-6	3847-3857	Thirty-six	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-7	3858-3863	IWMUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence[5]	
24-8	3863-3864	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-9	3865-3869	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-10	3870-3871	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-11	3872-3879	minimum	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-12	3880-3882	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-13	3883-3884	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-14	3885-3888	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-15	3889-3896	maximum	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-16	3897-3899	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-17	3900-3901	6	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-18	3902-3908	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-19	3909-3911	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-20	3912-3922	abstinence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-21	3922-3923	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-22	3924-3928	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-23	3929-3938	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-24	3939-3943	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-25	3944-3945	"	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-26	3945-3953	Peyrovan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-27	3954-3960	Hemmat	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-28	3961-3965	Harm	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-29	3966-3975	Reduction	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-30	3976-3985	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-31	3985-3986	"	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-32	3987-3990	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-33	3991-3992	"	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-34	3992-3999	Iranian	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-35	4000-4008	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-36	4009-4015	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-37	4016-4019	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-38	4020-4029	Addiction	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-39	4030-4037	Studies	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-40	4038-4039	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-41	4039-4044	INCAS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-42	4044-4045	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-43	4046-4054	Academic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-44	4055-4061	Clinic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-45	4061-4062	"	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-46	4063-4070	located	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-47	4071-4073	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-48	4074-4080	Tehran	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-49	4080-4081	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-50	4082-4084	24	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-51	4085-4096	age-matched	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-52	4097-4100	NCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-53	4101-4105	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-54	4106-4110	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-55	4111-4120	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-56	4121-4123	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-57	4124-4127	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-58	4128-4136	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
24-59	4136-4137	.	_	

#Text=This research is part of a registered brain stimulation trial in Iranian Registry of Clinical Trials (IRCT) in 2018 (IRCT20170808035562N2).
25-1	4138-4142	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-2	4143-4151	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-3	4152-4154	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-4	4155-4159	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-5	4160-4162	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-6	4163-4164	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-7	4165-4175	registered	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-8	4176-4181	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-9	4182-4193	stimulation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-10	4194-4199	trial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-11	4200-4202	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-12	4203-4210	Iranian	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-13	4211-4219	Registry	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-14	4220-4222	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-15	4223-4231	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-16	4232-4238	Trials	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-17	4239-4240	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-18	4240-4244	IRCT	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-19	4244-4245	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-20	4246-4248	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-21	4249-4253	2018	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-22	4254-4255	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-23	4255-4275	IRCT20170808035562N2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-24	4275-4276	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
25-25	4276-4277	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=The rest EEG were recorded before any intervention.
26-1	4278-4281	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-2	4282-4286	rest	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-3	4287-4290	EEG	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[8]	
26-4	4291-4295	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-5	4296-4304	recorded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-6	4305-4311	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-7	4312-4315	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-8	4316-4328	intervention	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
26-9	4328-4329	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=All subjects signed a written informed consent form.
27-1	4330-4333	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-2	4334-4342	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-3	4343-4349	signed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-4	4350-4351	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-5	4352-4359	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-6	4360-4368	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-7	4369-4376	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-8	4377-4381	form	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
27-9	4381-4382	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	

#Text=Table 1 shows the demographic characteristics and drug use history of the participants.
28-1	4383-4388	Table	_	
28-2	4389-4390	1	_	
28-3	4391-4396	shows	_	
28-4	4397-4400	the	_	
28-5	4401-4412	demographic	_	
28-6	4413-4428	characteristics	_	
28-7	4429-4432	and	_	
28-8	4433-4437	drug	_	
28-9	4438-4441	use	_	
28-10	4442-4449	history	_	
28-11	4450-4452	of	_	
28-12	4453-4456	the	_	
28-13	4457-4469	participants	_	
28-14	4469-4470	.	_	

#Text=Demographic and substance abuse characteristics.
29-1	4471-4482	Demographic	_	
29-2	4483-4486	and	_	
29-3	4487-4496	substance	_	
29-4	4497-4502	abuse	_	
29-5	4503-4518	characteristics	_	
29-6	4518-4519	.	_	

#Text=Descriptive statistics\t \tIWMUD\tNCs\t \tGender (male)\t36/36\t24/24\t \tAge\t30.55±6.43\t30.75±4.63\t \tEducation (years)\t14.36±2.79\t16.58±2.5\t \tDuration of MA abstinence (months)\t1–6\t-\t \tDuration of MA use disorder (years)\t8.35±4.07\t-\t \tMarital status (married)\t25/36\t7/24\t \tNumber of subjects with a history of opium use\t20/36\t0/24\t \tNumber of subjects with a history of alcohol use\t23/36\t0/24\t \tNumber of subjects with a history of heroin use\t5/36\t0/24\t \tNumber of subjects with a history of cigarette smoking\t35/36\t2/24\t \t
#Text=2.2 EEG data acquisition
#Text=We recorded five minutes of rEEG while the participants' eyes were open.
30-1	4521-4532	Descriptive	_	
30-2	4533-4543	statistics	_	
30-3	4546-4551	IWMUD	_	
30-4	4552-4555	NCs	_	
30-5	4558-4564	Gender	_	
30-6	4565-4566	(	_	
30-7	4566-4570	male	_	
30-8	4570-4571	)	_	
30-9	4572-4574	36	_	
30-10	4574-4575	/	_	
30-11	4575-4577	36	_	
30-12	4578-4580	24	_	
30-13	4580-4581	/	_	
30-14	4581-4583	24	_	
30-15	4586-4589	Age	_	
30-16	4590-4595	30.55	_	
30-17	4595-4596	±	_	
30-18	4596-4600	6.43	_	
30-19	4601-4606	30.75	_	
30-20	4606-4607	±	_	
30-21	4607-4611	4.63	_	
30-22	4614-4623	Education	_	
30-23	4624-4625	(	_	
30-24	4625-4630	years	_	
30-25	4630-4631	)	_	
30-26	4632-4637	14.36	_	
30-27	4637-4638	±	_	
30-28	4638-4642	2.79	_	
30-29	4643-4648	16.58	_	
30-30	4648-4649	±	_	
30-31	4649-4652	2.5	_	
30-32	4655-4663	Duration	_	
30-33	4664-4666	of	_	
30-34	4667-4669	MA	_	
30-35	4670-4680	abstinence	_	
30-36	4681-4682	(	_	
30-37	4682-4688	months	_	
30-38	4688-4689	)	_	
30-39	4690-4691	1	_	
30-40	4691-4692	–	_	
30-41	4692-4693	6	_	
30-42	4694-4695	-	_	
30-43	4698-4706	Duration	_	
30-44	4707-4709	of	_	
30-45	4710-4712	MA	_	
30-46	4713-4716	use	_	
30-47	4717-4725	disorder	_	
30-48	4726-4727	(	_	
30-49	4727-4732	years	_	
30-50	4732-4733	)	_	
30-51	4734-4738	8.35	_	
30-52	4738-4739	±	_	
30-53	4739-4743	4.07	_	
30-54	4744-4745	-	_	
30-55	4748-4755	Marital	_	
30-56	4756-4762	status	_	
30-57	4763-4764	(	_	
30-58	4764-4771	married	_	
30-59	4771-4772	)	_	
30-60	4773-4775	25	_	
30-61	4775-4776	/	_	
30-62	4776-4778	36	_	
30-63	4779-4780	7	_	
30-64	4780-4781	/	_	
30-65	4781-4783	24	_	
30-66	4786-4792	Number	_	
30-67	4793-4795	of	_	
30-68	4796-4804	subjects	_	
30-69	4805-4809	with	_	
30-70	4810-4811	a	_	
30-71	4812-4819	history	_	
30-72	4820-4822	of	_	
30-73	4823-4828	opium	_	
30-74	4829-4832	use	_	
30-75	4833-4835	20	_	
30-76	4835-4836	/	_	
30-77	4836-4838	36	_	
30-78	4839-4840	0	_	
30-79	4840-4841	/	_	
30-80	4841-4843	24	_	
30-81	4846-4852	Number	_	
30-82	4853-4855	of	_	
30-83	4856-4864	subjects	_	
30-84	4865-4869	with	_	
30-85	4870-4871	a	_	
30-86	4872-4879	history	_	
30-87	4880-4882	of	_	
30-88	4883-4890	alcohol	_	
30-89	4891-4894	use	_	
30-90	4895-4897	23	_	
30-91	4897-4898	/	_	
30-92	4898-4900	36	_	
30-93	4901-4902	0	_	
30-94	4902-4903	/	_	
30-95	4903-4905	24	_	
30-96	4908-4914	Number	_	
30-97	4915-4917	of	_	
30-98	4918-4926	subjects	_	
30-99	4927-4931	with	_	
30-100	4932-4933	a	_	
30-101	4934-4941	history	_	
30-102	4942-4944	of	_	
30-103	4945-4951	heroin	_	
30-104	4952-4955	use	_	
30-105	4956-4957	5	_	
30-106	4957-4958	/	_	
30-107	4958-4960	36	_	
30-108	4961-4962	0	_	
30-109	4962-4963	/	_	
30-110	4963-4965	24	_	
30-111	4968-4974	Number	_	
30-112	4975-4977	of	_	
30-113	4978-4986	subjects	_	
30-114	4987-4991	with	_	
30-115	4992-4993	a	_	
30-116	4994-5001	history	_	
30-117	5002-5004	of	_	
30-118	5005-5014	cigarette	_	
30-119	5015-5022	smoking	_	
30-120	5023-5025	35	_	
30-121	5025-5026	/	_	
30-122	5026-5028	36	_	
30-123	5029-5030	2	_	
30-124	5030-5031	/	_	
30-125	5031-5033	24	_	
30-126	5037-5040	2.2	_	
30-127	5041-5044	EEG	_	
30-128	5045-5049	data	_	
30-129	5050-5061	acquisition	_	
30-130	5062-5064	We	_	
30-131	5065-5073	recorded	_	
30-132	5074-5078	five	_	
30-133	5079-5086	minutes	_	
30-134	5087-5089	of	_	
30-135	5090-5094	rEEG	_	
30-136	5095-5100	while	_	
30-137	5101-5104	the	_	
30-138	5105-5117	participants	_	
30-139	5117-5118	'	_	
30-140	5119-5123	eyes	_	
30-141	5124-5128	were	_	
30-142	5129-5133	open	_	
30-143	5133-5134	.	_	

#Text=We instructed all individuals to pay attention to a black-background screen in front of them during the recording and attempt not to think about anything.
31-1	5135-5137	We	_	
31-2	5138-5148	instructed	_	
31-3	5149-5152	all	_	
31-4	5153-5164	individuals	_	
31-5	5165-5167	to	_	
31-6	5168-5171	pay	_	
31-7	5172-5181	attention	_	
31-8	5182-5184	to	_	
31-9	5185-5186	a	_	
31-10	5187-5203	black-background	_	
31-11	5204-5210	screen	_	
31-12	5211-5213	in	_	
31-13	5214-5219	front	_	
31-14	5220-5222	of	_	
31-15	5223-5227	them	_	
31-16	5228-5234	during	_	
31-17	5235-5238	the	_	
31-18	5239-5248	recording	_	
31-19	5249-5252	and	_	
31-20	5253-5260	attempt	_	
31-21	5261-5264	not	_	
31-22	5265-5267	to	_	
31-23	5268-5273	think	_	
31-24	5274-5279	about	_	
31-25	5280-5288	anything	_	
31-26	5288-5289	.	_	

#Text=All EEG data were recorded using a 62-channel g.tec (http://www.gtec.at/) EEG system (g.
32-1	5290-5293	All	_	
32-2	5294-5297	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
32-3	5298-5302	data	_	
32-4	5303-5307	were	_	
32-5	5308-5316	recorded	_	
32-6	5317-5322	using	_	
32-7	5323-5324	a	_	
32-8	5325-5327	62	_	
32-9	5327-5328	-	_	
32-10	5328-5335	channel	_	
32-11	5336-5341	g.tec	_	
32-12	5342-5343	(	_	
32-13	5343-5347	http	_	
32-14	5347-5348	:	_	
32-15	5348-5349	/	_	
32-16	5349-5350	/	_	
32-17	5350-5361	www.gtec.at	_	
32-18	5361-5362	/	_	
32-19	5362-5363	)	_	
32-20	5364-5367	EEG	_	
32-21	5368-5374	system	_	
32-22	5375-5376	(	_	
32-23	5376-5377	g	_	
32-24	5377-5378	.	_	

#Text=HIamp) in National Brain Mapping Laboratory (NBML) (https://nbml.ir/EN).
33-1	5379-5384	HIamp	_	
33-2	5384-5385	)	_	
33-3	5386-5388	in	_	
33-4	5389-5397	National	_	
33-5	5398-5403	Brain	_	
33-6	5404-5411	Mapping	_	
33-7	5412-5422	Laboratory	_	
33-8	5423-5424	(	_	
33-9	5424-5428	NBML	_	
33-10	5428-5429	)	_	
33-11	5430-5431	(	_	
33-12	5431-5436	https	_	
33-13	5436-5437	:	_	
33-14	5437-5438	/	_	
33-15	5438-5439	/	_	
33-16	5439-5446	nbml.ir	_	
33-17	5446-5447	/	_	
33-18	5447-5449	EN	_	
33-19	5449-5450	)	_	
33-20	5450-5451	.	_	

#Text=The reference channel was placed on right ear lobe for all individuals.
34-1	5452-5455	The	_	
34-2	5456-5465	reference	_	
34-3	5466-5473	channel	_	
34-4	5474-5477	was	_	
34-5	5478-5484	placed	_	
34-6	5485-5487	on	_	
34-7	5488-5493	right	_	
34-8	5494-5497	ear	_	
34-9	5498-5502	lobe	_	
34-10	5503-5506	for	_	
34-11	5507-5510	all	_	
34-12	5511-5522	individuals	_	
34-13	5522-5523	.	_	

#Text=The sampling frequency of 512 Hz was selected for EEG recording.
35-1	5524-5527	The	_	
35-2	5528-5536	sampling	_	
35-3	5537-5546	frequency	_	
35-4	5547-5549	of	_	
35-5	5550-5553	512	_	
35-6	5554-5556	Hz	_	
35-7	5557-5560	was	_	
35-8	5561-5569	selected	_	
35-9	5570-5573	for	_	
35-10	5574-5577	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
35-11	5578-5587	recording	_	
35-12	5587-5588	.	_	

#Text=All data were resampled to 200 Hz in preprocessing step to decrease the computational cost.
#Text=2.3 Data preprocessing
#Text=EEG data were preprocessed using EEGLAB and Fieldtrip toolboxes of MATLAB.
36-1	5589-5592	All	_	
36-2	5593-5597	data	_	
36-3	5598-5602	were	_	
36-4	5603-5612	resampled	_	
36-5	5613-5615	to	_	
36-6	5616-5619	200	_	
36-7	5620-5622	Hz	_	
36-8	5623-5625	in	_	
36-9	5626-5639	preprocessing	_	
36-10	5640-5644	step	_	
36-11	5645-5647	to	_	
36-12	5648-5656	decrease	_	
36-13	5657-5660	the	_	
36-14	5661-5674	computational	_	
36-15	5675-5679	cost	_	
36-16	5679-5680	.	_	
36-17	5681-5684	2.3	_	
36-18	5685-5689	Data	_	
36-19	5690-5703	preprocessing	_	
36-20	5704-5707	EEG	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence	
36-21	5708-5712	data	_	
36-22	5713-5717	were	_	
36-23	5718-5730	preprocessed	_	
36-24	5731-5736	using	_	
36-25	5737-5743	EEGLAB	_	
36-26	5744-5747	and	_	
36-27	5748-5757	Fieldtrip	_	
36-28	5758-5767	toolboxes	_	
36-29	5768-5770	of	_	
36-30	5771-5777	MATLAB	_	
36-31	5777-5778	.	_	

#Text=The datasets were filtered by a 0.1 Hz high-pass filter and a notch filter to remove the voltage drift and 50 Hz power line noise.
37-1	5779-5782	The	_	
37-2	5783-5791	datasets	_	
37-3	5792-5796	were	_	
37-4	5797-5805	filtered	_	
37-5	5806-5808	by	_	
37-6	5809-5810	a	_	
37-7	5811-5814	0.1	_	
37-8	5815-5817	Hz	_	
37-9	5818-5827	high-pass	_	
37-10	5828-5834	filter	_	
37-11	5835-5838	and	_	
37-12	5839-5840	a	_	
37-13	5841-5846	notch	_	
37-14	5847-5853	filter	_	
37-15	5854-5856	to	_	
37-16	5857-5863	remove	_	
37-17	5864-5867	the	_	
37-18	5868-5875	voltage	_	
37-19	5876-5881	drift	_	
37-20	5882-5885	and	_	
37-21	5886-5888	50	_	
37-22	5889-5891	Hz	_	
37-23	5892-5897	power	_	
37-24	5898-5902	line	_	
37-25	5903-5908	noise	_	
37-26	5908-5909	.	_	

#Text=The data were referenced to common average and artifact rejection was firstly performed by visual inspection.
38-1	5910-5913	The	_	
38-2	5914-5918	data	_	
38-3	5919-5923	were	_	
38-4	5924-5934	referenced	_	
38-5	5935-5937	to	_	
38-6	5938-5944	common	_	
38-7	5945-5952	average	_	
38-8	5953-5956	and	_	
38-9	5957-5965	artifact	_	
38-10	5966-5975	rejection	_	
38-11	5976-5979	was	_	
38-12	5980-5987	firstly	_	
38-13	5988-5997	performed	_	
38-14	5998-6000	by	_	
38-15	6001-6007	visual	_	
38-16	6008-6018	inspection	_	
38-17	6018-6019	.	_	

#Text=Independent component analysis was employed to remove artifactual components (e.g. eye blinks, eye movements, heartbeat, and muscle artifacts).
39-1	6020-6031	Independent	_	
39-2	6032-6041	component	_	
39-3	6042-6050	analysis	_	
39-4	6051-6054	was	_	
39-5	6055-6063	employed	_	
39-6	6064-6066	to	_	
39-7	6067-6073	remove	_	
39-8	6074-6085	artifactual	_	
39-9	6086-6096	components	_	
39-10	6097-6098	(	_	
39-11	6098-6101	e.g	_	
39-12	6101-6102	.	_	
39-13	6103-6106	eye	_	
39-14	6107-6113	blinks	_	
39-15	6113-6114	,	_	
39-16	6115-6118	eye	_	
39-17	6119-6128	movements	_	
39-18	6128-6129	,	_	
39-19	6130-6139	heartbeat	_	
39-20	6139-6140	,	_	
39-21	6141-6144	and	_	
39-22	6145-6151	muscle	_	
39-23	6152-6161	artifacts	_	
39-24	6161-6162	)	_	
39-25	6162-6163	.	_	

#Text=Then, with a moving window and a peak-to-peak threshold all parts, which exceeded ±100 μv were removed.
40-1	6164-6168	Then	_	
40-2	6168-6169	,	_	
40-3	6170-6174	with	_	
40-4	6175-6176	a	_	
40-5	6177-6183	moving	_	
40-6	6184-6190	window	_	
40-7	6191-6194	and	_	
40-8	6195-6196	a	_	
40-9	6197-6209	peak-to-peak	_	
40-10	6210-6219	threshold	_	
40-11	6220-6223	all	_	
40-12	6224-6229	parts	_	
40-13	6229-6230	,	_	
40-14	6231-6236	which	_	
40-15	6237-6245	exceeded	_	
40-16	6246-6247	±	_	
40-17	6247-6250	100	_	
40-18	6251-6253	μv	_	
40-19	6254-6258	were	_	
40-20	6259-6266	removed	_	
40-21	6266-6267	.	_	

#Text=The preprocessed data, containing the least amount of artifacts, was segmented into 5-second trials (24 trials, totally 120 sec) which were in the range of other resting-state EEG studies.
#Text=2.4.
41-1	6268-6271	The	_	
41-2	6272-6284	preprocessed	_	
41-3	6285-6289	data	_	
41-4	6289-6290	,	_	
41-5	6291-6301	containing	_	
41-6	6302-6305	the	_	
41-7	6306-6311	least	_	
41-8	6312-6318	amount	_	
41-9	6319-6321	of	_	
41-10	6322-6331	artifacts	_	
41-11	6331-6332	,	_	
41-12	6333-6336	was	_	
41-13	6337-6346	segmented	_	
41-14	6347-6351	into	_	
41-15	6352-6353	5	_	
41-16	6353-6354	-	_	
41-17	6354-6360	second	_	
41-18	6361-6367	trials	_	
41-19	6368-6369	(	_	
41-20	6369-6371	24	_	
41-21	6372-6378	trials	_	
41-22	6378-6379	,	_	
41-23	6380-6387	totally	_	
41-24	6388-6391	120	_	
41-25	6392-6395	sec	_	
41-26	6395-6396	)	_	
41-27	6397-6402	which	_	
41-28	6403-6407	were	_	
41-29	6408-6410	in	_	
41-30	6411-6414	the	_	
41-31	6415-6420	range	_	
41-32	6421-6423	of	_	
41-33	6424-6429	other	_	
41-34	6430-6443	resting-state	_	
41-35	6444-6447	EEG	_	
41-36	6448-6455	studies	_	
41-37	6455-6456	.	_	
41-38	6457-6460	2.4	_	
41-39	6460-6461	.	_	

#Text=Weighted phase lag index (WPLI) description
#Text=WPLI is the improved version of PLI connectivity index, proposed by Vinck et al..
42-1	6462-6470	Weighted	_	
42-2	6471-6476	phase	_	
42-3	6477-6480	lag	_	
42-4	6481-6486	index	_	
42-5	6487-6488	(	_	
42-6	6488-6492	WPLI	_	
42-7	6492-6493	)	_	
42-8	6494-6505	description	_	
42-9	6506-6510	WPLI	_	
42-10	6511-6513	is	_	
42-11	6514-6517	the	_	
42-12	6518-6526	improved	_	
42-13	6527-6534	version	_	
42-14	6535-6537	of	_	
42-15	6538-6541	PLI	_	
42-16	6542-6554	connectivity	_	
42-17	6555-6560	index	_	
42-18	6560-6561	,	_	
42-19	6562-6570	proposed	_	
42-20	6571-6573	by	_	
42-21	6574-6579	Vinck	_	
42-22	6580-6582	et	_	
42-23	6583-6585	al	_	
42-24	6585-6586	.	_	
42-25	6586-6587	.	_	

#Text=It is highly sensitive and powerful to properly detect phase interactions of spatially close signals and has shown robustness to volume conduction that outperforms PLI, coherence, and imaginary coherence (IC).
43-1	6588-6590	It	_	
43-2	6591-6593	is	_	
43-3	6594-6600	highly	_	
43-4	6601-6610	sensitive	_	
43-5	6611-6614	and	_	
43-6	6615-6623	powerful	_	
43-7	6624-6626	to	_	
43-8	6627-6635	properly	_	
43-9	6636-6642	detect	_	
43-10	6643-6648	phase	_	
43-11	6649-6661	interactions	_	
43-12	6662-6664	of	_	
43-13	6665-6674	spatially	_	
43-14	6675-6680	close	_	
43-15	6681-6688	signals	_	
43-16	6689-6692	and	_	
43-17	6693-6696	has	_	
43-18	6697-6702	shown	_	
43-19	6703-6713	robustness	_	
43-20	6714-6716	to	_	
43-21	6717-6723	volume	_	
43-22	6724-6734	conduction	_	
43-23	6735-6739	that	_	
43-24	6740-6751	outperforms	_	
43-25	6752-6755	PLI	_	
43-26	6755-6756	,	_	
43-27	6757-6766	coherence	_	
43-28	6766-6767	,	_	
43-29	6768-6771	and	_	
43-30	6772-6781	imaginary	_	
43-31	6782-6791	coherence	_	
43-32	6792-6793	(	_	
43-33	6793-6795	IC	_	
43-34	6795-6796	)	_	
43-35	6796-6797	.	_	

#Text=WPLI estimates the phase leads and lags between two interacted time-series as follows.
44-1	6798-6802	WPLI	_	
44-2	6803-6812	estimates	_	
44-3	6813-6816	the	_	
44-4	6817-6822	phase	_	
44-5	6823-6828	leads	_	
44-6	6829-6832	and	_	
44-7	6833-6837	lags	_	
44-8	6838-6845	between	_	
44-9	6846-6849	two	_	
44-10	6850-6860	interacted	_	
44-11	6861-6872	time-series	_	
44-12	6873-6875	as	_	
44-13	6876-6883	follows	_	
44-14	6883-6884	.	_	

#Text=Where Sxyt is the cross-spectrum of time-series x and y at time point t, and sgn is the sign function.
45-1	6886-6891	Where	_	
45-2	6892-6896	Sxyt	_	
45-3	6897-6899	is	_	
45-4	6900-6903	the	_	
45-5	6904-6918	cross-spectrum	_	
45-6	6919-6921	of	_	
45-7	6922-6933	time-series	_	
45-8	6934-6935	x	_	
45-9	6936-6939	and	_	
45-10	6940-6941	y	_	
45-11	6942-6944	at	_	
45-12	6945-6949	time	_	
45-13	6950-6955	point	_	
45-14	6956-6957	t	_	
45-15	6957-6958	,	_	
45-16	6959-6962	and	_	
45-17	6963-6966	sgn	_	
45-18	6967-6969	is	_	
45-19	6970-6973	the	_	
45-20	6974-6978	sign	_	
45-21	6979-6987	function	_	
45-22	6987-6988	.	_	

#Text=Function imag(.)returns only the imaginary component of the cross-spectrum.
46-1	6989-6997	Function	_	
46-2	6998-7002	imag	_	
46-3	7002-7003	(	_	
46-4	7003-7004	.	_	
46-5	7004-7005	)	_	
46-6	7005-7012	returns	_	
46-7	7013-7017	only	_	
46-8	7018-7021	the	_	
46-9	7022-7031	imaginary	_	
46-10	7032-7041	component	_	
46-11	7042-7044	of	_	
46-12	7045-7048	the	_	
46-13	7049-7063	cross-spectrum	_	
46-14	7063-7064	.	_	

#Text=WPLI weights the cross-spectrum according to the imaginary component’s magnitude.
47-1	7065-7069	WPLI	_	
47-2	7070-7077	weights	_	
47-3	7078-7081	the	_	
47-4	7082-7096	cross-spectrum	_	
47-5	7097-7106	according	_	
47-6	7107-7109	to	_	
47-7	7110-7113	the	_	
47-8	7114-7123	imaginary	_	
47-9	7124-7133	component	_	
47-10	7133-7134	’	_	
47-11	7134-7135	s	_	
47-12	7136-7145	magnitude	_	
47-13	7145-7146	.	_	

#Text=This allows it to limit the impact of small noise on “true “sign of cross-spectrum around the real axes.
#Text=2.5 Graph theory analysis
#Text=2.5.1.
48-1	7147-7151	This	_	
48-2	7152-7158	allows	_	
48-3	7159-7161	it	_	
48-4	7162-7164	to	_	
48-5	7165-7170	limit	_	
48-6	7171-7174	the	_	
48-7	7175-7181	impact	_	
48-8	7182-7184	of	_	
48-9	7185-7190	small	_	
48-10	7191-7196	noise	_	
48-11	7197-7199	on	_	
48-12	7200-7201	“	_	
48-13	7201-7205	true	_	
48-14	7206-7207	“	_	
48-15	7207-7211	sign	_	
48-16	7212-7214	of	_	
48-17	7215-7229	cross-spectrum	_	
48-18	7230-7236	around	_	
48-19	7237-7240	the	_	
48-20	7241-7245	real	_	
48-21	7246-7250	axes	_	
48-22	7250-7251	.	_	
48-23	7252-7255	2.5	_	
48-24	7256-7261	Graph	_	
48-25	7262-7268	theory	_	
48-26	7269-7277	analysis	_	
48-27	7278-7283	2.5.1	_	
48-28	7283-7284	.	_	

#Text=Network construction
#Text=After applying Laplacian filter to EEG data to reduce the volume conduction effect and spatially enhance the data quality, functional connectivity was computed in EEG-sensor space among pairwise electrodes.
49-1	7285-7292	Network	_	
49-2	7293-7305	construction	_	
49-3	7306-7311	After	_	
49-4	7312-7320	applying	_	
49-5	7321-7330	Laplacian	_	
49-6	7331-7337	filter	_	
49-7	7338-7340	to	_	
49-8	7341-7344	EEG	_	
49-9	7345-7349	data	_	
49-10	7350-7352	to	_	
49-11	7353-7359	reduce	_	
49-12	7360-7363	the	_	
49-13	7364-7370	volume	_	
49-14	7371-7381	conduction	_	
49-15	7382-7388	effect	_	
49-16	7389-7392	and	_	
49-17	7393-7402	spatially	_	
49-18	7403-7410	enhance	_	
49-19	7411-7414	the	_	
49-20	7415-7419	data	_	
49-21	7420-7427	quality	_	
49-22	7427-7428	,	_	
49-23	7429-7439	functional	_	
49-24	7440-7452	connectivity	_	
49-25	7453-7456	was	_	
49-26	7457-7465	computed	_	
49-27	7466-7468	in	_	
49-28	7469-7479	EEG-sensor	_	
49-29	7480-7485	space	_	
49-30	7486-7491	among	_	
49-31	7492-7500	pairwise	_	
49-32	7501-7511	electrodes	_	
49-33	7511-7512	.	_	

#Text=The connectivity values were calculated for five EEG frequency bands: delta (1–4 Hz), theta (4–8 Hz), alpha (8–15 Hz), beta (15–30 Hz), and gamma (30–45 Hz) according to previous addiction studies.
50-1	7513-7516	The	_	
50-2	7517-7529	connectivity	_	
50-3	7530-7536	values	_	
50-4	7537-7541	were	_	
50-5	7542-7552	calculated	_	
50-6	7553-7556	for	_	
50-7	7557-7561	five	_	
50-8	7562-7565	EEG	_	
50-9	7566-7575	frequency	_	
50-10	7576-7581	bands	_	
50-11	7581-7582	:	_	
50-12	7583-7588	delta	_	
50-13	7589-7590	(	_	
50-14	7590-7591	1	_	
50-15	7591-7592	–	_	
50-16	7592-7593	4	_	
50-17	7594-7596	Hz	_	
50-18	7596-7597	)	_	
50-19	7597-7598	,	_	
50-20	7599-7604	theta	_	
50-21	7605-7606	(	_	
50-22	7606-7607	4	_	
50-23	7607-7608	–	_	
50-24	7608-7609	8	_	
50-25	7610-7612	Hz	_	
50-26	7612-7613	)	_	
50-27	7613-7614	,	_	
50-28	7615-7620	alpha	_	
50-29	7621-7622	(	_	
50-30	7622-7623	8	_	
50-31	7623-7624	–	_	
50-32	7624-7626	15	_	
50-33	7627-7629	Hz	_	
50-34	7629-7630	)	_	
50-35	7630-7631	,	_	
50-36	7632-7636	beta	_	
50-37	7637-7638	(	_	
50-38	7638-7640	15	_	
50-39	7640-7641	–	_	
50-40	7641-7643	30	_	
50-41	7644-7646	Hz	_	
50-42	7646-7647	)	_	
50-43	7647-7648	,	_	
50-44	7649-7652	and	_	
50-45	7653-7658	gamma	_	
50-46	7659-7660	(	_	
50-47	7660-7662	30	_	
50-48	7662-7663	–	_	
50-49	7663-7665	45	_	
50-50	7666-7668	Hz	_	
50-51	7668-7669	)	_	
50-52	7670-7679	according	_	
50-53	7680-7682	to	_	
50-54	7683-7691	previous	_	
50-55	7692-7701	addiction	_	
50-56	7702-7709	studies	_	
50-57	7709-7710	.	_	

#Text=Accordingly, we obtained a functional network with 61 nodes in five bands (5×61×61 connectivity matrix) for each subject, where the nodes were considered the sensors and the link between them were acquired using the absolute value of the WPLI matrix.
#Text=2.5.2 Graph measures
#Text=2.5.2.1 Node strength (NS).
51-1	7711-7722	Accordingly	_	
51-2	7722-7723	,	_	
51-3	7724-7726	we	_	
51-4	7727-7735	obtained	_	
51-5	7736-7737	a	_	
51-6	7738-7748	functional	_	
51-7	7749-7756	network	_	
51-8	7757-7761	with	_	
51-9	7762-7764	61	_	
51-10	7765-7770	nodes	_	
51-11	7771-7773	in	_	
51-12	7774-7778	five	_	
51-13	7779-7784	bands	_	
51-14	7785-7786	(	_	
51-15	7786-7787	5	_	
51-16	7787-7788	×	_	
51-17	7788-7790	61	_	
51-18	7790-7791	×	_	
51-19	7791-7793	61	_	
51-20	7794-7806	connectivity	_	
51-21	7807-7813	matrix	_	
51-22	7813-7814	)	_	
51-23	7815-7818	for	_	
51-24	7819-7823	each	_	
51-25	7824-7831	subject	_	
51-26	7831-7832	,	_	
51-27	7833-7838	where	_	
51-28	7839-7842	the	_	
51-29	7843-7848	nodes	_	
51-30	7849-7853	were	_	
51-31	7854-7864	considered	_	
51-32	7865-7868	the	_	
51-33	7869-7876	sensors	_	
51-34	7877-7880	and	_	
51-35	7881-7884	the	_	
51-36	7885-7889	link	_	
51-37	7890-7897	between	_	
51-38	7898-7902	them	_	
51-39	7903-7907	were	_	
51-40	7908-7916	acquired	_	
51-41	7917-7922	using	_	
51-42	7923-7926	the	_	
51-43	7927-7935	absolute	_	
51-44	7936-7941	value	_	
51-45	7942-7944	of	_	
51-46	7945-7948	the	_	
51-47	7949-7953	WPLI	_	
51-48	7954-7960	matrix	_	
51-49	7960-7961	.	_	
51-50	7962-7967	2.5.2	_	
51-51	7968-7973	Graph	_	
51-52	7974-7982	measures	_	
51-53	7983-7990	2.5.2.1	_	
51-54	7991-7995	Node	_	
51-55	7996-8004	strength	_	
51-56	8005-8006	(	_	
51-57	8006-8008	NS	_	
51-58	8008-8009	)	_	
51-59	8009-8010	.	_	

#Text=It is sum of the weights of links or edges connected to a node.
52-1	8011-8013	It	_	
52-2	8014-8016	is	_	
52-3	8017-8020	sum	_	
52-4	8021-8023	of	_	
52-5	8024-8027	the	_	
52-6	8028-8035	weights	_	
52-7	8036-8038	of	_	
52-8	8039-8044	links	_	
52-9	8045-8047	or	_	
52-10	8048-8053	edges	_	
52-11	8054-8063	connected	_	
52-12	8064-8066	to	_	
52-13	8067-8068	a	_	
52-14	8069-8073	node	_	
52-15	8073-8074	.	_	

#Text=Where N is the set of all nodes in the network and the links (i,j) are related by connection weight wij.
#Text=2.5.2.2 Characteristic path length (CP).
53-1	8075-8080	Where	_	
53-2	8081-8082	N	_	
53-3	8083-8085	is	_	
53-4	8086-8089	the	_	
53-5	8090-8093	set	_	
53-6	8094-8096	of	_	
53-7	8097-8100	all	_	
53-8	8101-8106	nodes	_	
53-9	8107-8109	in	_	
53-10	8110-8113	the	_	
53-11	8114-8121	network	_	
53-12	8122-8125	and	_	
53-13	8126-8129	the	_	
53-14	8130-8135	links	_	
53-15	8136-8137	(	_	
53-16	8137-8138	i	_	
53-17	8138-8139	,	_	
53-18	8139-8140	j	_	
53-19	8140-8141	)	_	
53-20	8142-8145	are	_	
53-21	8146-8153	related	_	
53-22	8154-8156	by	_	
53-23	8157-8167	connection	_	
53-24	8168-8174	weight	_	
53-25	8175-8178	wij	_	
53-26	8178-8179	.	_	
53-27	8180-8187	2.5.2.2	_	
53-28	8188-8202	Characteristic	_	
53-29	8203-8207	path	_	
53-30	8208-8214	length	_	
53-31	8215-8216	(	_	
53-32	8216-8218	CP	_	
53-33	8218-8219	)	_	
53-34	8219-8220	.	_	

#Text=Shortest weighted path length between two nodes i and j is determined by  where f is a map (e.g. an inverse) from weight to length and  indicates the shortest weighted path between nodes i and j.
54-1	8221-8229	Shortest	_	
54-2	8230-8238	weighted	_	
54-3	8239-8243	path	_	
54-4	8244-8250	length	_	
54-5	8251-8258	between	_	
54-6	8259-8262	two	_	
54-7	8263-8268	nodes	_	
54-8	8269-8270	i	_	
54-9	8271-8274	and	_	
54-10	8275-8276	j	_	
54-11	8277-8279	is	_	
54-12	8280-8290	determined	_	
54-13	8291-8293	by	_	
54-14	8295-8300	where	_	
54-15	8301-8302	f	_	
54-16	8303-8305	is	_	
54-17	8306-8307	a	_	
54-18	8308-8311	map	_	
54-19	8312-8313	(	_	
54-20	8313-8316	e.g	_	
54-21	8316-8317	.	_	
54-22	8318-8320	an	_	
54-23	8321-8328	inverse	_	
54-24	8328-8329	)	_	
54-25	8330-8334	from	_	
54-26	8335-8341	weight	_	
54-27	8342-8344	to	_	
54-28	8345-8351	length	_	
54-29	8352-8355	and	_	
54-30	8357-8366	indicates	_	
54-31	8367-8370	the	_	
54-32	8371-8379	shortest	_	
54-33	8380-8388	weighted	_	
54-34	8389-8393	path	_	
54-35	8394-8401	between	_	
54-36	8402-8407	nodes	_	
54-37	8408-8409	i	_	
54-38	8410-8413	and	_	
54-39	8414-8415	j	_	
54-40	8415-8416	.	_	

#Text=The averaged shortest path length between all the node pairs in a network is known as the characteristic path length:  where n shows the number of nodes.
#Text=2.5.2.3 Clustering coefficient (CC).
55-1	8417-8420	The	_	
55-2	8421-8429	averaged	_	
55-3	8430-8438	shortest	_	
55-4	8439-8443	path	_	
55-5	8444-8450	length	_	
55-6	8451-8458	between	_	
55-7	8459-8462	all	_	
55-8	8463-8466	the	_	
55-9	8467-8471	node	_	
55-10	8472-8477	pairs	_	
55-11	8478-8480	in	_	
55-12	8481-8482	a	_	
55-13	8483-8490	network	_	
55-14	8491-8493	is	_	
55-15	8494-8499	known	_	
55-16	8500-8502	as	_	
55-17	8503-8506	the	_	
55-18	8507-8521	characteristic	_	
55-19	8522-8526	path	_	
55-20	8527-8533	length	_	
55-21	8533-8534	:	_	
55-22	8536-8541	where	_	
55-23	8542-8543	n	_	
55-24	8544-8549	shows	_	
55-25	8550-8553	the	_	
55-26	8554-8560	number	_	
55-27	8561-8563	of	_	
55-28	8564-8569	nodes	_	
55-29	8569-8570	.	_	
55-30	8571-8578	2.5.2.3	_	
55-31	8579-8589	Clustering	_	
55-32	8590-8601	coefficient	_	
55-33	8602-8603	(	_	
55-34	8603-8605	CC	_	
55-35	8605-8606	)	_	
55-36	8606-8607	.	_	

#Text=The number of weighted triangles around a node i is defined as a basis for measuring segregation: 
#Text=Clustering coefficient reflects the degree that the connected nodes in a graph tend to form clusters and can illustrate the degree of local connectivity in the network.
56-1	8608-8611	The	_	
56-2	8612-8618	number	_	
56-3	8619-8621	of	_	
56-4	8622-8630	weighted	_	
56-5	8631-8640	triangles	_	
56-6	8641-8647	around	_	
56-7	8648-8649	a	_	
56-8	8650-8654	node	_	
56-9	8655-8656	i	_	
56-10	8657-8659	is	_	
56-11	8660-8667	defined	_	
56-12	8668-8670	as	_	
56-13	8671-8672	a	_	
56-14	8673-8678	basis	_	
56-15	8679-8682	for	_	
56-16	8683-8692	measuring	_	
56-17	8693-8704	segregation	_	
56-18	8704-8705	:	_	
56-19	8707-8717	Clustering	_	
56-20	8718-8729	coefficient	_	
56-21	8730-8738	reflects	_	
56-22	8739-8742	the	_	
56-23	8743-8749	degree	_	
56-24	8750-8754	that	_	
56-25	8755-8758	the	_	
56-26	8759-8768	connected	_	
56-27	8769-8774	nodes	_	
56-28	8775-8777	in	_	
56-29	8778-8779	a	_	
56-30	8780-8785	graph	_	
56-31	8786-8790	tend	_	
56-32	8791-8793	to	_	
56-33	8794-8798	form	_	
56-34	8799-8807	clusters	_	
56-35	8808-8811	and	_	
56-36	8812-8815	can	_	
56-37	8816-8826	illustrate	_	
56-38	8827-8830	the	_	
56-39	8831-8837	degree	_	
56-40	8838-8840	of	_	
56-41	8841-8846	local	_	
56-42	8847-8859	connectivity	_	
56-43	8860-8862	in	_	
56-44	8863-8866	the	_	
56-45	8867-8874	network	_	
56-46	8874-8875	.	_	

#Text=The clustering coefficient of the network is described by: 
#Text=Characteristic path length measures the integration of the network, while the clustering coefficient is a measure for the network functional segregation.
57-1	8876-8879	The	_	
57-2	8880-8890	clustering	_	
57-3	8891-8902	coefficient	_	
57-4	8903-8905	of	_	
57-5	8906-8909	the	_	
57-6	8910-8917	network	_	
57-7	8918-8920	is	_	
57-8	8921-8930	described	_	
57-9	8931-8933	by	_	
57-10	8933-8934	:	_	
57-11	8936-8950	Characteristic	_	
57-12	8951-8955	path	_	
57-13	8956-8962	length	_	
57-14	8963-8971	measures	_	
57-15	8972-8975	the	_	
57-16	8976-8987	integration	_	
57-17	8988-8990	of	_	
57-18	8991-8994	the	_	
57-19	8995-9002	network	_	
57-20	9002-9003	,	_	
57-21	9004-9009	while	_	
57-22	9010-9013	the	_	
57-23	9014-9024	clustering	_	
57-24	9025-9036	coefficient	_	
57-25	9037-9039	is	_	
57-26	9040-9041	a	_	
57-27	9042-9049	measure	_	
57-28	9050-9053	for	_	
57-29	9054-9057	the	_	
57-30	9058-9065	network	_	
57-31	9066-9076	functional	_	
57-32	9077-9088	segregation	_	
57-33	9088-9089	.	_	

#Text=Next to C and L, by following previous studies, the small-world index (SWI = CCw/CPw) was obtained for each individual.
58-1	9090-9094	Next	_	
58-2	9095-9097	to	_	
58-3	9098-9099	C	_	
58-4	9100-9103	and	_	
58-5	9104-9105	L	_	
58-6	9105-9106	,	_	
58-7	9107-9109	by	_	
58-8	9110-9119	following	_	
58-9	9120-9128	previous	_	
58-10	9129-9136	studies	_	
58-11	9136-9137	,	_	
58-12	9138-9141	the	_	
58-13	9142-9153	small-world	_	
58-14	9154-9159	index	_	
58-15	9160-9161	(	_	
58-16	9161-9164	SWI	_	
58-17	9165-9166	=	_	
58-18	9167-9170	CCw	_	
58-19	9170-9171	/	_	
58-20	9171-9174	CPw	_	
58-21	9174-9175	)	_	
58-22	9176-9179	was	_	
58-23	9180-9188	obtained	_	
58-24	9189-9192	for	_	
58-25	9193-9197	each	_	
58-26	9198-9208	individual	_	
58-27	9208-9209	.	_	

#Text=The larger the SWI value is, the more small-world the network is.
59-1	9210-9213	The	_	
59-2	9214-9220	larger	_	
59-3	9221-9224	the	_	
59-4	9225-9228	SWI	_	
59-5	9229-9234	value	_	
59-6	9235-9237	is	_	
59-7	9237-9238	,	_	
59-8	9239-9242	the	_	
59-9	9243-9247	more	_	
59-10	9248-9259	small-world	_	
59-11	9260-9263	the	_	
59-12	9264-9271	network	_	
59-13	9272-9274	is	_	
59-14	9274-9275	.	_	

#Text=The small world organizations have simultaneously notably segregated and integrated topologies.
#Text=2.5.3 Hub identification
#Text=Hubs refer to highly linked nodes in the network.
60-1	9276-9279	The	_	
60-2	9280-9285	small	_	
60-3	9286-9291	world	_	
60-4	9292-9305	organizations	_	
60-5	9306-9310	have	_	
60-6	9311-9325	simultaneously	_	
60-7	9326-9333	notably	_	
60-8	9334-9344	segregated	_	
60-9	9345-9348	and	_	
60-10	9349-9359	integrated	_	
60-11	9360-9370	topologies	_	
60-12	9370-9371	.	_	
60-13	9372-9377	2.5.3	_	
60-14	9378-9381	Hub	_	
60-15	9382-9396	identification	_	
60-16	9397-9401	Hubs	_	
60-17	9402-9407	refer	_	
60-18	9408-9410	to	_	
60-19	9411-9417	highly	_	
60-20	9418-9424	linked	_	
60-21	9425-9430	nodes	_	
60-22	9431-9433	in	_	
60-23	9434-9437	the	_	
60-24	9438-9445	network	_	
60-25	9445-9446	.	_	

#Text=Following the method used in previous studies we used the node strength, betweenness centrality and eigenvector centrality to identify hubs using BCT toolbox.
61-1	9447-9456	Following	_	
61-2	9457-9460	the	_	
61-3	9461-9467	method	_	
61-4	9468-9472	used	_	
61-5	9473-9475	in	_	
61-6	9476-9484	previous	_	
61-7	9485-9492	studies	_	
61-8	9493-9495	we	_	
61-9	9496-9500	used	_	
61-10	9501-9504	the	_	
61-11	9505-9509	node	_	
61-12	9510-9518	strength	_	
61-13	9518-9519	,	_	
61-14	9520-9531	betweenness	_	
61-15	9532-9542	centrality	_	
61-16	9543-9546	and	_	
61-17	9547-9558	eigenvector	_	
61-18	9559-9569	centrality	_	
61-19	9570-9572	to	_	
61-20	9573-9581	identify	_	
61-21	9582-9586	hubs	_	
61-22	9587-9592	using	_	
61-23	9593-9596	BCT	_	
61-24	9597-9604	toolbox	_	
61-25	9604-9605	.	_	

#Text=Nodes in each of the mentioned measures that exceed one standard deviation from the mean value of the measure were considered as hubs.
62-1	9606-9611	Nodes	_	
62-2	9612-9614	in	_	
62-3	9615-9619	each	_	
62-4	9620-9622	of	_	
62-5	9623-9626	the	_	
62-6	9627-9636	mentioned	_	
62-7	9637-9645	measures	_	
62-8	9646-9650	that	_	
62-9	9651-9657	exceed	_	
62-10	9658-9661	one	_	
62-11	9662-9670	standard	_	
62-12	9671-9680	deviation	_	
62-13	9681-9685	from	_	
62-14	9686-9689	the	_	
62-15	9690-9694	mean	_	
62-16	9695-9700	value	_	
62-17	9701-9703	of	_	
62-18	9704-9707	the	_	
62-19	9708-9715	measure	_	
62-20	9716-9720	were	_	
62-21	9721-9731	considered	_	
62-22	9732-9734	as	_	
62-23	9735-9739	hubs	_	
62-24	9739-9740	.	_	

#Text=Once the hubs were identified using the different techniques, those hubs that were commonly obtained by the different techniques were compared between MA abusers and controls.
#Text=2.6.
63-1	9741-9745	Once	_	
63-2	9746-9749	the	_	
63-3	9750-9754	hubs	_	
63-4	9755-9759	were	_	
63-5	9760-9770	identified	_	
63-6	9771-9776	using	_	
63-7	9777-9780	the	_	
63-8	9781-9790	different	_	
63-9	9791-9801	techniques	_	
63-10	9801-9802	,	_	
63-11	9803-9808	those	_	
63-12	9809-9813	hubs	_	
63-13	9814-9818	that	_	
63-14	9819-9823	were	_	
63-15	9824-9832	commonly	_	
63-16	9833-9841	obtained	_	
63-17	9842-9844	by	_	
63-18	9845-9848	the	_	
63-19	9849-9858	different	_	
63-20	9859-9869	techniques	_	
63-21	9870-9874	were	_	
63-22	9875-9883	compared	_	
63-23	9884-9891	between	_	
63-24	9892-9894	MA	_	
63-25	9895-9902	abusers	_	
63-26	9903-9906	and	_	
63-27	9907-9915	controls	_	
63-28	9915-9916	.	_	
63-29	9917-9920	2.6	_	
63-30	9920-9921	.	_	

#Text=Source reconstruction
#Text=Standardized low-resolution brain electromagnetic tomography (sLORETA) was used to estimate the intracerebral electrical sources, using FieldTrip. sLORETA computes neuronal activity in current density (A/m2) without assuming a predefined number of active sources.
64-1	9922-9928	Source	_	
64-2	9929-9943	reconstruction	_	
64-3	9944-9956	Standardized	_	
64-4	9957-9971	low-resolution	_	
64-5	9972-9977	brain	_	
64-6	9978-9993	electromagnetic	_	
64-7	9994-10004	tomography	_	
64-8	10005-10006	(	_	
64-9	10006-10013	sLORETA	_	
64-10	10013-10014	)	_	
64-11	10015-10018	was	_	
64-12	10019-10023	used	_	
64-13	10024-10026	to	_	
64-14	10027-10035	estimate	_	
64-15	10036-10039	the	_	
64-16	10040-10053	intracerebral	_	
64-17	10054-10064	electrical	_	
64-18	10065-10072	sources	_	
64-19	10072-10073	,	_	
64-20	10074-10079	using	_	
64-21	10080-10089	FieldTrip	_	
64-22	10089-10090	.	_	
64-23	10091-10098	sLORETA	_	
64-24	10099-10107	computes	_	
64-25	10108-10116	neuronal	_	
64-26	10117-10125	activity	_	
64-27	10126-10128	in	_	
64-28	10129-10136	current	_	
64-29	10137-10144	density	_	
64-30	10145-10146	(	_	
64-31	10146-10147	A	_	
64-32	10147-10148	/	_	
64-33	10148-10150	m2	_	
64-34	10150-10151	)	_	
64-35	10152-10159	without	_	
64-36	10160-10168	assuming	_	
64-37	10169-10170	a	_	
64-38	10171-10181	predefined	_	
64-39	10182-10188	number	_	
64-40	10189-10191	of	_	
64-41	10192-10198	active	_	
64-42	10199-10206	sources	_	
64-43	10206-10207	.	_	

#Text=We first acquired a lead field (forward model) by creating a FEM volume conduction model of the head.
65-1	10208-10210	We	_	
65-2	10211-10216	first	_	
65-3	10217-10225	acquired	_	
65-4	10226-10227	a	_	
65-5	10228-10232	lead	_	
65-6	10233-10238	field	_	
65-7	10239-10240	(	_	
65-8	10240-10247	forward	_	
65-9	10248-10253	model	_	
65-10	10253-10254	)	_	
65-11	10255-10257	by	_	
65-12	10258-10266	creating	_	
65-13	10267-10268	a	_	
65-14	10269-10272	FEM	_	
65-15	10273-10279	volume	_	
65-16	10280-10290	conduction	_	
65-17	10291-10296	model	_	
65-18	10297-10299	of	_	
65-19	10300-10303	the	_	
65-20	10304-10308	head	_	
65-21	10308-10309	.	_	

#Text=To do this, we used 61 electrodes, a grid with 3 mm3 resolution, and voxels of the anatomical MRI (colin27 brain), segmented (i.e. separated) into the five different tissue types: scalp, skull, CSF (Cerebro-Spinal Fluid), gray and white matter.
66-1	10310-10312	To	_	
66-2	10313-10315	do	_	
66-3	10316-10320	this	_	
66-4	10320-10321	,	_	
66-5	10322-10324	we	_	
66-6	10325-10329	used	_	
66-7	10330-10332	61	_	
66-8	10333-10343	electrodes	_	
66-9	10343-10344	,	_	
66-10	10345-10346	a	_	
66-11	10347-10351	grid	_	
66-12	10352-10356	with	_	
66-13	10357-10358	3	_	
66-14	10359-10362	mm3	_	
66-15	10363-10373	resolution	_	
66-16	10373-10374	,	_	
66-17	10375-10378	and	_	
66-18	10379-10385	voxels	_	
66-19	10386-10388	of	_	
66-20	10389-10392	the	_	
66-21	10393-10403	anatomical	_	
66-22	10404-10407	MRI	_	
66-23	10408-10409	(	_	
66-24	10409-10416	colin27	_	
66-25	10417-10422	brain	_	
66-26	10422-10423	)	_	
66-27	10423-10424	,	_	
66-28	10425-10434	segmented	_	
66-29	10435-10436	(	_	
66-30	10436-10439	i.e	_	
66-31	10439-10440	.	_	
66-32	10441-10450	separated	_	
66-33	10450-10451	)	_	
66-34	10452-10456	into	_	
66-35	10457-10460	the	_	
66-36	10461-10465	five	_	
66-37	10466-10475	different	_	
66-38	10476-10482	tissue	_	
66-39	10483-10488	types	_	
66-40	10488-10489	:	_	
66-41	10490-10495	scalp	_	
66-42	10495-10496	,	_	
66-43	10497-10502	skull	_	
66-44	10502-10503	,	_	
66-45	10504-10507	CSF	_	
66-46	10508-10509	(	_	
66-47	10509-10523	Cerebro-Spinal	_	
66-48	10524-10529	Fluid	_	
66-49	10529-10530	)	_	
66-50	10530-10531	,	_	
66-51	10532-10536	gray	_	
66-52	10537-10540	and	_	
66-53	10541-10546	white	_	
66-54	10547-10553	matter	_	
66-55	10553-10554	.	_	

#Text=We used sLORETA to reconstruct neuronal activities in source points in the gray matter (cortical regions).
67-1	10555-10557	We	_	
67-2	10558-10562	used	_	
67-3	10563-10570	sLORETA	_	
67-4	10571-10573	to	_	
67-5	10574-10585	reconstruct	_	
67-6	10586-10594	neuronal	_	
67-7	10595-10605	activities	_	
67-8	10606-10608	in	_	
67-9	10609-10615	source	_	
67-10	10616-10622	points	_	
67-11	10623-10625	in	_	
67-12	10626-10629	the	_	
67-13	10630-10634	gray	_	
67-14	10635-10641	matter	_	
67-15	10642-10643	(	_	
67-16	10643-10651	cortical	_	
67-17	10652-10659	regions	_	
67-18	10659-10660	)	_	
67-19	10660-10661	.	_	

#Text=To parcellate the brain into 90 (45 in each hemisphere) regions of interest (ROIs), automated anatomical labeling (AAL) atlas were applied.
68-1	10662-10664	To	_	
68-2	10665-10675	parcellate	_	
68-3	10676-10679	the	_	
68-4	10680-10685	brain	_	
68-5	10686-10690	into	_	
68-6	10691-10693	90	_	
68-7	10694-10695	(	_	
68-8	10695-10697	45	_	
68-9	10698-10700	in	_	
68-10	10701-10705	each	_	
68-11	10706-10716	hemisphere	_	
68-12	10716-10717	)	_	
68-13	10718-10725	regions	_	
68-14	10726-10728	of	_	
68-15	10729-10737	interest	_	
68-16	10738-10739	(	_	
68-17	10739-10743	ROIs	_	
68-18	10743-10744	)	_	
68-19	10744-10745	,	_	
68-20	10746-10755	automated	_	
68-21	10756-10766	anatomical	_	
68-22	10767-10775	labeling	_	
68-23	10776-10777	(	_	
68-24	10777-10780	AAL	_	
68-25	10780-10781	)	_	
68-26	10782-10787	atlas	_	
68-27	10788-10792	were	_	
68-28	10793-10800	applied	_	
68-29	10800-10801	.	_	

#Text=Table 2 lists the name of the ROIs and their corresponding abbreviations.
69-1	10802-10807	Table	_	
69-2	10808-10809	2	_	
69-3	10810-10815	lists	_	
69-4	10816-10819	the	_	
69-5	10820-10824	name	_	
69-6	10825-10827	of	_	
69-7	10828-10831	the	_	
69-8	10832-10836	ROIs	_	
69-9	10837-10840	and	_	
69-10	10841-10846	their	_	
69-11	10847-10860	corresponding	_	
69-12	10861-10874	abbreviations	_	
69-13	10874-10875	.	_	

#Text=The single nearest voxel to central voxel has been considered as the great representation of each ROI by following previous studies.
70-1	10876-10879	The	_	
70-2	10880-10886	single	_	
70-3	10887-10894	nearest	_	
70-4	10895-10900	voxel	_	
70-5	10901-10903	to	_	
70-6	10904-10911	central	_	
70-7	10912-10917	voxel	_	
70-8	10918-10921	has	_	
70-9	10922-10926	been	_	
70-10	10927-10937	considered	_	
70-11	10938-10940	as	_	
70-12	10941-10944	the	_	
70-13	10945-10950	great	_	
70-14	10951-10965	representation	_	
70-15	10966-10968	of	_	
70-16	10969-10973	each	_	
70-17	10974-10977	ROI	_	
70-18	10978-10980	by	_	
70-19	10981-10990	following	_	
70-20	10991-10999	previous	_	
70-21	11000-11007	studies	_	
70-22	11007-11008	.	_	

#Text=Accordingly, we obtained a functional network with 90 nodes in the five frequency bands (5×90×90 connectivity matrix) for each subject, where the nodes are equivalent to the central points of ROIs of AAL template and the link between them are the absolute value of the WPLI matrix.
71-1	11009-11020	Accordingly	_	
71-2	11020-11021	,	_	
71-3	11022-11024	we	_	
71-4	11025-11033	obtained	_	
71-5	11034-11035	a	_	
71-6	11036-11046	functional	_	
71-7	11047-11054	network	_	
71-8	11055-11059	with	_	
71-9	11060-11062	90	_	
71-10	11063-11068	nodes	_	
71-11	11069-11071	in	_	
71-12	11072-11075	the	_	
71-13	11076-11080	five	_	
71-14	11081-11090	frequency	_	
71-15	11091-11096	bands	_	
71-16	11097-11098	(	_	
71-17	11098-11099	5	_	
71-18	11099-11100	×	_	
71-19	11100-11102	90	_	
71-20	11102-11103	×	_	
71-21	11103-11105	90	_	
71-22	11106-11118	connectivity	_	
71-23	11119-11125	matrix	_	
71-24	11125-11126	)	_	
71-25	11127-11130	for	_	
71-26	11131-11135	each	_	
71-27	11136-11143	subject	_	
71-28	11143-11144	,	_	
71-29	11145-11150	where	_	
71-30	11151-11154	the	_	
71-31	11155-11160	nodes	_	
71-32	11161-11164	are	_	
71-33	11165-11175	equivalent	_	
71-34	11176-11178	to	_	
71-35	11179-11182	the	_	
71-36	11183-11190	central	_	
71-37	11191-11197	points	_	
71-38	11198-11200	of	_	
71-39	11201-11205	ROIs	_	
71-40	11206-11208	of	_	
71-41	11209-11212	AAL	_	
71-42	11213-11221	template	_	
71-43	11222-11225	and	_	
71-44	11226-11229	the	_	
71-45	11230-11234	link	_	
71-46	11235-11242	between	_	
71-47	11243-11247	them	_	
71-48	11248-11251	are	_	
71-49	11252-11255	the	_	
71-50	11256-11264	absolute	_	
71-51	11265-11270	value	_	
71-52	11271-11273	of	_	
71-53	11274-11277	the	_	
71-54	11278-11282	WPLI	_	
71-55	11283-11289	matrix	_	
71-56	11289-11290	.	_	

#Text=MNI coordinates of the selected central voxels are brought in S1 Table.
72-1	11291-11294	MNI	_	
72-2	11295-11306	coordinates	_	
72-3	11307-11309	of	_	
72-4	11310-11313	the	_	
72-5	11314-11322	selected	_	
72-6	11323-11330	central	_	
72-7	11331-11337	voxels	_	
72-8	11338-11341	are	_	
72-9	11342-11349	brought	_	
72-10	11350-11352	in	_	
72-11	11353-11355	S1	_	
72-12	11356-11361	Table	_	
72-13	11361-11362	.	_	

#Text=The names and the corresponding abbreviations of the ROIs specified in the AAL brain template (45 regions for each hemisphere) described by Tzourio-Mazoyer et al..
73-1	11363-11366	The	_	
73-2	11367-11372	names	_	
73-3	11373-11376	and	_	
73-4	11377-11380	the	_	
73-5	11381-11394	corresponding	_	
73-6	11395-11408	abbreviations	_	
73-7	11409-11411	of	_	
73-8	11412-11415	the	_	
73-9	11416-11420	ROIs	_	
73-10	11421-11430	specified	_	
73-11	11431-11433	in	_	
73-12	11434-11437	the	_	
73-13	11438-11441	AAL	_	
73-14	11442-11447	brain	_	
73-15	11448-11456	template	_	
73-16	11457-11458	(	_	
73-17	11458-11460	45	_	
73-18	11461-11468	regions	_	
73-19	11469-11472	for	_	
73-20	11473-11477	each	_	
73-21	11478-11488	hemisphere	_	
73-22	11488-11489	)	_	
73-23	11490-11499	described	_	
73-24	11500-11502	by	_	
73-25	11503-11518	Tzourio-Mazoyer	_	
73-26	11519-11521	et	_	
73-27	11522-11524	al	_	
73-28	11524-11525	.	_	
73-29	11525-11526	.	_	

#Text=Regions\tAbb.
74-1	11527-11534	Regions	_	
74-2	11535-11538	Abb	_	
74-3	11538-11539	.	_	

#Text=Regions\tAbb.
75-1	11540-11547	Regions	_	
75-2	11548-11551	Abb	_	
75-3	11551-11552	.	_	

#Text=Precentral gyrus\tPreCG\tLingual gyrus\tLING\t \tSuperior frontal gyrus (dorsal)\tSFGdor\tSuperior Occipital gyrus\tSOG\t \tOrbitofrontal cortex (superior)\tORBsup\tMiddle occipital gyrus\tMOG\t \tMiddle frontal gyrus\tMFG\tInferior occipital gyrus\tIOG\t \tOrbitofrontal cortex (middle)\tORBmid\tFusiform gyrus\tFFG\t \tInferior frontal gyrus (opercular)\tIFGoperc\tPostcentral gyrus\tPoCG\t \tInferior frontal gyrus (triangular)\tIFGtriang\tSuperior parietal gyrus\tSPG\t \tOrbitofrontal cortex (inferior)\tORBinf\tInferior parietal lobule\tIPL\t \tRolandic operculum\tROL\tSupramarginal gyrus\tSMG\t \tSupplementary motor area\tSMA\tAngular gyrus\tANG\t \tOlfactory\tOLF\tPrecuneus\tPCUN\t \tSuperior frontal gyrus (medial)\tSFGmed\tParacentral lobule\tPCL\t \tOrbitofrontal cortex (medial)\tORBmed\tCaudate\tCAU\t \tRectus gyrus\tREC\tPutamen\tPUT\t \tInsula\tINS\tPallidum\tPAL\t \tAnterior cingulate gyrus\tACG\tThalamus\tTHA\t \tMiddle cingulate gyrus\tDCG\tHeschl gyrus\tHES\t \tPosterior cingulate gyrus\tPCG\tSuperior temporal gyrus\tSTG\t \tHippocampus\tHIP\tTemporal pole (superior)\tTPOsup\t \tParahippocampal gyrus\tPHG\tMiddle temporal gyrus\tMTG\t \tAmygdala\tAMYG\tTemporal pole (middle)\tTPOmid\t \tCalcarine cortex\tCAL\tInferior temporal gyrus\tITG\t \tCuneus\tCUN\t\t\t \t
#Text=3.Statistical analysis
#Text=We used the most relevant study carried out by Ahmadlou et al. to obtain the effect size for most important variable.
76-1	11555-11565	Precentral	_	
76-2	11566-11571	gyrus	_	
76-3	11572-11577	PreCG	_	
76-4	11578-11585	Lingual	_	
76-5	11586-11591	gyrus	_	
76-6	11592-11596	LING	_	
76-7	11599-11607	Superior	_	
76-8	11608-11615	frontal	_	
76-9	11616-11621	gyrus	_	
76-10	11622-11623	(	_	
76-11	11623-11629	dorsal	_	
76-12	11629-11630	)	_	
76-13	11631-11637	SFGdor	_	
76-14	11638-11646	Superior	_	
76-15	11647-11656	Occipital	_	
76-16	11657-11662	gyrus	_	
76-17	11663-11666	SOG	_	
76-18	11669-11682	Orbitofrontal	_	
76-19	11683-11689	cortex	_	
76-20	11690-11691	(	_	
76-21	11691-11699	superior	_	
76-22	11699-11700	)	_	
76-23	11701-11707	ORBsup	_	
76-24	11708-11714	Middle	_	
76-25	11715-11724	occipital	_	
76-26	11725-11730	gyrus	_	
76-27	11731-11734	MOG	_	
76-28	11737-11743	Middle	_	
76-29	11744-11751	frontal	_	
76-30	11752-11757	gyrus	_	
76-31	11758-11761	MFG	_	
76-32	11762-11770	Inferior	_	
76-33	11771-11780	occipital	_	
76-34	11781-11786	gyrus	_	
76-35	11787-11790	IOG	_	
76-36	11793-11806	Orbitofrontal	_	
76-37	11807-11813	cortex	_	
76-38	11814-11815	(	_	
76-39	11815-11821	middle	_	
76-40	11821-11822	)	_	
76-41	11823-11829	ORBmid	_	
76-42	11830-11838	Fusiform	_	
76-43	11839-11844	gyrus	_	
76-44	11845-11848	FFG	_	
76-45	11851-11859	Inferior	_	
76-46	11860-11867	frontal	_	
76-47	11868-11873	gyrus	_	
76-48	11874-11875	(	_	
76-49	11875-11884	opercular	_	
76-50	11884-11885	)	_	
76-51	11886-11894	IFGoperc	_	
76-52	11895-11906	Postcentral	_	
76-53	11907-11912	gyrus	_	
76-54	11913-11917	PoCG	_	
76-55	11920-11928	Inferior	_	
76-56	11929-11936	frontal	_	
76-57	11937-11942	gyrus	_	
76-58	11943-11944	(	_	
76-59	11944-11954	triangular	_	
76-60	11954-11955	)	_	
76-61	11956-11965	IFGtriang	_	
76-62	11966-11974	Superior	_	
76-63	11975-11983	parietal	_	
76-64	11984-11989	gyrus	_	
76-65	11990-11993	SPG	_	
76-66	11996-12009	Orbitofrontal	_	
76-67	12010-12016	cortex	_	
76-68	12017-12018	(	_	
76-69	12018-12026	inferior	_	
76-70	12026-12027	)	_	
76-71	12028-12034	ORBinf	_	
76-72	12035-12043	Inferior	_	
76-73	12044-12052	parietal	_	
76-74	12053-12059	lobule	_	
76-75	12060-12063	IPL	_	
76-76	12066-12074	Rolandic	_	
76-77	12075-12084	operculum	_	
76-78	12085-12088	ROL	_	
76-79	12089-12102	Supramarginal	_	
76-80	12103-12108	gyrus	_	
76-81	12109-12112	SMG	_	
76-82	12115-12128	Supplementary	_	
76-83	12129-12134	motor	_	
76-84	12135-12139	area	_	
76-85	12140-12143	SMA	_	
76-86	12144-12151	Angular	_	
76-87	12152-12157	gyrus	_	
76-88	12158-12161	ANG	_	
76-89	12164-12173	Olfactory	_	
76-90	12174-12177	OLF	_	
76-91	12178-12187	Precuneus	_	
76-92	12188-12192	PCUN	_	
76-93	12195-12203	Superior	_	
76-94	12204-12211	frontal	_	
76-95	12212-12217	gyrus	_	
76-96	12218-12219	(	_	
76-97	12219-12225	medial	_	
76-98	12225-12226	)	_	
76-99	12227-12233	SFGmed	_	
76-100	12234-12245	Paracentral	_	
76-101	12246-12252	lobule	_	
76-102	12253-12256	PCL	_	
76-103	12259-12272	Orbitofrontal	_	
76-104	12273-12279	cortex	_	
76-105	12280-12281	(	_	
76-106	12281-12287	medial	_	
76-107	12287-12288	)	_	
76-108	12289-12295	ORBmed	_	
76-109	12296-12303	Caudate	_	
76-110	12304-12307	CAU	_	
76-111	12310-12316	Rectus	_	
76-112	12317-12322	gyrus	_	
76-113	12323-12326	REC	_	
76-114	12327-12334	Putamen	_	
76-115	12335-12338	PUT	_	
76-116	12341-12347	Insula	_	
76-117	12348-12351	INS	_	
76-118	12352-12360	Pallidum	_	
76-119	12361-12364	PAL	_	
76-120	12367-12375	Anterior	_	
76-121	12376-12385	cingulate	_	
76-122	12386-12391	gyrus	_	
76-123	12392-12395	ACG	_	
76-124	12396-12404	Thalamus	_	
76-125	12405-12408	THA	_	
76-126	12411-12417	Middle	_	
76-127	12418-12427	cingulate	_	
76-128	12428-12433	gyrus	_	
76-129	12434-12437	DCG	_	
76-130	12438-12444	Heschl	_	
76-131	12445-12450	gyrus	_	
76-132	12451-12454	HES	_	
76-133	12457-12466	Posterior	_	
76-134	12467-12476	cingulate	_	
76-135	12477-12482	gyrus	_	
76-136	12483-12486	PCG	_	
76-137	12487-12495	Superior	_	
76-138	12496-12504	temporal	_	
76-139	12505-12510	gyrus	_	
76-140	12511-12514	STG	_	
76-141	12517-12528	Hippocampus	_	
76-142	12529-12532	HIP	_	
76-143	12533-12541	Temporal	_	
76-144	12542-12546	pole	_	
76-145	12547-12548	(	_	
76-146	12548-12556	superior	_	
76-147	12556-12557	)	_	
76-148	12558-12564	TPOsup	_	
76-149	12567-12582	Parahippocampal	_	
76-150	12583-12588	gyrus	_	
76-151	12589-12592	PHG	_	
76-152	12593-12599	Middle	_	
76-153	12600-12608	temporal	_	
76-154	12609-12614	gyrus	_	
76-155	12615-12618	MTG	_	
76-156	12621-12629	Amygdala	_	
76-157	12630-12634	AMYG	_	
76-158	12635-12643	Temporal	_	
76-159	12644-12648	pole	_	
76-160	12649-12650	(	_	
76-161	12650-12656	middle	_	
76-162	12656-12657	)	_	
76-163	12658-12664	TPOmid	_	
76-164	12667-12676	Calcarine	_	
76-165	12677-12683	cortex	_	
76-166	12684-12687	CAL	_	
76-167	12688-12696	Inferior	_	
76-168	12697-12705	temporal	_	
76-169	12706-12711	gyrus	_	
76-170	12712-12715	ITG	_	
76-171	12718-12724	Cuneus	_	
76-172	12725-12728	CUN	_	
76-173	12734-12735	3	_	
76-174	12735-12736	.	_	
76-175	12736-12747	Statistical	_	
76-176	12748-12756	analysis	_	
76-177	12757-12759	We	_	
76-178	12760-12764	used	_	
76-179	12765-12768	the	_	
76-180	12769-12773	most	_	
76-181	12774-12782	relevant	_	
76-182	12783-12788	study	_	
76-183	12789-12796	carried	_	
76-184	12797-12800	out	_	
76-185	12801-12803	by	_	
76-186	12804-12812	Ahmadlou	_	
76-187	12813-12815	et	_	
76-188	12816-12818	al	_	
76-189	12818-12819	.	_	
76-190	12820-12822	to	_	
76-191	12823-12829	obtain	_	
76-192	12830-12833	the	_	
76-193	12834-12840	effect	_	
76-194	12841-12845	size	_	
76-195	12846-12849	for	_	
76-196	12850-12854	most	_	
76-197	12855-12864	important	_	
76-198	12865-12873	variable	_	
76-199	12873-12874	.	_	

#Text=As in that study, SWI in the gamma frequency band, which is a ratio of CC and CP, has been suggested as a potential bio-marker for IWMD who are in early stage of MA withdrawal (<1 month), we considered it as the most important variable, primary endpoint, to assess it for IWMD who are in middle stage of MA abstinence (>1 month).
77-1	12875-12877	As	_	
77-2	12878-12880	in	_	
77-3	12881-12885	that	_	
77-4	12886-12891	study	_	
77-5	12891-12892	,	_	
77-6	12893-12896	SWI	_	
77-7	12897-12899	in	_	
77-8	12900-12903	the	_	
77-9	12904-12909	gamma	_	
77-10	12910-12919	frequency	_	
77-11	12920-12924	band	_	
77-12	12924-12925	,	_	
77-13	12926-12931	which	_	
77-14	12932-12934	is	_	
77-15	12935-12936	a	_	
77-16	12937-12942	ratio	_	
77-17	12943-12945	of	_	
77-18	12946-12948	CC	_	
77-19	12949-12952	and	_	
77-20	12953-12955	CP	_	
77-21	12955-12956	,	_	
77-22	12957-12960	has	_	
77-23	12961-12965	been	_	
77-24	12966-12975	suggested	_	
77-25	12976-12978	as	_	
77-26	12979-12980	a	_	
77-27	12981-12990	potential	_	
77-28	12991-13001	bio-marker	_	
77-29	13002-13005	for	_	
77-30	13006-13010	IWMD	_	
77-31	13011-13014	who	_	
77-32	13015-13018	are	_	
77-33	13019-13021	in	_	
77-34	13022-13027	early	_	
77-35	13028-13033	stage	_	
77-36	13034-13036	of	_	
77-37	13037-13039	MA	_	
77-38	13040-13050	withdrawal	_	
77-39	13051-13052	(	_	
77-40	13052-13053	<	_	
77-41	13053-13054	1	_	
77-42	13055-13060	month	_	
77-43	13060-13061	)	_	
77-44	13061-13062	,	_	
77-45	13063-13065	we	_	
77-46	13066-13076	considered	_	
77-47	13077-13079	it	_	
77-48	13080-13082	as	_	
77-49	13083-13086	the	_	
77-50	13087-13091	most	_	
77-51	13092-13101	important	_	
77-52	13102-13110	variable	_	
77-53	13110-13111	,	_	
77-54	13112-13119	primary	_	
77-55	13120-13128	endpoint	_	
77-56	13128-13129	,	_	
77-57	13130-13132	to	_	
77-58	13133-13139	assess	_	
77-59	13140-13142	it	_	
77-60	13143-13146	for	_	
77-61	13147-13151	IWMD	_	
77-62	13152-13155	who	_	
77-63	13156-13159	are	_	
77-64	13160-13162	in	_	
77-65	13163-13169	middle	_	
77-66	13170-13175	stage	_	
77-67	13176-13178	of	_	
77-68	13179-13181	MA	_	
77-69	13182-13192	abstinence	_	
77-70	13193-13194	(	_	
77-71	13194-13195	>	_	
77-72	13195-13196	1	_	
77-73	13197-13202	month	_	
77-74	13202-13203	)	_	
77-75	13203-13204	.	_	

#Text=We obtained an effect size of 0.96 and yielded a size of 18 in each group with type I error 5% (α = 0.05) and study power 80% (β = 0.2) using two-tailed test and G*Power software.
78-1	13205-13207	We	_	
78-2	13208-13216	obtained	_	
78-3	13217-13219	an	_	
78-4	13220-13226	effect	_	
78-5	13227-13231	size	_	
78-6	13232-13234	of	_	
78-7	13235-13239	0.96	_	
78-8	13240-13243	and	_	
78-9	13244-13251	yielded	_	
78-10	13252-13253	a	_	
78-11	13254-13258	size	_	
78-12	13259-13261	of	_	
78-13	13262-13264	18	_	
78-14	13265-13267	in	_	
78-15	13268-13272	each	_	
78-16	13273-13278	group	_	
78-17	13279-13283	with	_	
78-18	13284-13288	type	_	
78-19	13289-13290	I	_	
78-20	13291-13296	error	_	
78-21	13297-13299	5%	_	
78-22	13300-13301	(	_	
78-23	13301-13302	α	_	
78-24	13303-13304	=	_	
78-25	13305-13309	0.05	_	
78-26	13309-13310	)	_	
78-27	13311-13314	and	_	
78-28	13315-13320	study	_	
78-29	13321-13326	power	_	
78-30	13327-13330	80%	_	
78-31	13331-13332	(	_	
78-32	13332-13333	β	_	
78-33	13334-13335	=	_	
78-34	13336-13339	0.2	_	
78-35	13339-13340	)	_	
78-36	13341-13346	using	_	
78-37	13347-13357	two-tailed	_	
78-38	13358-13362	test	_	
78-39	13363-13366	and	_	
78-40	13367-13368	G	_	
78-41	13368-13369	*	_	
78-42	13369-13374	Power	_	
78-43	13375-13383	software	_	
78-44	13383-13384	.	_	

#Text=A multivariate analysis of variance (MANOVA) model was used to investigate statistical differences between topological metrics of brain FCN in IWMD and NCs.
79-1	13385-13386	A	_	
79-2	13387-13399	multivariate	_	
79-3	13400-13408	analysis	_	
79-4	13409-13411	of	_	
79-5	13412-13420	variance	_	
79-6	13421-13422	(	_	
79-7	13422-13428	MANOVA	_	
79-8	13428-13429	)	_	
79-9	13430-13435	model	_	
79-10	13436-13439	was	_	
79-11	13440-13444	used	_	
79-12	13445-13447	to	_	
79-13	13448-13459	investigate	_	
79-14	13460-13471	statistical	_	
79-15	13472-13483	differences	_	
79-16	13484-13491	between	_	
79-17	13492-13503	topological	_	
79-18	13504-13511	metrics	_	
79-19	13512-13514	of	_	
79-20	13515-13520	brain	_	
79-21	13521-13524	FCN	_	
79-22	13525-13527	in	_	
79-23	13528-13532	IWMD	_	
79-24	13533-13536	and	_	
79-25	13537-13540	NCs	_	
79-26	13540-13541	.	_	

#Text=The model assumptions were checked to be held: multivariate normality by Shapiro-Wilk test; homogeneity of covariance matrices by Box’s M test; homogeneity of variance by Levene’s test; further, the absence of multicollinearity was checked by variance inflation factor.
80-1	13542-13545	The	_	
80-2	13546-13551	model	_	
80-3	13552-13563	assumptions	_	
80-4	13564-13568	were	_	
80-5	13569-13576	checked	_	
80-6	13577-13579	to	_	
80-7	13580-13582	be	_	
80-8	13583-13587	held	_	
80-9	13587-13588	:	_	
80-10	13589-13601	multivariate	_	
80-11	13602-13611	normality	_	
80-12	13612-13614	by	_	
80-13	13615-13627	Shapiro-Wilk	_	
80-14	13628-13632	test	_	
80-15	13632-13633	;	_	
80-16	13634-13645	homogeneity	_	
80-17	13646-13648	of	_	
80-18	13649-13659	covariance	_	
80-19	13660-13668	matrices	_	
80-20	13669-13671	by	_	
80-21	13672-13675	Box	_	
80-22	13675-13676	’	_	
80-23	13676-13677	s	_	
80-24	13678-13679	M	_	
80-25	13680-13684	test	_	
80-26	13684-13685	;	_	
80-27	13686-13697	homogeneity	_	
80-28	13698-13700	of	_	
80-29	13701-13709	variance	_	
80-30	13710-13712	by	_	
80-31	13713-13719	Levene	_	
80-32	13719-13720	’	_	
80-33	13720-13721	s	_	
80-34	13722-13726	test	_	
80-35	13726-13727	;	_	
80-36	13728-13735	further	_	
80-37	13735-13736	,	_	
80-38	13737-13740	the	_	
80-39	13741-13748	absence	_	
80-40	13749-13751	of	_	
80-41	13752-13769	multicollinearity	_	
80-42	13770-13773	was	_	
80-43	13774-13781	checked	_	
80-44	13782-13784	by	_	
80-45	13785-13793	variance	_	
80-46	13794-13803	inflation	_	
80-47	13804-13810	factor	_	
80-48	13810-13811	.	_	

#Text=The effects of potential baseline confounding variables, including age and total-score of depression, anxiety and stress (DASS-21 scale) were controlled in the model.
81-1	13812-13815	The	_	
81-2	13816-13823	effects	_	
81-3	13824-13826	of	_	
81-4	13827-13836	potential	_	
81-5	13837-13845	baseline	_	
81-6	13846-13857	confounding	_	
81-7	13858-13867	variables	_	
81-8	13867-13868	,	_	
81-9	13869-13878	including	_	
81-10	13879-13882	age	_	
81-11	13883-13886	and	_	
81-12	13887-13898	total-score	_	
81-13	13899-13901	of	_	
81-14	13902-13912	depression	_	
81-15	13912-13913	,	_	
81-16	13914-13921	anxiety	_	
81-17	13922-13925	and	_	
81-18	13926-13932	stress	_	
81-19	13933-13934	(	_	
81-20	13934-13938	DASS	_	
81-21	13938-13939	-	_	
81-22	13939-13941	21	_	
81-23	13942-13947	scale	_	
81-24	13947-13948	)	_	
81-25	13949-13953	were	_	
81-26	13954-13964	controlled	_	
81-27	13965-13967	in	_	
81-28	13968-13971	the	_	
81-29	13972-13977	model	_	
81-30	13977-13978	.	_	

#Text=There was no any missing variable in the twenty topological characteristics but there were a few ones for the DASS-21 scale that have been replaced by mean imputation.
82-1	13979-13984	There	_	
82-2	13985-13988	was	_	
82-3	13989-13991	no	_	
82-4	13992-13995	any	_	
82-5	13996-14003	missing	_	
82-6	14004-14012	variable	_	
82-7	14013-14015	in	_	
82-8	14016-14019	the	_	
82-9	14020-14026	twenty	_	
82-10	14027-14038	topological	_	
82-11	14039-14054	characteristics	_	
82-12	14055-14058	but	_	
82-13	14059-14064	there	_	
82-14	14065-14069	were	_	
82-15	14070-14071	a	_	
82-16	14072-14075	few	_	
82-17	14076-14080	ones	_	
82-18	14081-14084	for	_	
82-19	14085-14088	the	_	
82-20	14089-14093	DASS	_	
82-21	14093-14094	-	_	
82-22	14094-14096	21	_	
82-23	14097-14102	scale	_	
82-24	14103-14107	that	_	
82-25	14108-14112	have	_	
82-26	14113-14117	been	_	
82-27	14118-14126	replaced	_	
82-28	14127-14129	by	_	
82-29	14130-14134	mean	_	
82-30	14135-14145	imputation	_	
82-31	14145-14146	.	_	

#Text=Among the twenty variables, just six variables met the assumptions.
83-1	14147-14152	Among	_	
83-2	14153-14156	the	_	
83-3	14157-14163	twenty	_	
83-4	14164-14173	variables	_	
83-5	14173-14174	,	_	
83-6	14175-14179	just	_	
83-7	14180-14183	six	_	
83-8	14184-14193	variables	_	
83-9	14194-14197	met	_	
83-10	14198-14201	the	_	
83-11	14202-14213	assumptions	_	
83-12	14213-14214	.	_	

#Text=Hence, the MANOVA in sensor and source spaces comprised six dependent variables (DVs) and one independent variable with two levels (IWMD vs.
84-1	14215-14220	Hence	_	
84-2	14220-14221	,	_	
84-3	14222-14225	the	_	
84-4	14226-14232	MANOVA	_	
84-5	14233-14235	in	_	
84-6	14236-14242	sensor	_	
84-7	14243-14246	and	_	
84-8	14247-14253	source	_	
84-9	14254-14260	spaces	_	
84-10	14261-14270	comprised	_	
84-11	14271-14274	six	_	
84-12	14275-14284	dependent	_	
84-13	14285-14294	variables	_	
84-14	14295-14296	(	_	
84-15	14296-14299	DVs	_	
84-16	14299-14300	)	_	
84-17	14301-14304	and	_	
84-18	14305-14308	one	_	
84-19	14309-14320	independent	_	
84-20	14321-14329	variable	_	
84-21	14330-14334	with	_	
84-22	14335-14338	two	_	
84-23	14339-14345	levels	_	
84-24	14346-14347	(	_	
84-25	14347-14351	IWMD	_	
84-26	14352-14354	vs	_	
84-27	14354-14355	.	_	

#Text=NCs).
85-1	14356-14359	NCs	_	
85-2	14359-14360	)	_	
85-3	14360-14361	.	_	

#Text=For the remaining variables, non-parametric test (Mann–Whitney) was used.
86-1	14362-14365	For	_	
86-2	14366-14369	the	_	
86-3	14370-14379	remaining	_	
86-4	14380-14389	variables	_	
86-5	14389-14390	,	_	
86-6	14391-14405	non-parametric	_	
86-7	14406-14410	test	_	
86-8	14411-14412	(	_	
86-9	14412-14424	Mann–Whitney	_	
86-10	14424-14425	)	_	
86-11	14426-14429	was	_	
86-12	14430-14434	used	_	
86-13	14434-14435	.	_	

#Text=An α level of less than 0.05 was considered significant.
87-1	14436-14438	An	_	
87-2	14439-14440	α	_	
87-3	14441-14446	level	_	
87-4	14447-14449	of	_	
87-5	14450-14454	less	_	
87-6	14455-14459	than	_	
87-7	14460-14464	0.05	_	
87-8	14465-14468	was	_	
87-9	14469-14479	considered	_	
87-10	14480-14491	significant	_	
87-11	14491-14492	.	_	

#Text=The analysis was carried out using “SPSS 22”.
88-1	14493-14496	The	_	
88-2	14497-14505	analysis	_	
88-3	14506-14509	was	_	
88-4	14510-14517	carried	_	
88-5	14518-14521	out	_	
88-6	14522-14527	using	_	
88-7	14528-14529	“	_	
88-8	14529-14533	SPSS	_	
88-9	14534-14536	22	_	
88-10	14536-14537	”	_	
88-11	14537-14538	.	_	

#Text=To control the type I error in multiple comparisons of connectivity differences in each frequency band, Benjamini–Hochberg procedure was carried out with false discovery rate 0.05 (q-value<0.05).
89-1	14539-14541	To	_	
89-2	14542-14549	control	_	
89-3	14550-14553	the	_	
89-4	14554-14558	type	_	
89-5	14559-14560	I	_	
89-6	14561-14566	error	_	
89-7	14567-14569	in	_	
89-8	14570-14578	multiple	_	
89-9	14579-14590	comparisons	_	
89-10	14591-14593	of	_	
89-11	14594-14606	connectivity	_	
89-12	14607-14618	differences	_	
89-13	14619-14621	in	_	
89-14	14622-14626	each	_	
89-15	14627-14636	frequency	_	
89-16	14637-14641	band	_	
89-17	14641-14642	,	_	
89-18	14643-14661	Benjamini–Hochberg	_	
89-19	14662-14671	procedure	_	
89-20	14672-14675	was	_	
89-21	14676-14683	carried	_	
89-22	14684-14687	out	_	
89-23	14688-14692	with	_	
89-24	14693-14698	false	_	
89-25	14699-14708	discovery	_	
89-26	14709-14713	rate	_	
89-27	14714-14718	0.05	_	
89-28	14719-14720	(	_	
89-29	14720-14727	q-value	_	
89-30	14727-14728	<	_	
89-31	14728-14732	0.05	_	
89-32	14732-14733	)	_	
89-33	14733-14734	.	_	

#Text=The analysis was performed using MATLAB software.
#Text=4.
90-1	14735-14738	The	_	
90-2	14739-14747	analysis	_	
90-3	14748-14751	was	_	
90-4	14752-14761	performed	_	
90-5	14762-14767	using	_	
90-6	14768-14774	MATLAB	_	
90-7	14775-14783	software	_	
90-8	14783-14784	.	_	
90-9	14785-14786	4	_	
90-10	14786-14787	.	_	

#Text=Results
#Text=4.1 Sensor space results
#Text=MANOVA showed that there was no statistically significant difference in DVs based on group levels (IWMD and NCs), F (1, 58) = 0.83, p = 0.54; Wilk's Λ = 0.9.
91-1	14788-14795	Results	_	
91-2	14796-14799	4.1	_	
91-3	14800-14806	Sensor	_	
91-4	14807-14812	space	_	
91-5	14813-14820	results	_	
91-6	14821-14827	MANOVA	_	
91-7	14828-14834	showed	_	
91-8	14835-14839	that	_	
91-9	14840-14845	there	_	
91-10	14846-14849	was	_	
91-11	14850-14852	no	_	
91-12	14853-14866	statistically	_	
91-13	14867-14878	significant	_	
91-14	14879-14889	difference	_	
91-15	14890-14892	in	_	
91-16	14893-14896	DVs	_	
91-17	14897-14902	based	_	
91-18	14903-14905	on	_	
91-19	14906-14911	group	_	
91-20	14912-14918	levels	_	
91-21	14919-14920	(	_	
91-22	14920-14924	IWMD	_	
91-23	14925-14928	and	_	
91-24	14929-14932	NCs	_	
91-25	14932-14933	)	_	
91-26	14933-14934	,	_	
91-27	14935-14936	F	_	
91-28	14937-14938	(	_	
91-29	14938-14939	1	_	
91-30	14939-14940	,	_	
91-31	14941-14943	58	_	
91-32	14943-14944	)	_	
91-33	14945-14946	=	_	
91-34	14947-14951	0.83	_	
91-35	14951-14952	,	_	
91-36	14953-14954	p	_	
91-37	14955-14956	=	_	
91-38	14957-14961	0.54	_	
91-39	14961-14962	;	_	
91-40	14963-14969	Wilk's	_	
91-41	14970-14971	Λ	_	
91-42	14972-14973	=	_	
91-43	14974-14977	0.9	_	
91-44	14977-14978	.	_	

#Text=Adjusting for potential confounders including DASS and age had no significant effect on this association.
92-1	14979-14988	Adjusting	_	
92-2	14989-14992	for	_	
92-3	14993-15002	potential	_	
92-4	15003-15014	confounders	_	
92-5	15015-15024	including	_	
92-6	15025-15029	DASS	_	
92-7	15030-15033	and	_	
92-8	15034-15037	age	_	
92-9	15038-15041	had	_	
92-10	15042-15044	no	_	
92-11	15045-15056	significant	_	
92-12	15057-15063	effect	_	
92-13	15064-15066	on	_	
92-14	15067-15071	this	_	
92-15	15072-15083	association	_	
92-16	15083-15084	.	_	

#Text=Mann–Whitney test revealed that NS (U = 224,p = 0.002) and SWI(U = 225, p = 0.002) of IWMD in the delta frequency band is statistically significantly higher than those of NCs.
93-1	15085-15097	Mann–Whitney	_	
93-2	15098-15102	test	_	
93-3	15103-15111	revealed	_	
93-4	15112-15116	that	_	
93-5	15117-15119	NS	_	
93-6	15120-15121	(	_	
93-7	15121-15122	U	_	
93-8	15123-15124	=	_	
93-9	15125-15128	224	_	
93-10	15128-15129	,	_	
93-11	15129-15130	p	_	
93-12	15131-15132	=	_	
93-13	15133-15138	0.002	_	
93-14	15138-15139	)	_	
93-15	15140-15143	and	_	
93-16	15144-15147	SWI	_	
93-17	15147-15148	(	_	
93-18	15148-15149	U	_	
93-19	15150-15151	=	_	
93-20	15152-15155	225	_	
93-21	15155-15156	,	_	
93-22	15157-15158	p	_	
93-23	15159-15160	=	_	
93-24	15161-15166	0.002	_	
93-25	15166-15167	)	_	
93-26	15168-15170	of	_	
93-27	15171-15175	IWMD	_	
93-28	15176-15178	in	_	
93-29	15179-15182	the	_	
93-30	15183-15188	delta	_	
93-31	15189-15198	frequency	_	
93-32	15199-15203	band	_	
93-33	15204-15206	is	_	
93-34	15207-15220	statistically	_	
93-35	15221-15234	significantly	_	
93-36	15235-15241	higher	_	
93-37	15242-15246	than	_	
93-38	15247-15252	those	_	
93-39	15253-15255	of	_	
93-40	15256-15259	NCs	_	
93-41	15259-15260	.	_	

#Text=Further, CP of IWMD in delta frequency band are statistically significantly lesser than those of NCs, (U = 246,p = 0.007), (Table 3).
94-1	15261-15268	Further	_	
94-2	15268-15269	,	_	
94-3	15270-15272	CP	_	
94-4	15273-15275	of	_	
94-5	15276-15280	IWMD	_	
94-6	15281-15283	in	_	
94-7	15284-15289	delta	_	
94-8	15290-15299	frequency	_	
94-9	15300-15304	band	_	
94-10	15305-15308	are	_	
94-11	15309-15322	statistically	_	
94-12	15323-15336	significantly	_	
94-13	15337-15343	lesser	_	
94-14	15344-15348	than	_	
94-15	15349-15354	those	_	
94-16	15355-15357	of	_	
94-17	15358-15361	NCs	_	
94-18	15361-15362	,	_	
94-19	15363-15364	(	_	
94-20	15364-15365	U	_	
94-21	15366-15367	=	_	
94-22	15368-15371	246	_	
94-23	15371-15372	,	_	
94-24	15372-15373	p	_	
94-25	15374-15375	=	_	
94-26	15376-15381	0.007	_	
94-27	15381-15382	)	_	
94-28	15382-15383	,	_	
94-29	15384-15385	(	_	
94-30	15385-15390	Table	_	
94-31	15391-15392	3	_	
94-32	15392-15393	)	_	
94-33	15393-15394	.	_	

#Text=The statistical differences of topology metrics between IWMD and NCs (Mann–Whitney U / p-value) or (F/p-value) in sensore space.
95-1	15395-15398	The	_	
95-2	15399-15410	statistical	_	
95-3	15411-15422	differences	_	
95-4	15423-15425	of	_	
95-5	15426-15434	topology	_	
95-6	15435-15442	metrics	_	
95-7	15443-15450	between	_	
95-8	15451-15455	IWMD	_	
95-9	15456-15459	and	_	
95-10	15460-15463	NCs	_	
95-11	15464-15465	(	_	
95-12	15465-15477	Mann–Whitney	_	
95-13	15478-15479	U	_	
95-14	15480-15481	/	_	
95-15	15482-15489	p-value	_	
95-16	15489-15490	)	_	
95-17	15491-15493	or	_	
95-18	15494-15495	(	_	
95-19	15495-15496	F	_	
95-20	15496-15497	/	_	
95-21	15497-15504	p-value	_	
95-22	15504-15505	)	_	
95-23	15506-15508	in	_	
95-24	15509-15516	sensore	_	
95-25	15517-15522	space	_	
95-26	15522-15523	.	_	

#Text=delta\tTheta\talpha\tbeta\tgamma\t \tNS\t224/ 0.002\t345/ 0.24\t419/0.9\t331/0.17\t331/0.17\t \tCC\t323/0.13\t338/0.2\t0.56/0.4a\t0.002/0.9a\t0.9/0.7a\t \tCP\t246/0.007\t1.9/0.1a\t0.003/0.9a\t322/0.13\t1.6/0.2a\t \tSWI\t225/0.002\t325/0.14\t362/0.37\t392/0.6\t354/0.3\t \t
#Text=The ‘a’ indicates parametric test.
96-1	15525-15530	delta	_	
96-2	15531-15536	Theta	_	
96-3	15537-15542	alpha	_	
96-4	15543-15547	beta	_	
96-5	15548-15553	gamma	_	
96-6	15556-15558	NS	_	
96-7	15559-15562	224	_	
96-8	15562-15563	/	_	
96-9	15564-15569	0.002	_	
96-10	15570-15573	345	_	
96-11	15573-15574	/	_	
96-12	15575-15579	0.24	_	
96-13	15580-15583	419	_	
96-14	15583-15584	/	_	
96-15	15584-15587	0.9	_	
96-16	15588-15591	331	_	
96-17	15591-15592	/	_	
96-18	15592-15596	0.17	_	
96-19	15597-15600	331	_	
96-20	15600-15601	/	_	
96-21	15601-15605	0.17	_	
96-22	15608-15610	CC	_	
96-23	15611-15614	323	_	
96-24	15614-15615	/	_	
96-25	15615-15619	0.13	_	
96-26	15620-15623	338	_	
96-27	15623-15624	/	_	
96-28	15624-15627	0.2	_	
96-29	15628-15632	0.56	_	
96-30	15632-15633	/	_	
96-31	15633-15637	0.4a	_	
96-32	15638-15643	0.002	_	
96-33	15643-15644	/	_	
96-34	15644-15648	0.9a	_	
96-35	15649-15652	0.9	_	
96-36	15652-15653	/	_	
96-37	15653-15657	0.7a	_	
96-38	15660-15662	CP	_	
96-39	15663-15666	246	_	
96-40	15666-15667	/	_	
96-41	15667-15672	0.007	_	
96-42	15673-15676	1.9	_	
96-43	15676-15677	/	_	
96-44	15677-15681	0.1a	_	
96-45	15682-15687	0.003	_	
96-46	15687-15688	/	_	
96-47	15688-15692	0.9a	_	
96-48	15693-15696	322	_	
96-49	15696-15697	/	_	
96-50	15697-15701	0.13	_	
96-51	15702-15705	1.6	_	
96-52	15705-15706	/	_	
96-53	15706-15710	0.2a	_	
96-54	15713-15716	SWI	_	
96-55	15717-15720	225	_	
96-56	15720-15721	/	_	
96-57	15721-15726	0.002	_	
96-58	15727-15730	325	_	
96-59	15730-15731	/	_	
96-60	15731-15735	0.14	_	
96-61	15736-15739	362	_	
96-62	15739-15740	/	_	
96-63	15740-15744	0.37	_	
96-64	15745-15748	392	_	
96-65	15748-15749	/	_	
96-66	15749-15752	0.6	_	
96-67	15753-15756	354	_	
96-68	15756-15757	/	_	
96-69	15757-15760	0.3	_	
96-70	15764-15767	The	_	
96-71	15768-15769	‘	_	
96-72	15769-15770	a	_	
96-73	15770-15771	’	_	
96-74	15772-15781	indicates	_	
96-75	15782-15792	parametric	_	
96-76	15793-15797	test	_	
96-77	15797-15798	.	_	

#Text=Significant differences (p<0.05) are bold.
97-1	15799-15810	Significant	_	
97-2	15811-15822	differences	_	
97-3	15823-15824	(	_	
97-4	15824-15825	p	_	
97-5	15825-15826	<	_	
97-6	15826-15830	0.05	_	
97-7	15830-15831	)	_	
97-8	15832-15835	are	_	
97-9	15836-15840	bold	_	
97-10	15840-15841	.	_	

#Text=The mean and SD of the topological metrics at all the frequency bands are brought in Table 4 and shown in Fig 1.
98-1	15842-15845	The	_	
98-2	15846-15850	mean	_	
98-3	15851-15854	and	_	
98-4	15855-15857	SD	_	
98-5	15858-15860	of	_	
98-6	15861-15864	the	_	
98-7	15865-15876	topological	_	
98-8	15877-15884	metrics	_	
98-9	15885-15887	at	_	
98-10	15888-15891	all	_	
98-11	15892-15895	the	_	
98-12	15896-15905	frequency	_	
98-13	15906-15911	bands	_	
98-14	15912-15915	are	_	
98-15	15916-15923	brought	_	
98-16	15924-15926	in	_	
98-17	15927-15932	Table	_	
98-18	15933-15934	4	_	
98-19	15935-15938	and	_	
98-20	15939-15944	shown	_	
98-21	15945-15947	in	_	
98-22	15948-15951	Fig	_	
98-23	15952-15953	1	_	
98-24	15953-15954	.	_	

#Text=The values of topological metrics in sensor space along with related statistical log file are brought in S2 Table and S1 File.
99-1	15955-15958	The	_	
99-2	15959-15965	values	_	
99-3	15966-15968	of	_	
99-4	15969-15980	topological	_	
99-5	15981-15988	metrics	_	
99-6	15989-15991	in	_	
99-7	15992-15998	sensor	_	
99-8	15999-16004	space	_	
99-9	16005-16010	along	_	
99-10	16011-16015	with	_	
99-11	16016-16023	related	_	
99-12	16024-16035	statistical	_	
99-13	16036-16039	log	_	
99-14	16040-16044	file	_	
99-15	16045-16048	are	_	
99-16	16049-16056	brought	_	
99-17	16057-16059	in	_	
99-18	16060-16062	S2	_	
99-19	16063-16068	Table	_	
99-20	16069-16072	and	_	
99-21	16073-16075	S1	_	
99-22	16076-16080	File	_	
99-23	16080-16081	.	_	

#Text=Left column: Computed topological metrics (NS, CC, CP, and SWI) in the sensor space.
100-1	16082-16086	Left	_	
100-2	16087-16093	column	_	
100-3	16093-16094	:	_	
100-4	16095-16103	Computed	_	
100-5	16104-16115	topological	_	
100-6	16116-16123	metrics	_	
100-7	16124-16125	(	_	
100-8	16125-16127	NS	_	
100-9	16127-16128	,	_	
100-10	16129-16131	CC	_	
100-11	16131-16132	,	_	
100-12	16133-16135	CP	_	
100-13	16135-16136	,	_	
100-14	16137-16140	and	_	
100-15	16141-16144	SWI	_	
100-16	16144-16145	)	_	
100-17	16146-16148	in	_	
100-18	16149-16152	the	_	
100-19	16153-16159	sensor	_	
100-20	16160-16165	space	_	
100-21	16165-16166	.	_	

#Text=Right column: computed topological metrics in the source space.
101-1	16167-16172	Right	_	
101-2	16173-16179	column	_	
101-3	16179-16180	:	_	
101-4	16181-16189	computed	_	
101-5	16190-16201	topological	_	
101-6	16202-16209	metrics	_	
101-7	16210-16212	in	_	
101-8	16213-16216	the	_	
101-9	16217-16223	source	_	
101-10	16224-16229	space	_	
101-11	16229-16230	.	_	

#Text=If the p-value is less than 0.05 it is flagged with one star (*).
102-1	16231-16233	If	_	
102-2	16234-16237	the	_	
102-3	16238-16245	p-value	_	
102-4	16246-16248	is	_	
102-5	16249-16253	less	_	
102-6	16254-16258	than	_	
102-7	16259-16263	0.05	_	
102-8	16264-16266	it	_	
102-9	16267-16269	is	_	
102-10	16270-16277	flagged	_	
102-11	16278-16282	with	_	
102-12	16283-16286	one	_	
102-13	16287-16291	star	_	
102-14	16292-16293	(	_	
102-15	16293-16294	*	_	
102-16	16294-16295	)	_	
102-17	16295-16296	.	_	

#Text=Each bar represents mean values ±SE.
103-1	16297-16301	Each	_	
103-2	16302-16305	bar	_	
103-3	16306-16316	represents	_	
103-4	16317-16321	mean	_	
103-5	16322-16328	values	_	
103-6	16329-16330	±	_	
103-7	16330-16332	SE	_	
103-8	16332-16333	.	_	

#Text=Mean and standard deviation of the brain topology metrics in five frequency bands for IWMUD and NCs acquired in sensor space.
104-1	16334-16338	Mean	_	
104-2	16339-16342	and	_	
104-3	16343-16351	standard	_	
104-4	16352-16361	deviation	_	
104-5	16362-16364	of	_	
104-6	16365-16368	the	_	
104-7	16369-16374	brain	_	
104-8	16375-16383	topology	_	
104-9	16384-16391	metrics	_	
104-10	16392-16394	in	_	
104-11	16395-16399	five	_	
104-12	16400-16409	frequency	_	
104-13	16410-16415	bands	_	
104-14	16416-16419	for	_	
104-15	16420-16425	IWMUD	_	
104-16	16426-16429	and	_	
104-17	16430-16433	NCs	_	
104-18	16434-16442	acquired	_	
104-19	16443-16445	in	_	
104-20	16446-16452	sensor	_	
104-21	16453-16458	space	_	
104-22	16458-16459	.	_	

#Text=Frequency Band\tNS\tCC\tCP\tSWI\t \tMean(SD) Patient/Control\tMean(SD) Patient/Control\tMean(SD) Patient/Control\tMean(SD)Patient/Control\t \tDelta\t5.8663 (1.6133) / 5.2585 (1.0389)\t0.18299 (0.030608) / 0.17685 (0.026965)\t8.34(1.06)/ 8.9861 (0.64487)\t0.2235(0.00357)/ 0.019796 (0.0034958)\t \tTheta\t5.0234 (1.3399) / 4.7144 (1.0519)\t0.18181 (0.032516) / 0.1763 (0.028919)\t9.73 (1.29) / 10.1423 (1.0025)\t0.01913(0.003938)/ 0.017494 (0.0034958)\t \tAlpha\t5.2648 (2.1662) / 5.1363 (1.8444)\t0.17625 (0.047435) / 0.18263 (0.040771)\t9.97 (2.29) / 10.0138 (2.1707)\t0.01926(0.008890)/ 0.019305 (0.0034958)\t \tBeta\t2.8326 (0.84394) /2.8701 (0.75815)\t0.12963 (0.038471) / 0.12923 (0.046343)\t17.16 (2.73) / 16.6225 (2.0136)\t0.0077(0.00240)/ 0.0078475 (0.0034958)\t \tGamma\t2.8529 (0.88257) /2.6812 (0.83643)\t0.11636 (0.04189) / 0.11292 (0.046492)\t16.95(2.62)/ 17.8008 (2.3357)\t0.0068(0.00194)/ 0.00624 (0.0034958)\t \t
#Text=4.2 Source space results
#Text=The MANOVA showed that there was no statistically significant difference in DVs based on group levels (IWMD and NCs), F (1, 58) = 1.13, p = 0.35; Wilk's Λ = 0.88.
105-1	16460-16469	Frequency	_	
105-2	16470-16474	Band	_	
105-3	16475-16477	NS	_	
105-4	16478-16480	CC	_	
105-5	16481-16483	CP	_	
105-6	16484-16487	SWI	_	
105-7	16490-16494	Mean	_	
105-8	16494-16495	(	_	
105-9	16495-16497	SD	_	
105-10	16497-16498	)	_	
105-11	16499-16506	Patient	_	
105-12	16506-16507	/	_	
105-13	16507-16514	Control	_	
105-14	16515-16519	Mean	_	
105-15	16519-16520	(	_	
105-16	16520-16522	SD	_	
105-17	16522-16523	)	_	
105-18	16524-16531	Patient	_	
105-19	16531-16532	/	_	
105-20	16532-16539	Control	_	
105-21	16540-16544	Mean	_	
105-22	16544-16545	(	_	
105-23	16545-16547	SD	_	
105-24	16547-16548	)	_	
105-25	16549-16556	Patient	_	
105-26	16556-16557	/	_	
105-27	16557-16564	Control	_	
105-28	16565-16569	Mean	_	
105-29	16569-16570	(	_	
105-30	16570-16572	SD	_	
105-31	16572-16573	)	_	
105-32	16573-16580	Patient	_	
105-33	16580-16581	/	_	
105-34	16581-16588	Control	_	
105-35	16591-16596	Delta	_	
105-36	16597-16603	5.8663	_	
105-37	16604-16605	(	_	
105-38	16605-16611	1.6133	_	
105-39	16611-16612	)	_	
105-40	16613-16614	/	_	
105-41	16615-16621	5.2585	_	
105-42	16622-16623	(	_	
105-43	16623-16629	1.0389	_	
105-44	16629-16630	)	_	
105-45	16631-16638	0.18299	_	
105-46	16639-16640	(	_	
105-47	16640-16648	0.030608	_	
105-48	16648-16649	)	_	
105-49	16650-16651	/	_	
105-50	16652-16659	0.17685	_	
105-51	16660-16661	(	_	
105-52	16661-16669	0.026965	_	
105-53	16669-16670	)	_	
105-54	16671-16675	8.34	_	
105-55	16675-16676	(	_	
105-56	16676-16680	1.06	_	
105-57	16680-16681	)	_	
105-58	16681-16682	/	_	
105-59	16683-16689	8.9861	_	
105-60	16690-16691	(	_	
105-61	16691-16698	0.64487	_	
105-62	16698-16699	)	_	
105-63	16700-16706	0.2235	_	
105-64	16706-16707	(	_	
105-65	16707-16714	0.00357	_	
105-66	16714-16715	)	_	
105-67	16715-16716	/	_	
105-68	16717-16725	0.019796	_	
105-69	16726-16727	(	_	
105-70	16727-16736	0.0034958	_	
105-71	16736-16737	)	_	
105-72	16740-16745	Theta	_	
105-73	16746-16752	5.0234	_	
105-74	16753-16754	(	_	
105-75	16754-16760	1.3399	_	
105-76	16760-16761	)	_	
105-77	16762-16763	/	_	
105-78	16764-16770	4.7144	_	
105-79	16771-16772	(	_	
105-80	16772-16778	1.0519	_	
105-81	16778-16779	)	_	
105-82	16780-16787	0.18181	_	
105-83	16788-16789	(	_	
105-84	16789-16797	0.032516	_	
105-85	16797-16798	)	_	
105-86	16799-16800	/	_	
105-87	16801-16807	0.1763	_	
105-88	16808-16809	(	_	
105-89	16809-16817	0.028919	_	
105-90	16817-16818	)	_	
105-91	16819-16823	9.73	_	
105-92	16824-16825	(	_	
105-93	16825-16829	1.29	_	
105-94	16829-16830	)	_	
105-95	16831-16832	/	_	
105-96	16833-16840	10.1423	_	
105-97	16841-16842	(	_	
105-98	16842-16848	1.0025	_	
105-99	16848-16849	)	_	
105-100	16850-16857	0.01913	_	
105-101	16857-16858	(	_	
105-102	16858-16866	0.003938	_	
105-103	16866-16867	)	_	
105-104	16867-16868	/	_	
105-105	16869-16877	0.017494	_	
105-106	16878-16879	(	_	
105-107	16879-16888	0.0034958	_	
105-108	16888-16889	)	_	
105-109	16892-16897	Alpha	_	
105-110	16898-16904	5.2648	_	
105-111	16905-16906	(	_	
105-112	16906-16912	2.1662	_	
105-113	16912-16913	)	_	
105-114	16914-16915	/	_	
105-115	16916-16922	5.1363	_	
105-116	16923-16924	(	_	
105-117	16924-16930	1.8444	_	
105-118	16930-16931	)	_	
105-119	16932-16939	0.17625	_	
105-120	16940-16941	(	_	
105-121	16941-16949	0.047435	_	
105-122	16949-16950	)	_	
105-123	16951-16952	/	_	
105-124	16953-16960	0.18263	_	
105-125	16961-16962	(	_	
105-126	16962-16970	0.040771	_	
105-127	16970-16971	)	_	
105-128	16972-16976	9.97	_	
105-129	16977-16978	(	_	
105-130	16978-16982	2.29	_	
105-131	16982-16983	)	_	
105-132	16984-16985	/	_	
105-133	16986-16993	10.0138	_	
105-134	16994-16995	(	_	
105-135	16995-17001	2.1707	_	
105-136	17001-17002	)	_	
105-137	17003-17010	0.01926	_	
105-138	17010-17011	(	_	
105-139	17011-17019	0.008890	_	
105-140	17019-17020	)	_	
105-141	17020-17021	/	_	
105-142	17022-17030	0.019305	_	
105-143	17031-17032	(	_	
105-144	17032-17041	0.0034958	_	
105-145	17041-17042	)	_	
105-146	17045-17049	Beta	_	
105-147	17050-17056	2.8326	_	
105-148	17057-17058	(	_	
105-149	17058-17065	0.84394	_	
105-150	17065-17066	)	_	
105-151	17067-17068	/	_	
105-152	17068-17074	2.8701	_	
105-153	17075-17076	(	_	
105-154	17076-17083	0.75815	_	
105-155	17083-17084	)	_	
105-156	17085-17092	0.12963	_	
105-157	17093-17094	(	_	
105-158	17094-17102	0.038471	_	
105-159	17102-17103	)	_	
105-160	17104-17105	/	_	
105-161	17106-17113	0.12923	_	
105-162	17114-17115	(	_	
105-163	17115-17123	0.046343	_	
105-164	17123-17124	)	_	
105-165	17125-17130	17.16	_	
105-166	17131-17132	(	_	
105-167	17132-17136	2.73	_	
105-168	17136-17137	)	_	
105-169	17138-17139	/	_	
105-170	17140-17147	16.6225	_	
105-171	17148-17149	(	_	
105-172	17149-17155	2.0136	_	
105-173	17155-17156	)	_	
105-174	17157-17163	0.0077	_	
105-175	17163-17164	(	_	
105-176	17164-17171	0.00240	_	
105-177	17171-17172	)	_	
105-178	17172-17173	/	_	
105-179	17174-17183	0.0078475	_	
105-180	17184-17185	(	_	
105-181	17185-17194	0.0034958	_	
105-182	17194-17195	)	_	
105-183	17198-17203	Gamma	_	
105-184	17204-17210	2.8529	_	
105-185	17211-17212	(	_	
105-186	17212-17219	0.88257	_	
105-187	17219-17220	)	_	
105-188	17221-17222	/	_	
105-189	17222-17228	2.6812	_	
105-190	17229-17230	(	_	
105-191	17230-17237	0.83643	_	
105-192	17237-17238	)	_	
105-193	17239-17246	0.11636	_	
105-194	17247-17248	(	_	
105-195	17248-17255	0.04189	_	
105-196	17255-17256	)	_	
105-197	17257-17258	/	_	
105-198	17259-17266	0.11292	_	
105-199	17267-17268	(	_	
105-200	17268-17276	0.046492	_	
105-201	17276-17277	)	_	
105-202	17278-17283	16.95	_	
105-203	17283-17284	(	_	
105-204	17284-17288	2.62	_	
105-205	17288-17289	)	_	
105-206	17289-17290	/	_	
105-207	17291-17298	17.8008	_	
105-208	17299-17300	(	_	
105-209	17300-17306	2.3357	_	
105-210	17306-17307	)	_	
105-211	17308-17314	0.0068	_	
105-212	17314-17315	(	_	
105-213	17315-17322	0.00194	_	
105-214	17322-17323	)	_	
105-215	17323-17324	/	_	
105-216	17325-17332	0.00624	_	
105-217	17333-17334	(	_	
105-218	17334-17343	0.0034958	_	
105-219	17343-17344	)	_	
105-220	17348-17351	4.2	_	
105-221	17352-17358	Source	_	
105-222	17359-17364	space	_	
105-223	17365-17372	results	_	
105-224	17373-17376	The	_	
105-225	17377-17383	MANOVA	_	
105-226	17384-17390	showed	_	
105-227	17391-17395	that	_	
105-228	17396-17401	there	_	
105-229	17402-17405	was	_	
105-230	17406-17408	no	_	
105-231	17409-17422	statistically	_	
105-232	17423-17434	significant	_	
105-233	17435-17445	difference	_	
105-234	17446-17448	in	_	
105-235	17449-17452	DVs	_	
105-236	17453-17458	based	_	
105-237	17459-17461	on	_	
105-238	17462-17467	group	_	
105-239	17468-17474	levels	_	
105-240	17475-17476	(	_	
105-241	17476-17480	IWMD	_	
105-242	17481-17484	and	_	
105-243	17485-17488	NCs	_	
105-244	17488-17489	)	_	
105-245	17489-17490	,	_	
105-246	17491-17492	F	_	
105-247	17493-17494	(	_	
105-248	17494-17495	1	_	
105-249	17495-17496	,	_	
105-250	17497-17499	58	_	
105-251	17499-17500	)	_	
105-252	17501-17502	=	_	
105-253	17503-17507	1.13	_	
105-254	17507-17508	,	_	
105-255	17509-17510	p	_	
105-256	17511-17512	=	_	
105-257	17513-17517	0.35	_	
105-258	17517-17518	;	_	
105-259	17519-17525	Wilk's	_	
105-260	17526-17527	Λ	_	
105-261	17528-17529	=	_	
105-262	17530-17534	0.88	_	
105-263	17534-17535	.	_	

#Text=Adjusting for potential confounders including DASS and age had no significant effect on this association.
106-1	17536-17545	Adjusting	_	
106-2	17546-17549	for	_	
106-3	17550-17559	potential	_	
106-4	17560-17571	confounders	_	
106-5	17572-17581	including	_	
106-6	17582-17586	DASS	_	
106-7	17587-17590	and	_	
106-8	17591-17594	age	_	
106-9	17595-17598	had	_	
106-10	17599-17601	no	_	
106-11	17602-17613	significant	_	
106-12	17614-17620	effect	_	
106-13	17621-17623	on	_	
106-14	17624-17628	this	_	
106-15	17629-17640	association	_	
106-16	17640-17641	.	_	

#Text=Mann–Whitney test revealed that NS (U = 254,p = 0.007) and SWI (U = 284, p = 0.02) of IWMD in the gamma frequency band are statistically significantly higher than those of NCs (Table 5).
107-1	17642-17654	Mann–Whitney	_	
107-2	17655-17659	test	_	
107-3	17660-17668	revealed	_	
107-4	17669-17673	that	_	
107-5	17674-17676	NS	_	
107-6	17677-17678	(	_	
107-7	17678-17679	U	_	
107-8	17680-17681	=	_	
107-9	17682-17685	254	_	
107-10	17685-17686	,	_	
107-11	17686-17687	p	_	
107-12	17688-17689	=	_	
107-13	17690-17695	0.007	_	
107-14	17695-17696	)	_	
107-15	17697-17700	and	_	
107-16	17701-17704	SWI	_	
107-17	17705-17706	(	_	
107-18	17706-17707	U	_	
107-19	17708-17709	=	_	
107-20	17710-17713	284	_	
107-21	17713-17714	,	_	
107-22	17715-17716	p	_	
107-23	17717-17718	=	_	
107-24	17719-17723	0.02	_	
107-25	17723-17724	)	_	
107-26	17725-17727	of	_	
107-27	17728-17732	IWMD	_	
107-28	17733-17735	in	_	
107-29	17736-17739	the	_	
107-30	17740-17745	gamma	_	
107-31	17746-17755	frequency	_	
107-32	17756-17760	band	_	
107-33	17761-17764	are	_	
107-34	17765-17778	statistically	_	
107-35	17779-17792	significantly	_	
107-36	17793-17799	higher	_	
107-37	17800-17804	than	_	
107-38	17805-17810	those	_	
107-39	17811-17813	of	_	
107-40	17814-17817	NCs	_	
107-41	17818-17819	(	_	
107-42	17819-17824	Table	_	
107-43	17825-17826	5	_	
107-44	17826-17827	)	_	
107-45	17827-17828	.	_	

#Text=The differences of all topology metrics between IWMD and NCs (Mann–Whitney U / p-value) or (F/p-value) in source space.
108-1	17829-17832	The	_	
108-2	17833-17844	differences	_	
108-3	17845-17847	of	_	
108-4	17848-17851	all	_	
108-5	17852-17860	topology	_	
108-6	17861-17868	metrics	_	
108-7	17869-17876	between	_	
108-8	17877-17881	IWMD	_	
108-9	17882-17885	and	_	
108-10	17886-17889	NCs	_	
108-11	17890-17891	(	_	
108-12	17891-17903	Mann–Whitney	_	
108-13	17904-17905	U	_	
108-14	17906-17907	/	_	
108-15	17908-17915	p-value	_	
108-16	17915-17916	)	_	
108-17	17917-17919	or	_	
108-18	17920-17921	(	_	
108-19	17921-17922	F	_	
108-20	17922-17923	/	_	
108-21	17923-17930	p-value	_	
108-22	17930-17931	)	_	
108-23	17932-17934	in	_	
108-24	17935-17941	source	_	
108-25	17942-17947	space	_	
108-26	17947-17948	.	_	

#Text=delta\ttheta\talpha\tbeta\tgamma\t \tNS\t338/0.15\t412/0.7\t0.032/0.8a\t322/0.09\t254/0.007\t \tCC\t365/0.3\t1.8/0.178a\t0.024/0.8a\t0.96/0.3a\t416/0.8\t \tCP\t2.3/0.13a\t422/0.8\t0.2/0.6a\t323/0.1\t269/0.01\t \tSWI\t325/0.1\t371/0.3\t393/0.5\t331/0.1\t284/0.02\t \t
#Text=The ‘a’ indicates parametric test.
109-1	17950-17955	delta	_	
109-2	17956-17961	theta	_	
109-3	17962-17967	alpha	_	
109-4	17968-17972	beta	_	
109-5	17973-17978	gamma	_	
109-6	17981-17983	NS	_	
109-7	17984-17987	338	_	
109-8	17987-17988	/	_	
109-9	17988-17992	0.15	_	
109-10	17993-17996	412	_	
109-11	17996-17997	/	_	
109-12	17997-18000	0.7	_	
109-13	18001-18006	0.032	_	
109-14	18006-18007	/	_	
109-15	18007-18011	0.8a	_	
109-16	18012-18015	322	_	
109-17	18015-18016	/	_	
109-18	18016-18020	0.09	_	
109-19	18021-18024	254	_	
109-20	18024-18025	/	_	
109-21	18025-18030	0.007	_	
109-22	18033-18035	CC	_	
109-23	18036-18039	365	_	
109-24	18039-18040	/	_	
109-25	18040-18043	0.3	_	
109-26	18044-18047	1.8	_	
109-27	18047-18048	/	_	
109-28	18048-18054	0.178a	_	
109-29	18055-18060	0.024	_	
109-30	18060-18061	/	_	
109-31	18061-18065	0.8a	_	
109-32	18066-18070	0.96	_	
109-33	18070-18071	/	_	
109-34	18071-18075	0.3a	_	
109-35	18076-18079	416	_	
109-36	18079-18080	/	_	
109-37	18080-18083	0.8	_	
109-38	18086-18088	CP	_	
109-39	18089-18092	2.3	_	
109-40	18092-18093	/	_	
109-41	18093-18098	0.13a	_	
109-42	18099-18102	422	_	
109-43	18102-18103	/	_	
109-44	18103-18106	0.8	_	
109-45	18107-18110	0.2	_	
109-46	18110-18111	/	_	
109-47	18111-18115	0.6a	_	
109-48	18116-18119	323	_	
109-49	18119-18120	/	_	
109-50	18120-18123	0.1	_	
109-51	18124-18127	269	_	
109-52	18127-18128	/	_	
109-53	18128-18132	0.01	_	
109-54	18135-18138	SWI	_	
109-55	18139-18142	325	_	
109-56	18142-18143	/	_	
109-57	18143-18146	0.1	_	
109-58	18147-18150	371	_	
109-59	18150-18151	/	_	
109-60	18151-18154	0.3	_	
109-61	18155-18158	393	_	
109-62	18158-18159	/	_	
109-63	18159-18162	0.5	_	
109-64	18163-18166	331	_	
109-65	18166-18167	/	_	
109-66	18167-18170	0.1	_	
109-67	18171-18174	284	_	
109-68	18174-18175	/	_	
109-69	18175-18179	0.02	_	
109-70	18183-18186	The	_	
109-71	18187-18188	‘	_	
109-72	18188-18189	a	_	
109-73	18189-18190	’	_	
109-74	18191-18200	indicates	_	
109-75	18201-18211	parametric	_	
109-76	18212-18216	test	_	
109-77	18216-18217	.	_	

#Text=Significant differences (p<0.05) are bold.
110-1	18218-18229	Significant	_	
110-2	18230-18241	differences	_	
110-3	18242-18243	(	_	
110-4	18243-18244	p	_	
110-5	18244-18245	<	_	
110-6	18245-18249	0.05	_	
110-7	18249-18250	)	_	
110-8	18251-18254	are	_	
110-9	18255-18259	bold	_	
110-10	18259-18260	.	_	

#Text=The mean and SD of the topological measurements at all the frequency bands are brought in Table 6 and shown in Fig 1.
111-1	18261-18264	The	_	
111-2	18265-18269	mean	_	
111-3	18270-18273	and	_	
111-4	18274-18276	SD	_	
111-5	18277-18279	of	_	
111-6	18280-18283	the	_	
111-7	18284-18295	topological	_	
111-8	18296-18308	measurements	_	
111-9	18309-18311	at	_	
111-10	18312-18315	all	_	
111-11	18316-18319	the	_	
111-12	18320-18329	frequency	_	
111-13	18330-18335	bands	_	
111-14	18336-18339	are	_	
111-15	18340-18347	brought	_	
111-16	18348-18350	in	_	
111-17	18351-18356	Table	_	
111-18	18357-18358	6	_	
111-19	18359-18362	and	_	
111-20	18363-18368	shown	_	
111-21	18369-18371	in	_	
111-22	18372-18375	Fig	_	
111-23	18376-18377	1	_	
111-24	18377-18378	.	_	

#Text=The values of topological metrics in source space along with related statistical log files are brought in S3 Table and S2 File.
112-1	18379-18382	The	_	
112-2	18383-18389	values	_	
112-3	18390-18392	of	_	
112-4	18393-18404	topological	_	
112-5	18405-18412	metrics	_	
112-6	18413-18415	in	_	
112-7	18416-18422	source	_	
112-8	18423-18428	space	_	
112-9	18429-18434	along	_	
112-10	18435-18439	with	_	
112-11	18440-18447	related	_	
112-12	18448-18459	statistical	_	
112-13	18460-18463	log	_	
112-14	18464-18469	files	_	
112-15	18470-18473	are	_	
112-16	18474-18481	brought	_	
112-17	18482-18484	in	_	
112-18	18485-18487	S3	_	
112-19	18488-18493	Table	_	
112-20	18494-18497	and	_	
112-21	18498-18500	S2	_	
112-22	18501-18505	File	_	
112-23	18505-18506	.	_	

#Text=Mean and standard deviation of the brain topology metrics in five frequency bands for IWMUD and NCs acquired in source space.
113-1	18507-18511	Mean	_	
113-2	18512-18515	and	_	
113-3	18516-18524	standard	_	
113-4	18525-18534	deviation	_	
113-5	18535-18537	of	_	
113-6	18538-18541	the	_	
113-7	18542-18547	brain	_	
113-8	18548-18556	topology	_	
113-9	18557-18564	metrics	_	
113-10	18565-18567	in	_	
113-11	18568-18572	five	_	
113-12	18573-18582	frequency	_	
113-13	18583-18588	bands	_	
113-14	18589-18592	for	_	
113-15	18593-18598	IWMUD	_	
113-16	18599-18602	and	_	
113-17	18603-18606	NCs	_	
113-18	18607-18615	acquired	_	
113-19	18616-18618	in	_	
113-20	18619-18625	source	_	
113-21	18626-18631	space	_	
113-22	18631-18632	.	_	

#Text=Frequency Band\tNS\tCC\tCP\tSWI\t \tMean(SD) Patient/Control\tMean(SD) Patient/Control\tMean(SD) Patient/Control\tMean(SD)Patient/Control\t \tdelta\t8.1383 (2.3436) / 7.3786 (1.1594)\t0.19055 (0.030569) / 0.18306 (0.024361)\t8.7826 (1.45) / 9.2687 (0.72281)\t0.0228 (0.008) / 0.019924 (0.0033749)\t \ttheta\t6.9361 (1.9247) / 6.6823 (1.107)\t0.1868 (0.029246) / 0.17952 (0.025357)\t10.24 (1.53) / 10.3356 (0.90367)\t0.0189 (0.0055) / 0.01754 (0.0033749)\t \talpha\t6.5183 (1.5906) / 6.5775 (1.3634)\t0.18508 (0.028833) / 0.18584 (0.026051)\t10.91 (1.93) / 10.6937 (1.4524)\t0.0175 (0.0039) / 0.017707 (0.0033749)\t \tbeta\t3.86 (1.1416) / 3.9243 (0.78829)\t0.17541 (0.026241) / 0.17984 (0.024427)\t18.43 (3.43) / 17.6271 (2.17)\t0.0099 (0.0029) / 0.010369 (0.0033749)\t \tgamma\t3.7041 (0.83654) / 3.338 (0.57717)\t0.17577 (0.027282) / 0.17171 (0.033844)\t18.76 (2.50) / 20.402 (1.8259)\t0.0095 (0.001728826) / 0.0084513 (0.0033749)\t \t
#Text=The functional connectivity values were significantly different between two groups for some pairs of AAL regions at all the frequency bands except at the theta band.
114-1	18633-18642	Frequency	_	
114-2	18643-18647	Band	_	
114-3	18648-18650	NS	_	
114-4	18651-18653	CC	_	
114-5	18654-18656	CP	_	
114-6	18657-18660	SWI	_	
114-7	18663-18667	Mean	_	
114-8	18667-18668	(	_	
114-9	18668-18670	SD	_	
114-10	18670-18671	)	_	
114-11	18672-18679	Patient	_	
114-12	18679-18680	/	_	
114-13	18680-18687	Control	_	
114-14	18688-18692	Mean	_	
114-15	18692-18693	(	_	
114-16	18693-18695	SD	_	
114-17	18695-18696	)	_	
114-18	18697-18704	Patient	_	
114-19	18704-18705	/	_	
114-20	18705-18712	Control	_	
114-21	18713-18717	Mean	_	
114-22	18717-18718	(	_	
114-23	18718-18720	SD	_	
114-24	18720-18721	)	_	
114-25	18722-18729	Patient	_	
114-26	18729-18730	/	_	
114-27	18730-18737	Control	_	
114-28	18738-18742	Mean	_	
114-29	18742-18743	(	_	
114-30	18743-18745	SD	_	
114-31	18745-18746	)	_	
114-32	18746-18753	Patient	_	
114-33	18753-18754	/	_	
114-34	18754-18761	Control	_	
114-35	18764-18769	delta	_	
114-36	18770-18776	8.1383	_	
114-37	18777-18778	(	_	
114-38	18778-18784	2.3436	_	
114-39	18784-18785	)	_	
114-40	18786-18787	/	_	
114-41	18788-18794	7.3786	_	
114-42	18795-18796	(	_	
114-43	18796-18802	1.1594	_	
114-44	18802-18803	)	_	
114-45	18804-18811	0.19055	_	
114-46	18812-18813	(	_	
114-47	18813-18821	0.030569	_	
114-48	18821-18822	)	_	
114-49	18823-18824	/	_	
114-50	18825-18832	0.18306	_	
114-51	18833-18834	(	_	
114-52	18834-18842	0.024361	_	
114-53	18842-18843	)	_	
114-54	18844-18850	8.7826	_	
114-55	18851-18852	(	_	
114-56	18852-18856	1.45	_	
114-57	18856-18857	)	_	
114-58	18858-18859	/	_	
114-59	18860-18866	9.2687	_	
114-60	18867-18868	(	_	
114-61	18868-18875	0.72281	_	
114-62	18875-18876	)	_	
114-63	18877-18883	0.0228	_	
114-64	18884-18885	(	_	
114-65	18885-18890	0.008	_	
114-66	18890-18891	)	_	
114-67	18892-18893	/	_	
114-68	18894-18902	0.019924	_	
114-69	18903-18904	(	_	
114-70	18904-18913	0.0033749	_	
114-71	18913-18914	)	_	
114-72	18917-18922	theta	_	
114-73	18923-18929	6.9361	_	
114-74	18930-18931	(	_	
114-75	18931-18937	1.9247	_	
114-76	18937-18938	)	_	
114-77	18939-18940	/	_	
114-78	18941-18947	6.6823	_	
114-79	18948-18949	(	_	
114-80	18949-18954	1.107	_	
114-81	18954-18955	)	_	
114-82	18956-18962	0.1868	_	
114-83	18963-18964	(	_	
114-84	18964-18972	0.029246	_	
114-85	18972-18973	)	_	
114-86	18974-18975	/	_	
114-87	18976-18983	0.17952	_	
114-88	18984-18985	(	_	
114-89	18985-18993	0.025357	_	
114-90	18993-18994	)	_	
114-91	18995-19000	10.24	_	
114-92	19001-19002	(	_	
114-93	19002-19006	1.53	_	
114-94	19006-19007	)	_	
114-95	19008-19009	/	_	
114-96	19010-19017	10.3356	_	
114-97	19018-19019	(	_	
114-98	19019-19026	0.90367	_	
114-99	19026-19027	)	_	
114-100	19028-19034	0.0189	_	
114-101	19035-19036	(	_	
114-102	19036-19042	0.0055	_	
114-103	19042-19043	)	_	
114-104	19044-19045	/	_	
114-105	19046-19053	0.01754	_	
114-106	19054-19055	(	_	
114-107	19055-19064	0.0033749	_	
114-108	19064-19065	)	_	
114-109	19068-19073	alpha	_	
114-110	19074-19080	6.5183	_	
114-111	19081-19082	(	_	
114-112	19082-19088	1.5906	_	
114-113	19088-19089	)	_	
114-114	19090-19091	/	_	
114-115	19092-19098	6.5775	_	
114-116	19099-19100	(	_	
114-117	19100-19106	1.3634	_	
114-118	19106-19107	)	_	
114-119	19108-19115	0.18508	_	
114-120	19116-19117	(	_	
114-121	19117-19125	0.028833	_	
114-122	19125-19126	)	_	
114-123	19127-19128	/	_	
114-124	19129-19136	0.18584	_	
114-125	19137-19138	(	_	
114-126	19138-19146	0.026051	_	
114-127	19146-19147	)	_	
114-128	19148-19153	10.91	_	
114-129	19154-19155	(	_	
114-130	19155-19159	1.93	_	
114-131	19159-19160	)	_	
114-132	19161-19162	/	_	
114-133	19163-19170	10.6937	_	
114-134	19171-19172	(	_	
114-135	19172-19178	1.4524	_	
114-136	19178-19179	)	_	
114-137	19180-19186	0.0175	_	
114-138	19187-19188	(	_	
114-139	19188-19194	0.0039	_	
114-140	19194-19195	)	_	
114-141	19196-19197	/	_	
114-142	19198-19206	0.017707	_	
114-143	19207-19208	(	_	
114-144	19208-19217	0.0033749	_	
114-145	19217-19218	)	_	
114-146	19221-19225	beta	_	
114-147	19226-19230	3.86	_	
114-148	19231-19232	(	_	
114-149	19232-19238	1.1416	_	
114-150	19238-19239	)	_	
114-151	19240-19241	/	_	
114-152	19242-19248	3.9243	_	
114-153	19249-19250	(	_	
114-154	19250-19257	0.78829	_	
114-155	19257-19258	)	_	
114-156	19259-19266	0.17541	_	
114-157	19267-19268	(	_	
114-158	19268-19276	0.026241	_	
114-159	19276-19277	)	_	
114-160	19278-19279	/	_	
114-161	19280-19287	0.17984	_	
114-162	19288-19289	(	_	
114-163	19289-19297	0.024427	_	
114-164	19297-19298	)	_	
114-165	19299-19304	18.43	_	
114-166	19305-19306	(	_	
114-167	19306-19310	3.43	_	
114-168	19310-19311	)	_	
114-169	19312-19313	/	_	
114-170	19314-19321	17.6271	_	
114-171	19322-19323	(	_	
114-172	19323-19327	2.17	_	
114-173	19327-19328	)	_	
114-174	19329-19335	0.0099	_	
114-175	19336-19337	(	_	
114-176	19337-19343	0.0029	_	
114-177	19343-19344	)	_	
114-178	19345-19346	/	_	
114-179	19347-19355	0.010369	_	
114-180	19356-19357	(	_	
114-181	19357-19366	0.0033749	_	
114-182	19366-19367	)	_	
114-183	19370-19375	gamma	_	
114-184	19376-19382	3.7041	_	
114-185	19383-19384	(	_	
114-186	19384-19391	0.83654	_	
114-187	19391-19392	)	_	
114-188	19393-19394	/	_	
114-189	19395-19400	3.338	_	
114-190	19401-19402	(	_	
114-191	19402-19409	0.57717	_	
114-192	19409-19410	)	_	
114-193	19411-19418	0.17577	_	
114-194	19419-19420	(	_	
114-195	19420-19428	0.027282	_	
114-196	19428-19429	)	_	
114-197	19430-19431	/	_	
114-198	19432-19439	0.17171	_	
114-199	19440-19441	(	_	
114-200	19441-19449	0.033844	_	
114-201	19449-19450	)	_	
114-202	19451-19456	18.76	_	
114-203	19457-19458	(	_	
114-204	19458-19462	2.50	_	
114-205	19462-19463	)	_	
114-206	19464-19465	/	_	
114-207	19466-19472	20.402	_	
114-208	19473-19474	(	_	
114-209	19474-19480	1.8259	_	
114-210	19480-19481	)	_	
114-211	19482-19488	0.0095	_	
114-212	19489-19490	(	_	
114-213	19490-19501	0.001728826	_	
114-214	19501-19502	)	_	
114-215	19503-19504	/	_	
114-216	19505-19514	0.0084513	_	
114-217	19515-19516	(	_	
114-218	19516-19525	0.0033749	_	
114-219	19525-19526	)	_	
114-220	19530-19533	The	_	
114-221	19534-19544	functional	_	
114-222	19545-19557	connectivity	_	
114-223	19558-19564	values	_	
114-224	19565-19569	were	_	
114-225	19570-19583	significantly	_	
114-226	19584-19593	different	_	
114-227	19594-19601	between	_	
114-228	19602-19605	two	_	
114-229	19606-19612	groups	_	
114-230	19613-19616	for	_	
114-231	19617-19621	some	_	
114-232	19622-19627	pairs	_	
114-233	19628-19630	of	_	
114-234	19631-19634	AAL	_	
114-235	19635-19642	regions	_	
114-236	19643-19645	at	_	
114-237	19646-19649	all	_	
114-238	19650-19653	the	_	
114-239	19654-19663	frequency	_	
114-240	19664-19669	bands	_	
114-241	19670-19676	except	_	
114-242	19677-19679	at	_	
114-243	19680-19683	the	_	
114-244	19684-19689	theta	_	
114-245	19690-19694	band	_	
114-246	19694-19695	.	_	

#Text=In this regard, the significance level was α = 0.05 using false discovery rate (FDR) q<0.05 to correct for multiple comparisons.
115-1	19696-19698	In	_	
115-2	19699-19703	this	_	
115-3	19704-19710	regard	_	
115-4	19710-19711	,	_	
115-5	19712-19715	the	_	
115-6	19716-19728	significance	_	
115-7	19729-19734	level	_	
115-8	19735-19738	was	_	
115-9	19739-19740	α	_	
115-10	19741-19742	=	_	
115-11	19743-19747	0.05	_	
115-12	19748-19753	using	_	
115-13	19754-19759	false	_	
115-14	19760-19769	discovery	_	
115-15	19770-19774	rate	_	
115-16	19775-19776	(	_	
115-17	19776-19779	FDR	_	
115-18	19779-19780	)	_	
115-19	19781-19782	q	_	
115-20	19782-19783	<	_	
115-21	19783-19787	0.05	_	
115-22	19788-19790	to	_	
115-23	19791-19798	correct	_	
115-24	19799-19802	for	_	
115-25	19803-19811	multiple	_	
115-26	19812-19823	comparisons	_	
115-27	19823-19824	.	_	

#Text=The gamma oscillatory rhythm revealed more connectivity differences compared to the other rhythms.
116-1	19825-19828	The	_	
116-2	19829-19834	gamma	_	
116-3	19835-19846	oscillatory	_	
116-4	19847-19853	rhythm	_	
116-5	19854-19862	revealed	_	
116-6	19863-19867	more	_	
116-7	19868-19880	connectivity	_	
116-8	19881-19892	differences	_	
116-9	19893-19901	compared	_	
116-10	19902-19904	to	_	
116-11	19905-19908	the	_	
116-12	19909-19914	other	_	
116-13	19915-19922	rhythms	_	
116-14	19922-19923	.	_	

#Text=At the gamma band range, the functional connectivity of IWMUD was greater than those of NCs, in seven AAL pairs, while for the delta band only two pairs have shown enhanced coupling values in IWMUD compared to those of NCs.
117-1	19924-19926	At	_	
117-2	19927-19930	the	_	
117-3	19931-19936	gamma	_	
117-4	19937-19941	band	_	
117-5	19942-19947	range	_	
117-6	19947-19948	,	_	
117-7	19949-19952	the	_	
117-8	19953-19963	functional	_	
117-9	19964-19976	connectivity	_	
117-10	19977-19979	of	_	
117-11	19980-19985	IWMUD	_	
117-12	19986-19989	was	_	
117-13	19990-19997	greater	_	
117-14	19998-20002	than	_	
117-15	20003-20008	those	_	
117-16	20009-20011	of	_	
117-17	20012-20015	NCs	_	
117-18	20015-20016	,	_	
117-19	20017-20019	in	_	
117-20	20020-20025	seven	_	
117-21	20026-20029	AAL	_	
117-22	20030-20035	pairs	_	
117-23	20035-20036	,	_	
117-24	20037-20042	while	_	
117-25	20043-20046	for	_	
117-26	20047-20050	the	_	
117-27	20051-20056	delta	_	
117-28	20057-20061	band	_	
117-29	20062-20066	only	_	
117-30	20067-20070	two	_	
117-31	20071-20076	pairs	_	
117-32	20077-20081	have	_	
117-33	20082-20087	shown	_	
117-34	20088-20096	enhanced	_	
117-35	20097-20105	coupling	_	
117-36	20106-20112	values	_	
117-37	20113-20115	in	_	
117-38	20116-20121	IWMUD	_	
117-39	20122-20130	compared	_	
117-40	20131-20133	to	_	
117-41	20134-20139	those	_	
117-42	20140-20142	of	_	
117-43	20143-20146	NCs	_	
117-44	20146-20147	.	_	

#Text=At the alpha frequency band, IWMUD showed just attenuated functional coupling in two AAL pairs compared two NCs, while at the beta oscillatory rhythm both enhanced and attenuated functional couplings were revealed.
118-1	20148-20150	At	_	
118-2	20151-20154	the	_	
118-3	20155-20160	alpha	_	
118-4	20161-20170	frequency	_	
118-5	20171-20175	band	_	
118-6	20175-20176	,	_	
118-7	20177-20182	IWMUD	_	
118-8	20183-20189	showed	_	
118-9	20190-20194	just	_	
118-10	20195-20205	attenuated	_	
118-11	20206-20216	functional	_	
118-12	20217-20225	coupling	_	
118-13	20226-20228	in	_	
118-14	20229-20232	two	_	
118-15	20233-20236	AAL	_	
118-16	20237-20242	pairs	_	
118-17	20243-20251	compared	_	
118-18	20252-20255	two	_	
118-19	20256-20259	NCs	_	
118-20	20259-20260	,	_	
118-21	20261-20266	while	_	
118-22	20267-20269	at	_	
118-23	20270-20273	the	_	
118-24	20274-20278	beta	_	
118-25	20279-20290	oscillatory	_	
118-26	20291-20297	rhythm	_	
118-27	20298-20302	both	_	
118-28	20303-20311	enhanced	_	
118-29	20312-20315	and	_	
118-30	20316-20326	attenuated	_	
118-31	20327-20337	functional	_	
118-32	20338-20347	couplings	_	
118-33	20348-20352	were	_	
118-34	20353-20361	revealed	_	
118-35	20361-20362	.	_	

#Text=There were no significant differences between two groups in the theta band.
119-1	20363-20368	There	_	
119-2	20369-20373	were	_	
119-3	20374-20376	no	_	
119-4	20377-20388	significant	_	
119-5	20389-20400	differences	_	
119-6	20401-20408	between	_	
119-7	20409-20412	two	_	
119-8	20413-20419	groups	_	
119-9	20420-20422	in	_	
119-10	20423-20426	the	_	
119-11	20427-20432	theta	_	
119-12	20433-20437	band	_	
119-13	20437-20438	.	_	

#Text=These coupling differences are mapped on the brain image in Fig 2 using BrainNet Viewer.
120-1	20439-20444	These	_	
120-2	20445-20453	coupling	_	
120-3	20454-20465	differences	_	
120-4	20466-20469	are	_	
120-5	20470-20476	mapped	_	
120-6	20477-20479	on	_	
120-7	20480-20483	the	_	
120-8	20484-20489	brain	_	
120-9	20490-20495	image	_	
120-10	20496-20498	in	_	
120-11	20499-20502	Fig	_	
120-12	20503-20504	2	_	
120-13	20505-20510	using	_	
120-14	20511-20519	BrainNet	_	
120-15	20520-20526	Viewer	_	
120-16	20526-20527	.	_	

#Text=Functional connectivity differences after FDR correction in the frequency bands.
121-1	20528-20538	Functional	_	
121-2	20539-20551	connectivity	_	
121-3	20552-20563	differences	_	
121-4	20564-20569	after	_	
121-5	20570-20573	FDR	_	
121-6	20574-20584	correction	_	
121-7	20585-20587	in	_	
121-8	20588-20591	the	_	
121-9	20592-20601	frequency	_	
121-10	20602-20607	bands	_	
121-11	20607-20608	.	_	

#Text=The red/blue means attenuated/enhanced inter-regional connectivity in IWMUD compared to NCs.
122-1	20609-20612	The	_	
122-2	20613-20616	red	_	
122-3	20616-20617	/	_	
122-4	20617-20621	blue	_	
122-5	20622-20627	means	_	
122-6	20628-20638	attenuated	_	
122-7	20638-20639	/	_	
122-8	20639-20647	enhanced	_	
122-9	20648-20662	inter-regional	_	
122-10	20663-20675	connectivity	_	
122-11	20676-20678	in	_	
122-12	20679-20684	IWMUD	_	
122-13	20685-20693	compared	_	
122-14	20694-20696	to	_	
122-15	20697-20700	NCs	_	
122-16	20700-20701	.	_	

#Text=Common hubs calculated from the FCN of the two groups using the centrality measures were different in the five frequency bands.
123-1	20702-20708	Common	_	
123-2	20709-20713	hubs	_	
123-3	20714-20724	calculated	_	
123-4	20725-20729	from	_	
123-5	20730-20733	the	_	
123-6	20734-20737	FCN	_	
123-7	20738-20740	of	_	
123-8	20741-20744	the	_	
123-9	20745-20748	two	_	
123-10	20749-20755	groups	_	
123-11	20756-20761	using	_	
123-12	20762-20765	the	_	
123-13	20766-20776	centrality	_	
123-14	20777-20785	measures	_	
123-15	20786-20790	were	_	
123-16	20791-20800	different	_	
123-17	20801-20803	in	_	
123-18	20804-20807	the	_	
123-19	20808-20812	five	_	
123-20	20813-20822	frequency	_	
123-21	20823-20828	bands	_	
123-22	20828-20829	.	_	

#Text=These hubs are listed in Table 7 and mapped on the brain in Fig 3.
124-1	20830-20835	These	_	
124-2	20836-20840	hubs	_	
124-3	20841-20844	are	_	
124-4	20845-20851	listed	_	
124-5	20852-20854	in	_	
124-6	20855-20860	Table	_	
124-7	20861-20862	7	_	
124-8	20863-20866	and	_	
124-9	20867-20873	mapped	_	
124-10	20874-20876	on	_	
124-11	20877-20880	the	_	
124-12	20881-20886	brain	_	
124-13	20887-20889	in	_	
124-14	20890-20893	Fig	_	
124-15	20894-20895	3	_	
124-16	20895-20896	.	_	

#Text=Hubs of IWMUD (top row) and NCs (bottom row) in the five frequency bands.
125-1	20897-20901	Hubs	_	
125-2	20902-20904	of	_	
125-3	20905-20910	IWMUD	_	
125-4	20911-20912	(	_	
125-5	20912-20915	top	_	
125-6	20916-20919	row	_	
125-7	20919-20920	)	_	
125-8	20921-20924	and	_	
125-9	20925-20928	NCs	_	
125-10	20929-20930	(	_	
125-11	20930-20936	bottom	_	
125-12	20937-20940	row	_	
125-13	20940-20941	)	_	
125-14	20942-20944	in	_	
125-15	20945-20948	the	_	
125-16	20949-20953	five	_	
125-17	20954-20963	frequency	_	
125-18	20964-20969	bands	_	
125-19	20969-20970	.	_	

#Text=The figures are ploted using brain net.
126-1	20971-20974	The	_	
126-2	20975-20982	figures	_	
126-3	20983-20986	are	_	
126-4	20987-20993	ploted	_	
126-5	20994-20999	using	_	
126-6	21000-21005	brain	_	
126-7	21006-21009	net	_	
126-8	21009-21010	.	_	

#Text=The name of specific hubs of patient and control and common hubs between the two groups.
127-1	21011-21014	The	_	
127-2	21015-21019	name	_	
127-3	21020-21022	of	_	
127-4	21023-21031	specific	_	
127-5	21032-21036	hubs	_	
127-6	21037-21039	of	_	
127-7	21040-21047	patient	_	
127-8	21048-21051	and	_	
127-9	21052-21059	control	_	
127-10	21060-21063	and	_	
127-11	21064-21070	common	_	
127-12	21071-21075	hubs	_	
127-13	21076-21083	between	_	
127-14	21084-21087	the	_	
127-15	21088-21091	two	_	
127-16	21092-21098	groups	_	
127-17	21098-21099	.	_	

#Text=IWMD\tdelta\tFrontal_Mid_Orb_L\tFrontal_Inf_Tri_R\tSupp_Motor_Area_L\tSupp_Motor_Area_R\tFrontal_Sup_Medial_R\tFrontal_Med_Orb_L\t\t\t \ttheta\tFrontal_Sup_Orb_R\tAngular_L\tPrecuneus_L\tPrecuneus_R\tParacentral_Lobule_L\tParacentral_Lobule_R\t\t\t \talpha\tSupp_Motor_Area_L\tSupp_Motor_Area_R\tFrontal_Med_Orb_L\tCalcarine_R\tCuneus_R\tOccipital_Inf_L\tTemporal_Sup_L\tTemporal_Pole_Mid_R\t \tbeta\tFrontal_Inf_Orb_L\tOlfactory_L\tSupraMarginal_L\tTemporal_Sup_L\tTemporal_Mid_L\t\t\t\t \tgamma\tFrontal_Sup_R\tFrontal_Inf_Orb_R\tCingulum_Ant_R\tCalcarine_R\tTemporal_Sup_L\tTemporal_Inf_L\t\t\t \tNCS\tdelta\tFrontal_Mid_Orb_L\tFrontal_Inf_Tri_L\tRectus_L\tFusiform_R\tParietal_Inf_R\t\t\t\t \ttheta\tRolandic_Oper_L\tCalcarine_R\tOccipital_Sup_R\tAngular_R\tPrecuneus_R\tParacentral_Lobule_R\t\t\t \talpha\tFrontal_Sup_Orb_R\tFrontal_Mid_Orb_L\tFrontal_Mid_Orb_R\tFrontal_Inf_Tri_L\tCuneus_R\tHeschl_L\t\t\t \tbeta\tFrontal_Mid_Orb_L\tFrontal_Mid_Orb_R\tSupp_Motor_Area_L\tFrontal_Med_Orb_R\tCalcarine_R\tPrecuneus_R\tTemporal_Mid_R\t\t \tgamma\tFrontal_Med_Orb_R\tOccipital_Inf_L\tParietal_Inf_L\tThalamus_R\tTemporal_Inf_R\t\t\t\t \tCommon Hubs\tdelta\tFrontal_Mid_Orb_L\t\t\t\t\t\t\t\t \ttheta\tPrecuneus_R\tParacentral_Lobule_R\t\t\t\t\t\t\t \talpha\tCuneus_R\t\t\t\t\t\t\t\t \t
#Text=4.3 Results of self-reported measurements
#Text=We used Barratt Impulsiveness Scale-11 (BIS-11) and Depression Anxiety Stress Scale-21 (DASS-21) to measure self-reported impulsivity, depression, anxiety and stress.
128-1	21100-21104	IWMD	_	
128-2	21105-21110	delta	_	
128-3	21111-21128	Frontal_Mid_Orb_L	_	
128-4	21129-21146	Frontal_Inf_Tri_R	_	
128-5	21147-21164	Supp_Motor_Area_L	_	
128-6	21165-21182	Supp_Motor_Area_R	_	
128-7	21183-21203	Frontal_Sup_Medial_R	_	
128-8	21204-21221	Frontal_Med_Orb_L	_	
128-9	21226-21231	theta	_	
128-10	21232-21249	Frontal_Sup_Orb_R	_	
128-11	21250-21259	Angular_L	_	
128-12	21260-21271	Precuneus_L	_	
128-13	21272-21283	Precuneus_R	_	
128-14	21284-21304	Paracentral_Lobule_L	_	
128-15	21305-21325	Paracentral_Lobule_R	_	
128-16	21330-21335	alpha	_	
128-17	21336-21353	Supp_Motor_Area_L	_	
128-18	21354-21371	Supp_Motor_Area_R	_	
128-19	21372-21389	Frontal_Med_Orb_L	_	
128-20	21390-21401	Calcarine_R	_	
128-21	21402-21410	Cuneus_R	_	
128-22	21411-21426	Occipital_Inf_L	_	
128-23	21427-21441	Temporal_Sup_L	_	
128-24	21442-21461	Temporal_Pole_Mid_R	_	
128-25	21464-21468	beta	_	
128-26	21469-21486	Frontal_Inf_Orb_L	_	
128-27	21487-21498	Olfactory_L	_	
128-28	21499-21514	SupraMarginal_L	_	
128-29	21515-21529	Temporal_Sup_L	_	
128-30	21530-21544	Temporal_Mid_L	_	
128-31	21550-21555	gamma	_	
128-32	21556-21569	Frontal_Sup_R	_	
128-33	21570-21587	Frontal_Inf_Orb_R	_	
128-34	21588-21602	Cingulum_Ant_R	_	
128-35	21603-21614	Calcarine_R	_	
128-36	21615-21629	Temporal_Sup_L	_	
128-37	21630-21644	Temporal_Inf_L	_	
128-38	21649-21652	NCS	_	
128-39	21653-21658	delta	_	
128-40	21659-21676	Frontal_Mid_Orb_L	_	
128-41	21677-21694	Frontal_Inf_Tri_L	_	
128-42	21695-21703	Rectus_L	_	
128-43	21704-21714	Fusiform_R	_	
128-44	21715-21729	Parietal_Inf_R	_	
128-45	21735-21740	theta	_	
128-46	21741-21756	Rolandic_Oper_L	_	
128-47	21757-21768	Calcarine_R	_	
128-48	21769-21784	Occipital_Sup_R	_	
128-49	21785-21794	Angular_R	_	
128-50	21795-21806	Precuneus_R	_	
128-51	21807-21827	Paracentral_Lobule_R	_	
128-52	21832-21837	alpha	_	
128-53	21838-21855	Frontal_Sup_Orb_R	_	
128-54	21856-21873	Frontal_Mid_Orb_L	_	
128-55	21874-21891	Frontal_Mid_Orb_R	_	
128-56	21892-21909	Frontal_Inf_Tri_L	_	
128-57	21910-21918	Cuneus_R	_	
128-58	21919-21927	Heschl_L	_	
128-59	21932-21936	beta	_	
128-60	21937-21954	Frontal_Mid_Orb_L	_	
128-61	21955-21972	Frontal_Mid_Orb_R	_	
128-62	21973-21990	Supp_Motor_Area_L	_	
128-63	21991-22008	Frontal_Med_Orb_R	_	
128-64	22009-22020	Calcarine_R	_	
128-65	22021-22032	Precuneus_R	_	
128-66	22033-22047	Temporal_Mid_R	_	
128-67	22051-22056	gamma	_	
128-68	22057-22074	Frontal_Med_Orb_R	_	
128-69	22075-22090	Occipital_Inf_L	_	
128-70	22091-22105	Parietal_Inf_L	_	
128-71	22106-22116	Thalamus_R	_	
128-72	22117-22131	Temporal_Inf_R	_	
128-73	22137-22143	Common	_	
128-74	22144-22148	Hubs	_	
128-75	22149-22154	delta	_	
128-76	22155-22172	Frontal_Mid_Orb_L	_	
128-77	22182-22187	theta	_	
128-78	22188-22199	Precuneus_R	_	
128-79	22200-22220	Paracentral_Lobule_R	_	
128-80	22229-22234	alpha	_	
128-81	22235-22243	Cuneus_R	_	
128-82	22254-22257	4.3	_	
128-83	22258-22265	Results	_	
128-84	22266-22268	of	_	
128-85	22269-22282	self-reported	_	
128-86	22283-22295	measurements	_	
128-87	22296-22298	We	_	
128-88	22299-22303	used	_	
128-89	22304-22311	Barratt	_	
128-90	22312-22325	Impulsiveness	_	
128-91	22326-22331	Scale	_	
128-92	22331-22332	-	_	
128-93	22332-22334	11	_	
128-94	22335-22336	(	_	
128-95	22336-22339	BIS	_	
128-96	22339-22340	-	_	
128-97	22340-22342	11	_	
128-98	22342-22343	)	_	
128-99	22344-22347	and	_	
128-100	22348-22358	Depression	_	
128-101	22359-22366	Anxiety	_	
128-102	22367-22373	Stress	_	
128-103	22374-22379	Scale	_	
128-104	22379-22380	-	_	
128-105	22380-22382	21	_	
128-106	22383-22384	(	_	
128-107	22384-22388	DASS	_	
128-108	22388-22389	-	_	
128-109	22389-22391	21	_	
128-110	22391-22392	)	_	
128-111	22393-22395	to	_	
128-112	22396-22403	measure	_	
128-113	22404-22417	self-reported	_	
128-114	22418-22429	impulsivity	_	
128-115	22429-22430	,	_	
128-116	22431-22441	depression	_	
128-117	22441-22442	,	_	
128-118	22443-22450	anxiety	_	
128-119	22451-22454	and	_	
128-120	22455-22461	stress	_	
128-121	22461-22462	.	_	

#Text=The anxiety and stress values were significantly different between the two groups (P<0.001), but the key variable, SWI in the gamma frequency band, was not significantly correlated with these self-reported scales (Table 8).
129-1	22463-22466	The	_	
129-2	22467-22474	anxiety	_	
129-3	22475-22478	and	_	
129-4	22479-22485	stress	_	
129-5	22486-22492	values	_	
129-6	22493-22497	were	_	
129-7	22498-22511	significantly	_	
129-8	22512-22521	different	_	
129-9	22522-22529	between	_	
129-10	22530-22533	the	_	
129-11	22534-22537	two	_	
129-12	22538-22544	groups	_	
129-13	22545-22546	(	_	
129-14	22546-22547	P	_	
129-15	22547-22548	<	_	
129-16	22548-22553	0.001	_	
129-17	22553-22554	)	_	
129-18	22554-22555	,	_	
129-19	22556-22559	but	_	
129-20	22560-22563	the	_	
129-21	22564-22567	key	_	
129-22	22568-22576	variable	_	
129-23	22576-22577	,	_	
129-24	22578-22581	SWI	_	
129-25	22582-22584	in	_	
129-26	22585-22588	the	_	
129-27	22589-22594	gamma	_	
129-28	22595-22604	frequency	_	
129-29	22605-22609	band	_	
129-30	22609-22610	,	_	
129-31	22611-22614	was	_	
129-32	22615-22618	not	_	
129-33	22619-22632	significantly	_	
129-34	22633-22643	correlated	_	
129-35	22644-22648	with	_	
129-36	22649-22654	these	_	
129-37	22655-22668	self-reported	_	
129-38	22669-22675	scales	_	
129-39	22676-22677	(	_	
129-40	22677-22682	Table	_	
129-41	22683-22684	8	_	
129-42	22684-22685	)	_	
129-43	22685-22686	.	_	

#Text=Results of correlations between anxiety, depression, stress and impulsivity and the SWI values in the gamma band for the patient and control groups.
130-1	22687-22694	Results	_	
130-2	22695-22697	of	_	
130-3	22698-22710	correlations	_	
130-4	22711-22718	between	_	
130-5	22719-22726	anxiety	_	
130-6	22726-22727	,	_	
130-7	22728-22738	depression	_	
130-8	22738-22739	,	_	
130-9	22740-22746	stress	_	
130-10	22747-22750	and	_	
130-11	22751-22762	impulsivity	_	
130-12	22763-22766	and	_	
130-13	22767-22770	the	_	
130-14	22771-22774	SWI	_	
130-15	22775-22781	values	_	
130-16	22782-22784	in	_	
130-17	22785-22788	the	_	
130-18	22789-22794	gamma	_	
130-19	22795-22799	band	_	
130-20	22800-22803	for	_	
130-21	22804-22807	the	_	
130-22	22808-22815	patient	_	
130-23	22816-22819	and	_	
130-24	22820-22827	control	_	
130-25	22828-22834	groups	_	
130-26	22834-22835	.	_	

#Text=Mean (SD)\tZ\tP-value\tCorr.
131-1	22837-22841	Mean	_	
131-2	22842-22843	(	_	
131-3	22843-22845	SD	_	
131-4	22845-22846	)	_	
131-5	22847-22848	Z	_	
131-6	22849-22856	P-value	_	
131-7	22857-22861	Corr	_	
131-8	22861-22862	.	_	

#Text=Coef. / P-Value\t \tCharacteristic\tSubjects (IWMD/NCS)\tIWMD\tNCs\tIWMD\tNCs\t \tStress\t30/21\t19.66(10.62)\t6.10(2.7)\t-4.7\t<0.001\t-.16/ 0.37\t-0.07/0.75\t \tAnxiety\t31/23\t12.90 (8.66)\t5.5(5.6)\t-3.4\t.001\t0.02/ 0.92\t-0.06/0.78\t \tDepression\t29/23\t18.34(10.14)\t14.2(6.4)\t-1.4\t0.15\t-0.008/ 0.96\t-0.12/0.58\t \tTotal DASS\t36/24\t46(21)\t26(12)\t-4.2\t<0.001\t-0.17/0.47\t-0.09/0.65\t \tAttention impulsivity\t36/-\t12.11(4.81)\t\t\t\t0.15 / 0.35\t\t \tMotor impulsivity\t33/-\t15.3(6.17)\t\t\t\t0.38/ 0.03\t\t \tNonplanning impulsivity\t35/-\t17.62 (4.09)\t\t\t\t-0.08 / 0.6\t\t \t
#Text=The missing values of Total DASS were replaced by mean series.
132-1	22863-22867	Coef	_	
132-2	22867-22868	.	_	
132-3	22869-22870	/	_	
132-4	22871-22878	P-Value	_	
132-5	22881-22895	Characteristic	_	
132-6	22896-22904	Subjects	_	
132-7	22905-22906	(	_	
132-8	22906-22910	IWMD	_	
132-9	22910-22911	/	_	
132-10	22911-22914	NCS	_	
132-11	22914-22915	)	_	
132-12	22916-22920	IWMD	_	
132-13	22921-22924	NCs	_	
132-14	22925-22929	IWMD	_	
132-15	22930-22933	NCs	_	
132-16	22936-22942	Stress	_	
132-17	22943-22945	30	_	
132-18	22945-22946	/	_	
132-19	22946-22948	21	_	
132-20	22949-22954	19.66	_	
132-21	22954-22955	(	_	
132-22	22955-22960	10.62	_	
132-23	22960-22961	)	_	
132-24	22962-22966	6.10	_	
132-25	22966-22967	(	_	
132-26	22967-22970	2.7	_	
132-27	22970-22971	)	_	
132-28	22972-22973	-	_	
132-29	22973-22976	4.7	_	
132-30	22977-22978	<	_	
132-31	22978-22983	0.001	_	
132-32	22984-22985	-	_	
132-33	22985-22988	.16	_	
132-34	22988-22989	/	_	
132-35	22990-22994	0.37	_	
132-36	22995-22996	-	_	
132-37	22996-23000	0.07	_	
132-38	23000-23001	/	_	
132-39	23001-23005	0.75	_	
132-40	23008-23015	Anxiety	_	
132-41	23016-23018	31	_	
132-42	23018-23019	/	_	
132-43	23019-23021	23	_	
132-44	23022-23027	12.90	_	
132-45	23028-23029	(	_	
132-46	23029-23033	8.66	_	
132-47	23033-23034	)	_	
132-48	23035-23038	5.5	_	
132-49	23038-23039	(	_	
132-50	23039-23042	5.6	_	
132-51	23042-23043	)	_	
132-52	23044-23045	-	_	
132-53	23045-23048	3.4	_	
132-54	23049-23053	.001	_	
132-55	23054-23058	0.02	_	
132-56	23058-23059	/	_	
132-57	23060-23064	0.92	_	
132-58	23065-23066	-	_	
132-59	23066-23070	0.06	_	
132-60	23070-23071	/	_	
132-61	23071-23075	0.78	_	
132-62	23078-23088	Depression	_	
132-63	23089-23091	29	_	
132-64	23091-23092	/	_	
132-65	23092-23094	23	_	
132-66	23095-23100	18.34	_	
132-67	23100-23101	(	_	
132-68	23101-23106	10.14	_	
132-69	23106-23107	)	_	
132-70	23108-23112	14.2	_	
132-71	23112-23113	(	_	
132-72	23113-23116	6.4	_	
132-73	23116-23117	)	_	
132-74	23118-23119	-	_	
132-75	23119-23122	1.4	_	
132-76	23123-23127	0.15	_	
132-77	23128-23129	-	_	
132-78	23129-23134	0.008	_	
132-79	23134-23135	/	_	
132-80	23136-23140	0.96	_	
132-81	23141-23142	-	_	
132-82	23142-23146	0.12	_	
132-83	23146-23147	/	_	
132-84	23147-23151	0.58	_	
132-85	23154-23159	Total	_	
132-86	23160-23164	DASS	_	
132-87	23165-23167	36	_	
132-88	23167-23168	/	_	
132-89	23168-23170	24	_	
132-90	23171-23173	46	_	
132-91	23173-23174	(	_	
132-92	23174-23176	21	_	
132-93	23176-23177	)	_	
132-94	23178-23180	26	_	
132-95	23180-23181	(	_	
132-96	23181-23183	12	_	
132-97	23183-23184	)	_	
132-98	23185-23186	-	_	
132-99	23186-23189	4.2	_	
132-100	23190-23191	<	_	
132-101	23191-23196	0.001	_	
132-102	23197-23198	-	_	
132-103	23198-23202	0.17	_	
132-104	23202-23203	/	_	
132-105	23203-23207	0.47	_	
132-106	23208-23209	-	_	
132-107	23209-23213	0.09	_	
132-108	23213-23214	/	_	
132-109	23214-23218	0.65	_	
132-110	23221-23230	Attention	_	
132-111	23231-23242	impulsivity	_	
132-112	23243-23245	36	_	
132-113	23245-23246	/	_	
132-114	23246-23247	-	_	
132-115	23248-23253	12.11	_	
132-116	23253-23254	(	_	
132-117	23254-23258	4.81	_	
132-118	23258-23259	)	_	
132-119	23263-23267	0.15	_	
132-120	23268-23269	/	_	
132-121	23270-23274	0.35	_	
132-122	23278-23283	Motor	_	
132-123	23284-23295	impulsivity	_	
132-124	23296-23298	33	_	
132-125	23298-23299	/	_	
132-126	23299-23300	-	_	
132-127	23301-23305	15.3	_	
132-128	23305-23306	(	_	
132-129	23306-23310	6.17	_	
132-130	23310-23311	)	_	
132-131	23315-23319	0.38	_	
132-132	23319-23320	/	_	
132-133	23321-23325	0.03	_	
132-134	23329-23340	Nonplanning	_	
132-135	23341-23352	impulsivity	_	
132-136	23353-23355	35	_	
132-137	23355-23356	/	_	
132-138	23356-23357	-	_	
132-139	23358-23363	17.62	_	
132-140	23364-23365	(	_	
132-141	23365-23369	4.09	_	
132-142	23369-23370	)	_	
132-143	23374-23375	-	_	
132-144	23375-23379	0.08	_	
132-145	23380-23381	/	_	
132-146	23382-23385	0.6	_	
132-147	23390-23393	The	_	
132-148	23394-23401	missing	_	
132-149	23402-23408	values	_	
132-150	23409-23411	of	_	
132-151	23412-23417	Total	_	
132-152	23418-23422	DASS	_	
132-153	23423-23427	were	_	
132-154	23428-23436	replaced	_	
132-155	23437-23439	by	_	
132-156	23440-23444	mean	_	
132-157	23445-23451	series	_	
132-158	23451-23452	.	_	

#Text=Spearman correlation was used.
#Text=4.4 Power results
#Text=Power analysis revealed no significant differences between IWMUD and NCs at all the frequency bands.
133-1	23453-23461	Spearman	_	
133-2	23462-23473	correlation	_	
133-3	23474-23477	was	_	
133-4	23478-23482	used	_	
133-5	23482-23483	.	_	
133-6	23484-23487	4.4	_	
133-7	23488-23493	Power	_	
133-8	23494-23501	results	_	
133-9	23502-23507	Power	_	
133-10	23508-23516	analysis	_	
133-11	23517-23525	revealed	_	
133-12	23526-23528	no	_	
133-13	23529-23540	significant	_	
133-14	23541-23552	differences	_	
133-15	23553-23560	between	_	
133-16	23561-23566	IWMUD	_	
133-17	23567-23570	and	_	
133-18	23571-23574	NCs	_	
133-19	23575-23577	at	_	
133-20	23578-23581	all	_	
133-21	23582-23585	the	_	
133-22	23586-23595	frequency	_	
133-23	23596-23601	bands	_	
133-24	23601-23602	.	_	

#Text=Fig 4 shows the power spectrum of the two groups.
134-1	23603-23606	Fig	_	
134-2	23607-23608	4	_	
134-3	23609-23614	shows	_	
134-4	23615-23618	the	_	
134-5	23619-23624	power	_	
134-6	23625-23633	spectrum	_	
134-7	23634-23636	of	_	
134-8	23637-23640	the	_	
134-9	23641-23644	two	_	
134-10	23645-23651	groups	_	
134-11	23651-23652	.	_	

#Text=The power spectrum of IWMUD and NCs computed in neural source space.
#Text=5.
135-1	23653-23656	The	_	
135-2	23657-23662	power	_	
135-3	23663-23671	spectrum	_	
135-4	23672-23674	of	_	
135-5	23675-23680	IWMUD	_	
135-6	23681-23684	and	_	
135-7	23685-23688	NCs	_	
135-8	23689-23697	computed	_	
135-9	23698-23700	in	_	
135-10	23701-23707	neural	_	
135-11	23708-23714	source	_	
135-12	23715-23720	space	_	
135-13	23720-23721	.	_	
135-14	23722-23723	5	_	
135-15	23723-23724	.	_	

#Text=Discussion
#Text=In this study, we compared brain FCN of IWMUD with that of NCs using graph features.
136-1	23725-23735	Discussion	_	
136-2	23736-23738	In	_	
136-3	23739-23743	this	_	
136-4	23744-23749	study	_	
136-5	23749-23750	,	_	
136-6	23751-23753	we	_	
136-7	23754-23762	compared	_	
136-8	23763-23768	brain	_	
136-9	23769-23772	FCN	_	
136-10	23773-23775	of	_	
136-11	23776-23781	IWMUD	_	
136-12	23782-23786	with	_	
136-13	23787-23791	that	_	
136-14	23792-23794	of	_	
136-15	23795-23798	NCs	_	
136-16	23799-23804	using	_	
136-17	23805-23810	graph	_	
136-18	23811-23819	features	_	
136-19	23819-23820	.	_	

#Text=To our knowledge, this is the first study that assessed FCN of IWMUD at neuronal source level using rEEG.
137-1	23821-23823	To	_	
137-2	23824-23827	our	_	
137-3	23828-23837	knowledge	_	
137-4	23837-23838	,	_	
137-5	23839-23843	this	_	
137-6	23844-23846	is	_	
137-7	23847-23850	the	_	
137-8	23851-23856	first	_	
137-9	23857-23862	study	_	
137-10	23863-23867	that	_	
137-11	23868-23876	assessed	_	
137-12	23877-23880	FCN	_	
137-13	23881-23883	of	_	
137-14	23884-23889	IWMUD	_	
137-15	23890-23892	at	_	
137-16	23893-23901	neuronal	_	
137-17	23902-23908	source	_	
137-18	23909-23914	level	_	
137-19	23915-23920	using	_	
137-20	23921-23925	rEEG	_	
137-21	23925-23926	.	_	

#Text=Table 9 summarizes the main findings of the current study along with previous related studies.
138-1	23927-23932	Table	_	
138-2	23933-23934	9	_	
138-3	23935-23945	summarizes	_	
138-4	23946-23949	the	_	
138-5	23950-23954	main	_	
138-6	23955-23963	findings	_	
138-7	23964-23966	of	_	
138-8	23967-23970	the	_	
138-9	23971-23978	current	_	
138-10	23979-23984	study	_	
138-11	23985-23990	along	_	
138-12	23991-23995	with	_	
138-13	23996-24004	previous	_	
138-14	24005-24012	related	_	
138-15	24013-24020	studies	_	
138-16	24020-24021	.	_	

#Text=Meta data of previous studies who recruited MA abusers with corresponding data of the current study.
139-1	24022-24026	Meta	_	
139-2	24027-24031	data	_	
139-3	24032-24034	of	_	
139-4	24035-24043	previous	_	
139-5	24044-24051	studies	_	
139-6	24052-24055	who	_	
139-7	24056-24065	recruited	_	
139-8	24066-24068	MA	_	
139-9	24069-24076	abusers	_	
139-10	24077-24081	with	_	
139-11	24082-24095	corresponding	_	
139-12	24096-24100	data	_	
139-13	24101-24103	of	_	
139-14	24104-24107	the	_	
139-15	24108-24115	current	_	
139-16	24116-24121	study	_	
139-17	24121-24122	.	_	

#Text=Study\tSubjects (number of males)\tAge (year) mean (SD)\tUse Duration (year)\tAbstinence Duration (days)\tAnalysisspace\tMain Findings\t \t \tIWMD/NCs\tIWMD/NCs\tMean (SD)\tMean (SD)\tEEG sensors\t \t \tNewton et al. \t11/11 (8/8)\t32.7 (7.5)/36.5 (7.3)\t11.0 (3.5)\t4 (0)\tEEG sensors\tEnhanced delta and theta power\t \tYun et al. \t48/20 all males\t37.0 (5.8) / 34.5 (7.7)\t11.8 (6.5)\t30.5 (27.2)\tEEG sensors\tDecreased cortical complexity\t \tKhajehpour et al. \t36/24 all males\t30.55 (6.43)/ 30.75(4.63)\t8.35(4.07)\tRange 30 to 180\tEEG sensors\tAutomatic discrimination of IWMD from NCS (F-score = 0.94)\t \tAhmadlou et al.\t36/36 all males\t31.7 (8.8)/32.7 (6.8)\t6.42 (3.13)\tRange 7 to 21\tEEG sensors\tDisrupted functional brain topology at gamma band\t \tThe Current study\t36/24 all males\t30.55(6.43)/ 30.75(4.63)\t8.35(4.07)\tRange 30 to 180\tNeural sources\tDisrupted functional brain topology in delta and especially in gamma bands.
140-1	24123-24128	Study	_	
140-2	24129-24137	Subjects	_	
140-3	24138-24139	(	_	
140-4	24139-24145	number	_	
140-5	24146-24148	of	_	
140-6	24149-24154	males	_	
140-7	24154-24155	)	_	
140-8	24156-24159	Age	_	
140-9	24160-24161	(	_	
140-10	24161-24165	year	_	
140-11	24165-24166	)	_	
140-12	24167-24171	mean	_	
140-13	24172-24173	(	_	
140-14	24173-24175	SD	_	
140-15	24175-24176	)	_	
140-16	24177-24180	Use	_	
140-17	24181-24189	Duration	_	
140-18	24190-24191	(	_	
140-19	24191-24195	year	_	
140-20	24195-24196	)	_	
140-21	24197-24207	Abstinence	_	
140-22	24208-24216	Duration	_	
140-23	24217-24218	(	_	
140-24	24218-24222	days	_	
140-25	24222-24223	)	_	
140-26	24224-24237	Analysisspace	_	
140-27	24238-24242	Main	_	
140-28	24243-24251	Findings	_	
140-29	24254-24255	 	_	
140-30	24256-24260	IWMD	_	
140-31	24260-24261	/	_	
140-32	24261-24264	NCs	_	
140-33	24265-24269	IWMD	_	
140-34	24269-24270	/	_	
140-35	24270-24273	NCs	_	
140-36	24274-24278	Mean	_	
140-37	24279-24280	(	_	
140-38	24280-24282	SD	_	
140-39	24282-24283	)	_	
140-40	24284-24288	Mean	_	
140-41	24289-24290	(	_	
140-42	24290-24292	SD	_	
140-43	24292-24293	)	_	
140-44	24294-24297	EEG	_	
140-45	24298-24305	sensors	_	
140-46	24306-24307	 	_	
140-47	24310-24316	Newton	_	
140-48	24317-24319	et	_	
140-49	24320-24322	al	_	
140-50	24322-24323	.	_	
140-51	24325-24327	11	_	
140-52	24327-24328	/	_	
140-53	24328-24330	11	_	
140-54	24331-24332	(	_	
140-55	24332-24333	8	_	
140-56	24333-24334	/	_	
140-57	24334-24335	8	_	
140-58	24335-24336	)	_	
140-59	24337-24341	32.7	_	
140-60	24342-24343	(	_	
140-61	24343-24346	7.5	_	
140-62	24346-24347	)	_	
140-63	24347-24348	/	_	
140-64	24348-24352	36.5	_	
140-65	24353-24354	(	_	
140-66	24354-24357	7.3	_	
140-67	24357-24358	)	_	
140-68	24359-24363	11.0	_	
140-69	24364-24365	(	_	
140-70	24365-24368	3.5	_	
140-71	24368-24369	)	_	
140-72	24370-24371	4	_	
140-73	24372-24373	(	_	
140-74	24373-24374	0	_	
140-75	24374-24375	)	_	
140-76	24376-24379	EEG	_	
140-77	24380-24387	sensors	_	
140-78	24388-24396	Enhanced	_	
140-79	24397-24402	delta	_	
140-80	24403-24406	and	_	
140-81	24407-24412	theta	_	
140-82	24413-24418	power	_	
140-83	24421-24424	Yun	_	
140-84	24425-24427	et	_	
140-85	24428-24430	al	_	
140-86	24430-24431	.	_	
140-87	24433-24435	48	_	
140-88	24435-24436	/	_	
140-89	24436-24438	20	_	
140-90	24439-24442	all	_	
140-91	24443-24448	males	_	
140-92	24449-24453	37.0	_	
140-93	24454-24455	(	_	
140-94	24455-24458	5.8	_	
140-95	24458-24459	)	_	
140-96	24460-24461	/	_	
140-97	24462-24466	34.5	_	
140-98	24467-24468	(	_	
140-99	24468-24471	7.7	_	
140-100	24471-24472	)	_	
140-101	24473-24477	11.8	_	
140-102	24478-24479	(	_	
140-103	24479-24482	6.5	_	
140-104	24482-24483	)	_	
140-105	24484-24488	30.5	_	
140-106	24489-24490	(	_	
140-107	24490-24494	27.2	_	
140-108	24494-24495	)	_	
140-109	24496-24499	EEG	_	
140-110	24500-24507	sensors	_	
140-111	24508-24517	Decreased	_	
140-112	24518-24526	cortical	_	
140-113	24527-24537	complexity	_	
140-114	24540-24550	Khajehpour	_	
140-115	24551-24553	et	_	
140-116	24554-24556	al	_	
140-117	24556-24557	.	_	
140-118	24559-24561	36	_	
140-119	24561-24562	/	_	
140-120	24562-24564	24	_	
140-121	24565-24568	all	_	
140-122	24569-24574	males	_	
140-123	24575-24580	30.55	_	
140-124	24581-24582	(	_	
140-125	24582-24586	6.43	_	
140-126	24586-24587	)	_	
140-127	24587-24588	/	_	
140-128	24589-24594	30.75	_	
140-129	24594-24595	(	_	
140-130	24595-24599	4.63	_	
140-131	24599-24600	)	_	
140-132	24601-24605	8.35	_	
140-133	24605-24606	(	_	
140-134	24606-24610	4.07	_	
140-135	24610-24611	)	_	
140-136	24612-24617	Range	_	
140-137	24618-24620	30	_	
140-138	24621-24623	to	_	
140-139	24624-24627	180	_	
140-140	24628-24631	EEG	_	
140-141	24632-24639	sensors	_	
140-142	24640-24649	Automatic	_	
140-143	24650-24664	discrimination	_	
140-144	24665-24667	of	_	
140-145	24668-24672	IWMD	_	
140-146	24673-24677	from	_	
140-147	24678-24681	NCS	_	
140-148	24682-24683	(	_	
140-149	24683-24690	F-score	_	
140-150	24691-24692	=	_	
140-151	24693-24697	0.94	_	
140-152	24697-24698	)	_	
140-153	24701-24709	Ahmadlou	_	
140-154	24710-24712	et	_	
140-155	24713-24715	al	_	
140-156	24715-24716	.	_	
140-157	24717-24719	36	_	
140-158	24719-24720	/	_	
140-159	24720-24722	36	_	
140-160	24723-24726	all	_	
140-161	24727-24732	males	_	
140-162	24733-24737	31.7	_	
140-163	24738-24739	(	_	
140-164	24739-24742	8.8	_	
140-165	24742-24743	)	_	
140-166	24743-24744	/	_	
140-167	24744-24748	32.7	_	
140-168	24749-24750	(	_	
140-169	24750-24753	6.8	_	
140-170	24753-24754	)	_	
140-171	24755-24759	6.42	_	
140-172	24760-24761	(	_	
140-173	24761-24765	3.13	_	
140-174	24765-24766	)	_	
140-175	24767-24772	Range	_	
140-176	24773-24774	7	_	
140-177	24775-24777	to	_	
140-178	24778-24780	21	_	
140-179	24781-24784	EEG	_	
140-180	24785-24792	sensors	_	
140-181	24793-24802	Disrupted	_	
140-182	24803-24813	functional	_	
140-183	24814-24819	brain	_	
140-184	24820-24828	topology	_	
140-185	24829-24831	at	_	
140-186	24832-24837	gamma	_	
140-187	24838-24842	band	_	
140-188	24845-24848	The	_	
140-189	24849-24856	Current	_	
140-190	24857-24862	study	_	
140-191	24863-24865	36	_	
140-192	24865-24866	/	_	
140-193	24866-24868	24	_	
140-194	24869-24872	all	_	
140-195	24873-24878	males	_	
140-196	24879-24884	30.55	_	
140-197	24884-24885	(	_	
140-198	24885-24889	6.43	_	
140-199	24889-24890	)	_	
140-200	24890-24891	/	_	
140-201	24892-24897	30.75	_	
140-202	24897-24898	(	_	
140-203	24898-24902	4.63	_	
140-204	24902-24903	)	_	
140-205	24904-24908	8.35	_	
140-206	24908-24909	(	_	
140-207	24909-24913	4.07	_	
140-208	24913-24914	)	_	
140-209	24915-24920	Range	_	
140-210	24921-24923	30	_	
140-211	24924-24926	to	_	
140-212	24927-24930	180	_	
140-213	24931-24937	Neural	_	
140-214	24938-24945	sources	_	
140-215	24946-24955	Disrupted	_	
140-216	24956-24966	functional	_	
140-217	24967-24972	brain	_	
140-218	24973-24981	topology	_	
140-219	24982-24984	in	_	
140-220	24985-24990	delta	_	
140-221	24991-24994	and	_	
140-222	24995-25005	especially	_	
140-223	25006-25008	in	_	
140-224	25009-25014	gamma	_	
140-225	25015-25020	bands	_	
140-226	25020-25021	.	_	

#Text=Altered inter-regional connectivity in delta, alpha, beta and gamma bands.
141-1	25022-25029	Altered	_	
141-2	25030-25044	inter-regional	_	
141-3	25045-25057	connectivity	_	
141-4	25058-25060	in	_	
141-5	25061-25066	delta	_	
141-6	25066-25067	,	_	
141-7	25068-25073	alpha	_	
141-8	25073-25074	,	_	
141-9	25075-25079	beta	_	
141-10	25080-25083	and	_	
141-11	25084-25089	gamma	_	
141-12	25090-25095	bands	_	
141-13	25095-25096	.	_	

#Text=Altered hub pattern in all the frequency bands.\t \t
#Text=5.1 Functional connectivity alterations
#Text=EEG oscillatory rhythms have been related to specific functions exclusively or in a combination.
142-1	25097-25104	Altered	_	
142-2	25105-25108	hub	_	
142-3	25109-25116	pattern	_	
142-4	25117-25119	in	_	
142-5	25120-25123	all	_	
142-6	25124-25127	the	_	
142-7	25128-25137	frequency	_	
142-8	25138-25143	bands	_	
142-9	25143-25144	.	_	
142-10	25148-25151	5.1	_	
142-11	25152-25162	Functional	_	
142-12	25163-25175	connectivity	_	
142-13	25176-25187	alterations	_	
142-14	25188-25191	EEG	_	
142-15	25192-25203	oscillatory	_	
142-16	25204-25211	rhythms	_	
142-17	25212-25216	have	_	
142-18	25217-25221	been	_	
142-19	25222-25229	related	_	
142-20	25230-25232	to	_	
142-21	25233-25241	specific	_	
142-22	25242-25251	functions	_	
142-23	25252-25263	exclusively	_	
142-24	25264-25266	or	_	
142-25	25267-25269	in	_	
142-26	25270-25271	a	_	
142-27	25272-25283	combination	_	
142-28	25283-25284	.	_	

#Text=In this context, studies show that gamma band frequencies are associated with perception, attention, stimulus selection, memory process and conscious awareness.
143-1	25285-25287	In	_	
143-2	25288-25292	this	_	
143-3	25293-25300	context	_	
143-4	25300-25301	,	_	
143-5	25302-25309	studies	_	
143-6	25310-25314	show	_	
143-7	25315-25319	that	_	
143-8	25320-25325	gamma	_	
143-9	25326-25330	band	_	
143-10	25331-25342	frequencies	_	
143-11	25343-25346	are	_	
143-12	25347-25357	associated	_	
143-13	25358-25362	with	_	
143-14	25363-25373	perception	_	
143-15	25373-25374	,	_	
143-16	25375-25384	attention	_	
143-17	25384-25385	,	_	
143-18	25386-25394	stimulus	_	
143-19	25395-25404	selection	_	
143-20	25404-25405	,	_	
143-21	25406-25412	memory	_	
143-22	25413-25420	process	_	
143-23	25421-25424	and	_	
143-24	25425-25434	conscious	_	
143-25	25435-25444	awareness	_	
143-26	25444-25445	.	_	

#Text=The theta rhythms have been related to attention, working memory, and emotional arousal.
144-1	25446-25449	The	_	
144-2	25450-25455	theta	_	
144-3	25456-25463	rhythms	_	
144-4	25464-25468	have	_	
144-5	25469-25473	been	_	
144-6	25474-25481	related	_	
144-7	25482-25484	to	_	
144-8	25485-25494	attention	_	
144-9	25494-25495	,	_	
144-10	25496-25503	working	_	
144-11	25504-25510	memory	_	
144-12	25510-25511	,	_	
144-13	25512-25515	and	_	
144-14	25516-25525	emotional	_	
144-15	25526-25533	arousal	_	
144-16	25533-25534	.	_	

#Text=The delta frequencies have been linked to learning motivation, memory and reward processing, while alpha-band oscillations that are the dominant oscillations in the human brain, has been linked to working memory functions.
145-1	25535-25538	The	_	
145-2	25539-25544	delta	_	
145-3	25545-25556	frequencies	_	
145-4	25557-25561	have	_	
145-5	25562-25566	been	_	
145-6	25567-25573	linked	_	
145-7	25574-25576	to	_	
145-8	25577-25585	learning	_	
145-9	25586-25596	motivation	_	
145-10	25596-25597	,	_	
145-11	25598-25604	memory	_	
145-12	25605-25608	and	_	
145-13	25609-25615	reward	_	
145-14	25616-25626	processing	_	
145-15	25626-25627	,	_	
145-16	25628-25633	while	_	
145-17	25634-25644	alpha-band	_	
145-18	25645-25657	oscillations	_	
145-19	25658-25662	that	_	
145-20	25663-25666	are	_	
145-21	25667-25670	the	_	
145-22	25671-25679	dominant	_	
145-23	25680-25692	oscillations	_	
145-24	25693-25695	in	_	
145-25	25696-25699	the	_	
145-26	25700-25705	human	_	
145-27	25706-25711	brain	_	
145-28	25711-25712	,	_	
145-29	25713-25716	has	_	
145-30	25717-25721	been	_	
145-31	25722-25728	linked	_	
145-32	25729-25731	to	_	
145-33	25732-25739	working	_	
145-34	25740-25746	memory	_	
145-35	25747-25756	functions	_	
145-36	25756-25757	.	_	

#Text=Beta-band activity is related to cognition.
146-1	25758-25767	Beta-band	_	
146-2	25768-25776	activity	_	
146-3	25777-25779	is	_	
146-4	25780-25787	related	_	
146-5	25788-25790	to	_	
146-6	25791-25800	cognition	_	
146-7	25800-25801	.	_	

#Text=A recent study reported that multiple oscillatory rhythms determine the temporal organization of perception.
147-1	25802-25803	A	_	
147-2	25804-25810	recent	_	
147-3	25811-25816	study	_	
147-4	25817-25825	reported	_	
147-5	25826-25830	that	_	
147-6	25831-25839	multiple	_	
147-7	25840-25851	oscillatory	_	
147-8	25852-25859	rhythms	_	
147-9	25860-25869	determine	_	
147-10	25870-25873	the	_	
147-11	25874-25882	temporal	_	
147-12	25883-25895	organization	_	
147-13	25896-25898	of	_	
147-14	25899-25909	perception	_	
147-15	25909-25910	.	_	

#Text=Hence, abnormal oscillations have been related to brain specific dysfunction.
148-1	25911-25916	Hence	_	
148-2	25916-25917	,	_	
148-3	25918-25926	abnormal	_	
148-4	25927-25939	oscillations	_	
148-5	25940-25944	have	_	
148-6	25945-25949	been	_	
148-7	25950-25957	related	_	
148-8	25958-25960	to	_	
148-9	25961-25966	brain	_	
148-10	25967-25975	specific	_	
148-11	25976-25987	dysfunction	_	
148-12	25987-25988	.	_	

#Text=For example, abnormal gamma oscillations, have been related to dysregulation of the dopaminergic system in the diseases of central nervous system, disinhibition in GABAergic system, excitatory activation of the brain, and drug-seeking behaviors in addiction.
149-1	25989-25992	For	_	
149-2	25993-26000	example	_	
149-3	26000-26001	,	_	
149-4	26002-26010	abnormal	_	
149-5	26011-26016	gamma	_	
149-6	26017-26029	oscillations	_	
149-7	26029-26030	,	_	
149-8	26031-26035	have	_	
149-9	26036-26040	been	_	
149-10	26041-26048	related	_	
149-11	26049-26051	to	_	
149-12	26052-26065	dysregulation	_	
149-13	26066-26068	of	_	
149-14	26069-26072	the	_	
149-15	26073-26085	dopaminergic	_	
149-16	26086-26092	system	_	
149-17	26093-26095	in	_	
149-18	26096-26099	the	_	
149-19	26100-26108	diseases	_	
149-20	26109-26111	of	_	
149-21	26112-26119	central	_	
149-22	26120-26127	nervous	_	
149-23	26128-26134	system	_	
149-24	26134-26135	,	_	
149-25	26136-26149	disinhibition	_	
149-26	26150-26152	in	_	
149-27	26153-26162	GABAergic	_	
149-28	26163-26169	system	_	
149-29	26169-26170	,	_	
149-30	26171-26181	excitatory	_	
149-31	26182-26192	activation	_	
149-32	26193-26195	of	_	
149-33	26196-26199	the	_	
149-34	26200-26205	brain	_	
149-35	26205-26206	,	_	
149-36	26207-26210	and	_	
149-37	26211-26223	drug-seeking	_	
149-38	26224-26233	behaviors	_	
149-39	26234-26236	in	_	
149-40	26237-26246	addiction	_	
149-41	26246-26247	.	_	

#Text=Task-based fMRI studies showed that there are six networks abnormally changed in addiction: default mode network (DMN), salience network, habit network, executive control network and memory network.
150-1	26248-26258	Task-based	_	
150-2	26259-26263	fMRI	_	
150-3	26264-26271	studies	_	
150-4	26272-26278	showed	_	
150-5	26279-26283	that	_	
150-6	26284-26289	there	_	
150-7	26290-26293	are	_	
150-8	26294-26297	six	_	
150-9	26298-26306	networks	_	
150-10	26307-26317	abnormally	_	
150-11	26318-26325	changed	_	
150-12	26326-26328	in	_	
150-13	26329-26338	addiction	_	
150-14	26338-26339	:	_	
150-15	26340-26347	default	_	
150-16	26348-26352	mode	_	
150-17	26353-26360	network	_	
150-18	26361-26362	(	_	
150-19	26362-26365	DMN	_	
150-20	26365-26366	)	_	
150-21	26366-26367	,	_	
150-22	26368-26376	salience	_	
150-23	26377-26384	network	_	
150-24	26384-26385	,	_	
150-25	26386-26391	habit	_	
150-26	26392-26399	network	_	
150-27	26399-26400	,	_	
150-28	26401-26410	executive	_	
150-29	26411-26418	control	_	
150-30	26419-26426	network	_	
150-31	26427-26430	and	_	
150-32	26431-26437	memory	_	
150-33	26438-26445	network	_	
150-34	26445-26446	.	_	

#Text=These networks revealed hyper-activation during drug cue exposure compared to neutral stimuli.
151-1	26447-26452	These	_	
151-2	26453-26461	networks	_	
151-3	26462-26470	revealed	_	
151-4	26471-26487	hyper-activation	_	
151-5	26488-26494	during	_	
151-6	26495-26499	drug	_	
151-7	26500-26503	cue	_	
151-8	26504-26512	exposure	_	
151-9	26513-26521	compared	_	
151-10	26522-26524	to	_	
151-11	26525-26532	neutral	_	
151-12	26533-26540	stimuli	_	
151-13	26540-26541	.	_	

#Text=Zilverstand et al., in accordance with impaired response inhibition and salience attribution (iRISA) model, proposed increased engagement of these networks to cognitive drug cue processing in addiction.
152-1	26542-26553	Zilverstand	_	
152-2	26554-26556	et	_	
152-3	26557-26559	al	_	
152-4	26559-26560	.	_	
152-5	26560-26561	,	_	
152-6	26562-26564	in	_	
152-7	26565-26575	accordance	_	
152-8	26576-26580	with	_	
152-9	26581-26589	impaired	_	
152-10	26590-26598	response	_	
152-11	26599-26609	inhibition	_	
152-12	26610-26613	and	_	
152-13	26614-26622	salience	_	
152-14	26623-26634	attribution	_	
152-15	26635-26636	(	_	
152-16	26636-26641	iRISA	_	
152-17	26641-26642	)	_	
152-18	26643-26648	model	_	
152-19	26648-26649	,	_	
152-20	26650-26658	proposed	_	
152-21	26659-26668	increased	_	
152-22	26669-26679	engagement	_	
152-23	26680-26682	of	_	
152-24	26683-26688	these	_	
152-25	26689-26697	networks	_	
152-26	26698-26700	to	_	
152-27	26701-26710	cognitive	_	
152-28	26711-26715	drug	_	
152-29	26716-26719	cue	_	
152-30	26720-26730	processing	_	
152-31	26731-26733	in	_	
152-32	26734-26743	addiction	_	
152-33	26743-26744	.	_	

#Text=The Resting-state fMRI (rfMRI) studies reported that in chronic stimulant users, the reward, salience, habit, and memory networks demonstrated enhanced coupling with each other, as well as with the executive network, whereas a decreased coupling was observed within the executive control network.
153-1	26745-26748	The	_	
153-2	26749-26762	Resting-state	_	
153-3	26763-26767	fMRI	_	
153-4	26768-26769	(	_	
153-5	26769-26774	rfMRI	_	
153-6	26774-26775	)	_	
153-7	26776-26783	studies	_	
153-8	26784-26792	reported	_	
153-9	26793-26797	that	_	
153-10	26798-26800	in	_	
153-11	26801-26808	chronic	_	
153-12	26809-26818	stimulant	_	
153-13	26819-26824	users	_	
153-14	26824-26825	,	_	
153-15	26826-26829	the	_	
153-16	26830-26836	reward	_	
153-17	26836-26837	,	_	
153-18	26838-26846	salience	_	
153-19	26846-26847	,	_	
153-20	26848-26853	habit	_	
153-21	26853-26854	,	_	
153-22	26855-26858	and	_	
153-23	26859-26865	memory	_	
153-24	26866-26874	networks	_	
153-25	26875-26887	demonstrated	_	
153-26	26888-26896	enhanced	_	
153-27	26897-26905	coupling	_	
153-28	26906-26910	with	_	
153-29	26911-26915	each	_	
153-30	26916-26921	other	_	
153-31	26921-26922	,	_	
153-32	26923-26925	as	_	
153-33	26926-26930	well	_	
153-34	26931-26933	as	_	
153-35	26934-26938	with	_	
153-36	26939-26942	the	_	
153-37	26943-26952	executive	_	
153-38	26953-26960	network	_	
153-39	26960-26961	,	_	
153-40	26962-26969	whereas	_	
153-41	26970-26971	a	_	
153-42	26972-26981	decreased	_	
153-43	26982-26990	coupling	_	
153-44	26991-26994	was	_	
153-45	26995-27003	observed	_	
153-46	27004-27010	within	_	
153-47	27011-27014	the	_	
153-48	27015-27024	executive	_	
153-49	27025-27032	control	_	
153-50	27033-27040	network	_	
153-51	27040-27041	.	_	

#Text=In the current study, neural source level connectivity revealed enhanced intra-connectivity at the gamma band within DMN network (Frontal-superior-R/L, frontal superior medial_R, Temporal_inf_L), improved inter-connectivity between DMN and visual network (cingulum-mid-right and ligual_L), also between executive control and sensorimotor networks (frontal-mid right, Paracentral-lobule_R).
154-1	27042-27044	In	_	
154-2	27045-27048	the	_	
154-3	27049-27056	current	_	
154-4	27057-27062	study	_	
154-5	27062-27063	,	_	
154-6	27064-27070	neural	_	
154-7	27071-27077	source	_	
154-8	27078-27083	level	_	
154-9	27084-27096	connectivity	_	
154-10	27097-27105	revealed	_	
154-11	27106-27114	enhanced	_	
154-12	27115-27133	intra-connectivity	_	
154-13	27134-27136	at	_	
154-14	27137-27140	the	_	
154-15	27141-27146	gamma	_	
154-16	27147-27151	band	_	
154-17	27152-27158	within	_	
154-18	27159-27162	DMN	_	
154-19	27163-27170	network	_	
154-20	27171-27172	(	_	
154-21	27172-27190	Frontal-superior-R	_	
154-22	27190-27191	/	_	
154-23	27191-27192	L	_	
154-24	27192-27193	,	_	
154-25	27194-27201	frontal	_	
154-26	27202-27210	superior	_	
154-27	27211-27219	medial_R	_	
154-28	27219-27220	,	_	
154-29	27221-27235	Temporal_inf_L	_	
154-30	27235-27236	)	_	
154-31	27236-27237	,	_	
154-32	27238-27246	improved	_	
154-33	27247-27265	inter-connectivity	_	
154-34	27266-27273	between	_	
154-35	27274-27277	DMN	_	
154-36	27278-27281	and	_	
154-37	27282-27288	visual	_	
154-38	27289-27296	network	_	
154-39	27297-27298	(	_	
154-40	27298-27316	cingulum-mid-right	_	
154-41	27317-27320	and	_	
154-42	27321-27329	ligual_L	_	
154-43	27329-27330	)	_	
154-44	27330-27331	,	_	
154-45	27332-27336	also	_	
154-46	27337-27344	between	_	
154-47	27345-27354	executive	_	
154-48	27355-27362	control	_	
154-49	27363-27366	and	_	
154-50	27367-27379	sensorimotor	_	
154-51	27380-27388	networks	_	
154-52	27389-27390	(	_	
154-53	27390-27401	frontal-mid	_	
154-54	27402-27407	right	_	
154-55	27407-27408	,	_	
154-56	27409-27429	Paracentral-lobule_R	_	
154-57	27429-27430	)	_	
154-58	27430-27431	.	_	

#Text=However previous resting-state studies did not find increased intra-connectivity within DMN, related results of this study are in line with those of fMRI studies with drug cue presentation.
155-1	27432-27439	However	_	
155-2	27440-27448	previous	_	
155-3	27449-27462	resting-state	_	
155-4	27463-27470	studies	_	
155-5	27471-27474	did	_	
155-6	27475-27478	not	_	
155-7	27479-27483	find	_	
155-8	27484-27493	increased	_	
155-9	27494-27512	intra-connectivity	_	
155-10	27513-27519	within	_	
155-11	27520-27523	DMN	_	
155-12	27523-27524	,	_	
155-13	27525-27532	related	_	
155-14	27533-27540	results	_	
155-15	27541-27543	of	_	
155-16	27544-27548	this	_	
155-17	27549-27554	study	_	
155-18	27555-27558	are	_	
155-19	27559-27561	in	_	
155-20	27562-27566	line	_	
155-21	27567-27571	with	_	
155-22	27572-27577	those	_	
155-23	27578-27580	of	_	
155-24	27581-27585	fMRI	_	
155-25	27586-27593	studies	_	
155-26	27594-27598	with	_	
155-27	27599-27603	drug	_	
155-28	27604-27607	cue	_	
155-29	27608-27620	presentation	_	
155-30	27620-27621	.	_	

#Text=The enhanced coupling between the executive network and sensorimotor is consistent with previous studies.
156-1	27622-27625	The	_	
156-2	27626-27634	enhanced	_	
156-3	27635-27643	coupling	_	
156-4	27644-27651	between	_	
156-5	27652-27655	the	_	
156-6	27656-27665	executive	_	
156-7	27666-27673	network	_	
156-8	27674-27677	and	_	
156-9	27678-27690	sensorimotor	_	
156-10	27691-27693	is	_	
156-11	27694-27704	consistent	_	
156-12	27705-27709	with	_	
156-13	27710-27718	previous	_	
156-14	27719-27726	studies	_	
156-15	27726-27727	.	_	

#Text=Taken together, the abnormally increased coupling at the gamma band may imply disrupted cognitive control regarding attention and self-monitoring that may be interpreted in the perspective of altered attention toward drug related stimuli.
157-1	27728-27733	Taken	_	
157-2	27734-27742	together	_	
157-3	27742-27743	,	_	
157-4	27744-27747	the	_	
157-5	27748-27758	abnormally	_	
157-6	27759-27768	increased	_	
157-7	27769-27777	coupling	_	
157-8	27778-27780	at	_	
157-9	27781-27784	the	_	
157-10	27785-27790	gamma	_	
157-11	27791-27795	band	_	
157-12	27796-27799	may	_	
157-13	27800-27805	imply	_	
157-14	27806-27815	disrupted	_	
157-15	27816-27825	cognitive	_	
157-16	27826-27833	control	_	
157-17	27834-27843	regarding	_	
157-18	27844-27853	attention	_	
157-19	27854-27857	and	_	
157-20	27858-27873	self-monitoring	_	
157-21	27874-27878	that	_	
157-22	27879-27882	may	_	
157-23	27883-27885	be	_	
157-24	27886-27897	interpreted	_	
157-25	27898-27900	in	_	
157-26	27901-27904	the	_	
157-27	27905-27916	perspective	_	
157-28	27917-27919	of	_	
157-29	27920-27927	altered	_	
157-30	27928-27937	attention	_	
157-31	27938-27944	toward	_	
157-32	27945-27949	drug	_	
157-33	27950-27957	related	_	
157-34	27958-27965	stimuli	_	
157-35	27965-27966	.	_	

#Text=Furthermore, the correlation between Putamen, which is an impaired region of habit network in addicts, and impulsivity in IWMUD at the gamma band may be another evidence for the addictive behavior.
158-1	27967-27978	Furthermore	_	
158-2	27978-27979	,	_	
158-3	27980-27983	the	_	
158-4	27984-27995	correlation	_	
158-5	27996-28003	between	_	
158-6	28004-28011	Putamen	_	
158-7	28011-28012	,	_	
158-8	28013-28018	which	_	
158-9	28019-28021	is	_	
158-10	28022-28024	an	_	
158-11	28025-28033	impaired	_	
158-12	28034-28040	region	_	
158-13	28041-28043	of	_	
158-14	28044-28049	habit	_	
158-15	28050-28057	network	_	
158-16	28058-28060	in	_	
158-17	28061-28068	addicts	_	
158-18	28068-28069	,	_	
158-19	28070-28073	and	_	
158-20	28074-28085	impulsivity	_	
158-21	28086-28088	in	_	
158-22	28089-28094	IWMUD	_	
158-23	28095-28097	at	_	
158-24	28098-28101	the	_	
158-25	28102-28107	gamma	_	
158-26	28108-28112	band	_	
158-27	28113-28116	may	_	
158-28	28117-28119	be	_	
158-29	28120-28127	another	_	
158-30	28128-28136	evidence	_	
158-31	28137-28140	for	_	
158-32	28141-28144	the	_	
158-33	28145-28154	addictive	_	
158-34	28155-28163	behavior	_	
158-35	28163-28164	.	_	

#Text=Evidence reveals that the left inferior temporal gyrus may be involved in retrieval load and visual perception.
159-1	28165-28173	Evidence	_	
159-2	28174-28181	reveals	_	
159-3	28182-28186	that	_	
159-4	28187-28190	the	_	
159-5	28191-28195	left	_	
159-6	28196-28204	inferior	_	
159-7	28205-28213	temporal	_	
159-8	28214-28219	gyrus	_	
159-9	28220-28223	may	_	
159-10	28224-28226	be	_	
159-11	28227-28235	involved	_	
159-12	28236-28238	in	_	
159-13	28239-28248	retrieval	_	
159-14	28249-28253	load	_	
159-15	28254-28257	and	_	
159-16	28258-28264	visual	_	
159-17	28265-28275	perception	_	
159-18	28275-28276	.	_	

#Text=Task-based and rfMRI studies have reported abnormally increased activity of left inferior temporal gyrus.
160-1	28277-28287	Task-based	_	
160-2	28288-28291	and	_	
160-3	28292-28297	rfMRI	_	
160-4	28298-28305	studies	_	
160-5	28306-28310	have	_	
160-6	28311-28319	reported	_	
160-7	28320-28330	abnormally	_	
160-8	28331-28340	increased	_	
160-9	28341-28349	activity	_	
160-10	28350-28352	of	_	
160-11	28353-28357	left	_	
160-12	28358-28366	inferior	_	
160-13	28367-28375	temporal	_	
160-14	28376-28381	gyrus	_	
160-15	28381-28382	.	_	

#Text=High-risk college students showed hyper-activation of this gyrus during exposure to poly-drug cues compared to neutral cues.
161-1	28383-28392	High-risk	_	
161-2	28393-28400	college	_	
161-3	28401-28409	students	_	
161-4	28410-28416	showed	_	
161-5	28417-28433	hyper-activation	_	
161-6	28434-28436	of	_	
161-7	28437-28441	this	_	
161-8	28442-28447	gyrus	_	
161-9	28448-28454	during	_	
161-10	28455-28463	exposure	_	
161-11	28464-28466	to	_	
161-12	28467-28476	poly-drug	_	
161-13	28477-28481	cues	_	
161-14	28482-28490	compared	_	
161-15	28491-28493	to	_	
161-16	28494-28501	neutral	_	
161-17	28502-28506	cues	_	
161-18	28506-28507	.	_	

#Text=Cocaine-dependent individuals encountered with increased activity of their left inferior temporal gyrus in the reward in comparison to no-reward condition.
162-1	28508-28525	Cocaine-dependent	_	
162-2	28526-28537	individuals	_	
162-3	28538-28549	encountered	_	
162-4	28550-28554	with	_	
162-5	28555-28564	increased	_	
162-6	28565-28573	activity	_	
162-7	28574-28576	of	_	
162-8	28577-28582	their	_	
162-9	28583-28587	left	_	
162-10	28588-28596	inferior	_	
162-11	28597-28605	temporal	_	
162-12	28606-28611	gyrus	_	
162-13	28612-28614	in	_	
162-14	28615-28618	the	_	
162-15	28619-28625	reward	_	
162-16	28626-28628	in	_	
162-17	28629-28639	comparison	_	
162-18	28640-28642	to	_	
162-19	28643-28652	no-reward	_	
162-20	28653-28662	condition	_	
162-21	28662-28663	.	_	

#Text=Amphetamine-type Stimulant abusers showed increased degree centrality in the left inferior temporal gyrus in a rfMRI study.
163-1	28664-28680	Amphetamine-type	_	
163-2	28681-28690	Stimulant	_	
163-3	28691-28698	abusers	_	
163-4	28699-28705	showed	_	
163-5	28706-28715	increased	_	
163-6	28716-28722	degree	_	
163-7	28723-28733	centrality	_	
163-8	28734-28736	in	_	
163-9	28737-28740	the	_	
163-10	28741-28745	left	_	
163-11	28746-28754	inferior	_	
163-12	28755-28763	temporal	_	
163-13	28764-28769	gyrus	_	
163-14	28770-28772	in	_	
163-15	28773-28774	a	_	
163-16	28775-28780	rfMRI	_	
163-17	28781-28786	study	_	
163-18	28786-28787	.	_	

#Text=In the current study, left inferior temporal gyrus showed increased node strength at the gamma band in IWMUD compared to NCs.
164-1	28788-28790	In	_	
164-2	28791-28794	the	_	
164-3	28795-28802	current	_	
164-4	28803-28808	study	_	
164-5	28808-28809	,	_	
164-6	28810-28814	left	_	
164-7	28815-28823	inferior	_	
164-8	28824-28832	temporal	_	
164-9	28833-28838	gyrus	_	
164-10	28839-28845	showed	_	
164-11	28846-28855	increased	_	
164-12	28856-28860	node	_	
164-13	28861-28869	strength	_	
164-14	28870-28872	at	_	
164-15	28873-28876	the	_	
164-16	28877-28882	gamma	_	
164-17	28883-28887	band	_	
164-18	28888-28890	in	_	
164-19	28891-28896	IWMUD	_	
164-20	28897-28905	compared	_	
164-21	28906-28908	to	_	
164-22	28909-28912	NCs	_	
164-23	28912-28913	.	_	

#Text=Hence, we may be able to conclude that the IWMUD may allocate more attention resources to think about obtaining and using methamphetamine, reflected in increased node strength of the left inferior temporal gyrus at the gamma oscillatory band.
165-1	28914-28919	Hence	_	
165-2	28919-28920	,	_	
165-3	28921-28923	we	_	
165-4	28924-28927	may	_	
165-5	28928-28930	be	_	
165-6	28931-28935	able	_	
165-7	28936-28938	to	_	
165-8	28939-28947	conclude	_	
165-9	28948-28952	that	_	
165-10	28953-28956	the	_	
165-11	28957-28962	IWMUD	_	
165-12	28963-28966	may	_	
165-13	28967-28975	allocate	_	
165-14	28976-28980	more	_	
165-15	28981-28990	attention	_	
165-16	28991-29000	resources	_	
165-17	29001-29003	to	_	
165-18	29004-29009	think	_	
165-19	29010-29015	about	_	
165-20	29016-29025	obtaining	_	
165-21	29026-29029	and	_	
165-22	29030-29035	using	_	
165-23	29036-29051	methamphetamine	_	
165-24	29051-29052	,	_	
165-25	29053-29062	reflected	_	
165-26	29063-29065	in	_	
165-27	29066-29075	increased	_	
165-28	29076-29080	node	_	
165-29	29081-29089	strength	_	
165-30	29090-29092	of	_	
165-31	29093-29096	the	_	
165-32	29097-29101	left	_	
165-33	29102-29110	inferior	_	
165-34	29111-29119	temporal	_	
165-35	29120-29125	gyrus	_	
165-36	29126-29128	at	_	
165-37	29129-29132	the	_	
165-38	29133-29138	gamma	_	
165-39	29139-29150	oscillatory	_	
165-40	29151-29155	band	_	
165-41	29155-29156	.	_	

#Text=Comprehensive systematic reviews on resting-state brain patterns proposed that salience and executive networks are tightly connected during acute drug use, while they become less connected during abstinence.
166-1	29157-29170	Comprehensive	_	
166-2	29171-29181	systematic	_	
166-3	29182-29189	reviews	_	
166-4	29190-29192	on	_	
166-5	29193-29206	resting-state	_	
166-6	29207-29212	brain	_	
166-7	29213-29221	patterns	_	
166-8	29222-29230	proposed	_	
166-9	29231-29235	that	_	
166-10	29236-29244	salience	_	
166-11	29245-29248	and	_	
166-12	29249-29258	executive	_	
166-13	29259-29267	networks	_	
166-14	29268-29271	are	_	
166-15	29272-29279	tightly	_	
166-16	29280-29289	connected	_	
166-17	29290-29296	during	_	
166-18	29297-29302	acute	_	
166-19	29303-29307	drug	_	
166-20	29308-29311	use	_	
166-21	29311-29312	,	_	
166-22	29313-29318	while	_	
166-23	29319-29323	they	_	
166-24	29324-29330	become	_	
166-25	29331-29335	less	_	
166-26	29336-29345	connected	_	
166-27	29346-29352	during	_	
166-28	29353-29363	abstinence	_	
166-29	29363-29364	.	_	

#Text=They further suggested that disengagement of the two networks during abstinence impairs non-drug-related processing.
167-1	29365-29369	They	_	
167-2	29370-29377	further	_	
167-3	29378-29387	suggested	_	
167-4	29388-29392	that	_	
167-5	29393-29406	disengagement	_	
167-6	29407-29409	of	_	
167-7	29410-29413	the	_	
167-8	29414-29417	two	_	
167-9	29418-29426	networks	_	
167-10	29427-29433	during	_	
167-11	29434-29444	abstinence	_	
167-12	29445-29452	impairs	_	
167-13	29453-29469	non-drug-related	_	
167-14	29470-29480	processing	_	
167-15	29480-29481	.	_	

#Text=We found consistent results with this disengagement at the alpha frequency band.
168-1	29482-29484	We	_	
168-2	29485-29490	found	_	
168-3	29491-29501	consistent	_	
168-4	29502-29509	results	_	
168-5	29510-29514	with	_	
168-6	29515-29519	this	_	
168-7	29520-29533	disengagement	_	
168-8	29534-29536	at	_	
168-9	29537-29540	the	_	
168-10	29541-29546	alpha	_	
168-11	29547-29556	frequency	_	
168-12	29557-29561	band	_	
168-13	29561-29562	.	_	

#Text=In this regard, our results revealed decreased intra-coupling in executive network (Frontal Mid-R and Frontal-Inf-Oper-L), which is consistent with rfMRI findings, and inter-coupling between executive and salience networks (Putamen-R and Frontal-Mid-R) that by following the reasoning of could lead to the disengagement of salience and executive networks during abstinent and impairs non-drug-related processing in IWMUD.
169-1	29563-29565	In	_	
169-2	29566-29570	this	_	
169-3	29571-29577	regard	_	
169-4	29577-29578	,	_	
169-5	29579-29582	our	_	
169-6	29583-29590	results	_	
169-7	29591-29599	revealed	_	
169-8	29600-29609	decreased	_	
169-9	29610-29624	intra-coupling	_	
169-10	29625-29627	in	_	
169-11	29628-29637	executive	_	
169-12	29638-29645	network	_	
169-13	29646-29647	(	_	
169-14	29647-29654	Frontal	_	
169-15	29655-29660	Mid-R	_	
169-16	29661-29664	and	_	
169-17	29665-29683	Frontal-Inf-Oper-L	_	
169-18	29683-29684	)	_	
169-19	29684-29685	,	_	
169-20	29686-29691	which	_	
169-21	29692-29694	is	_	
169-22	29695-29705	consistent	_	
169-23	29706-29710	with	_	
169-24	29711-29716	rfMRI	_	
169-25	29717-29725	findings	_	
169-26	29725-29726	,	_	
169-27	29727-29730	and	_	
169-28	29731-29745	inter-coupling	_	
169-29	29746-29753	between	_	
169-30	29754-29763	executive	_	
169-31	29764-29767	and	_	
169-32	29768-29776	salience	_	
169-33	29777-29785	networks	_	
169-34	29786-29787	(	_	
169-35	29787-29796	Putamen-R	_	
169-36	29797-29800	and	_	
169-37	29801-29814	Frontal-Mid-R	_	
169-38	29814-29815	)	_	
169-39	29816-29820	that	_	
169-40	29821-29823	by	_	
169-41	29824-29833	following	_	
169-42	29834-29837	the	_	
169-43	29838-29847	reasoning	_	
169-44	29848-29850	of	_	
169-45	29851-29856	could	_	
169-46	29857-29861	lead	_	
169-47	29862-29864	to	_	
169-48	29865-29868	the	_	
169-49	29869-29882	disengagement	_	
169-50	29883-29885	of	_	
169-51	29886-29894	salience	_	
169-52	29895-29898	and	_	
169-53	29899-29908	executive	_	
169-54	29909-29917	networks	_	
169-55	29918-29924	during	_	
169-56	29925-29934	abstinent	_	
169-57	29935-29938	and	_	
169-58	29939-29946	impairs	_	
169-59	29947-29963	non-drug-related	_	
169-60	29964-29974	processing	_	
169-61	29975-29977	in	_	
169-62	29978-29983	IWMUD	_	
169-63	29983-29984	.	_	

#Text=Although, at the gamma band the MA’s brain undergoes no decreased coupling, and this contrary-frequency alteration result requires further research using EEG to speculate why it is occurring.
170-1	29985-29993	Although	_	
170-2	29993-29994	,	_	
170-3	29995-29997	at	_	
170-4	29998-30001	the	_	
170-5	30002-30007	gamma	_	
170-6	30008-30012	band	_	
170-7	30013-30016	the	_	
170-8	30017-30019	MA	_	
170-9	30019-30020	’	_	
170-10	30020-30021	s	_	
170-11	30022-30027	brain	_	
170-12	30028-30037	undergoes	_	
170-13	30038-30040	no	_	
170-14	30041-30050	decreased	_	
170-15	30051-30059	coupling	_	
170-16	30059-30060	,	_	
170-17	30061-30064	and	_	
170-18	30065-30069	this	_	
170-19	30070-30088	contrary-frequency	_	
170-20	30089-30099	alteration	_	
170-21	30100-30106	result	_	
170-22	30107-30115	requires	_	
170-23	30116-30123	further	_	
170-24	30124-30132	research	_	
170-25	30133-30138	using	_	
170-26	30139-30142	EEG	_	
170-27	30143-30145	to	_	
170-28	30146-30155	speculate	_	
170-29	30156-30159	why	_	
170-30	30160-30162	it	_	
170-31	30163-30165	is	_	
170-32	30166-30175	occurring	_	
170-33	30175-30176	.	_	

#Text=The occipital lobe is the visual processing center of the brain and Medial-OFC is related to the reward system that has shown abnormally increased connectivity during drug cue exposure in substance abusers.
171-1	30177-30180	The	_	
171-2	30181-30190	occipital	_	
171-3	30191-30195	lobe	_	
171-4	30196-30198	is	_	
171-5	30199-30202	the	_	
171-6	30203-30209	visual	_	
171-7	30210-30220	processing	_	
171-8	30221-30227	center	_	
171-9	30228-30230	of	_	
171-10	30231-30234	the	_	
171-11	30235-30240	brain	_	
171-12	30241-30244	and	_	
171-13	30245-30255	Medial-OFC	_	
171-14	30256-30258	is	_	
171-15	30259-30266	related	_	
171-16	30267-30269	to	_	
171-17	30270-30273	the	_	
171-18	30274-30280	reward	_	
171-19	30281-30287	system	_	
171-20	30288-30292	that	_	
171-21	30293-30296	has	_	
171-22	30297-30302	shown	_	
171-23	30303-30313	abnormally	_	
171-24	30314-30323	increased	_	
171-25	30324-30336	connectivity	_	
171-26	30337-30343	during	_	
171-27	30344-30348	drug	_	
171-28	30349-30352	cue	_	
171-29	30353-30361	exposure	_	
171-30	30362-30364	in	_	
171-31	30365-30374	substance	_	
171-32	30375-30382	abusers	_	
171-33	30382-30383	.	_	

#Text=Hence, although resting-state were investigated, the findings of abnormally increased connectivity of medial-OFC and occipital lobe at the delta band may be related to deficits in behavioral inhibition in IWMUD.
172-1	30384-30389	Hence	_	
172-2	30389-30390	,	_	
172-3	30391-30399	although	_	
172-4	30400-30413	resting-state	_	
172-5	30414-30418	were	_	
172-6	30419-30431	investigated	_	
172-7	30431-30432	,	_	
172-8	30433-30436	the	_	
172-9	30437-30445	findings	_	
172-10	30446-30448	of	_	
172-11	30449-30459	abnormally	_	
172-12	30460-30469	increased	_	
172-13	30470-30482	connectivity	_	
172-14	30483-30485	of	_	
172-15	30486-30496	medial-OFC	_	
172-16	30497-30500	and	_	
172-17	30501-30510	occipital	_	
172-18	30511-30515	lobe	_	
172-19	30516-30518	at	_	
172-20	30519-30522	the	_	
172-21	30523-30528	delta	_	
172-22	30529-30533	band	_	
172-23	30534-30537	may	_	
172-24	30538-30540	be	_	
172-25	30541-30548	related	_	
172-26	30549-30551	to	_	
172-27	30552-30560	deficits	_	
172-28	30561-30563	in	_	
172-29	30564-30574	behavioral	_	
172-30	30575-30585	inhibition	_	
172-31	30586-30588	in	_	
172-32	30589-30594	IWMUD	_	
172-33	30594-30595	.	_	

#Text=Nevertheless, due to EEG high-pass filtering influence on the connectivity values at this oscillatory band, we should interpret the delta-related results cautiously.
#Text=5.2 Topological characteristic alterations
#Text=The present study examined the topological organization of the functional brain networks in IWMUD compared to NCs.
173-1	30596-30608	Nevertheless	_	
173-2	30608-30609	,	_	
173-3	30610-30613	due	_	
173-4	30614-30616	to	_	
173-5	30617-30620	EEG	_	
173-6	30621-30630	high-pass	_	
173-7	30631-30640	filtering	_	
173-8	30641-30650	influence	_	
173-9	30651-30653	on	_	
173-10	30654-30657	the	_	
173-11	30658-30670	connectivity	_	
173-12	30671-30677	values	_	
173-13	30678-30680	at	_	
173-14	30681-30685	this	_	
173-15	30686-30697	oscillatory	_	
173-16	30698-30702	band	_	
173-17	30702-30703	,	_	
173-18	30704-30706	we	_	
173-19	30707-30713	should	_	
173-20	30714-30723	interpret	_	
173-21	30724-30727	the	_	
173-22	30728-30741	delta-related	_	
173-23	30742-30749	results	_	
173-24	30750-30760	cautiously	_	
173-25	30760-30761	.	_	
173-26	30762-30765	5.2	_	
173-27	30766-30777	Topological	_	
173-28	30778-30792	characteristic	_	
173-29	30793-30804	alterations	_	
173-30	30805-30808	The	_	
173-31	30809-30816	present	_	
173-32	30817-30822	study	_	
173-33	30823-30831	examined	_	
173-34	30832-30835	the	_	
173-35	30836-30847	topological	_	
173-36	30848-30860	organization	_	
173-37	30861-30863	of	_	
173-38	30864-30867	the	_	
173-39	30868-30878	functional	_	
173-40	30879-30884	brain	_	
173-41	30885-30893	networks	_	
173-42	30894-30896	in	_	
173-43	30897-30902	IWMUD	_	
173-44	30903-30911	compared	_	
173-45	30912-30914	to	_	
173-46	30915-30918	NCs	_	
173-47	30918-30919	.	_	

#Text=The human brain is a complex system, with important topological attributes such as small-world property, high clustering coefficient, and small characteristic path length.
174-1	30920-30923	The	_	
174-2	30924-30929	human	_	
174-3	30930-30935	brain	_	
174-4	30936-30938	is	_	
174-5	30939-30940	a	_	
174-6	30941-30948	complex	_	
174-7	30949-30955	system	_	
174-8	30955-30956	,	_	
174-9	30957-30961	with	_	
174-10	30962-30971	important	_	
174-11	30972-30983	topological	_	
174-12	30984-30994	attributes	_	
174-13	30995-30999	such	_	
174-14	31000-31002	as	_	
174-15	31003-31014	small-world	_	
174-16	31015-31023	property	_	
174-17	31023-31024	,	_	
174-18	31025-31029	high	_	
174-19	31030-31040	clustering	_	
174-20	31041-31052	coefficient	_	
174-21	31052-31053	,	_	
174-22	31054-31057	and	_	
174-23	31058-31063	small	_	
174-24	31064-31078	characteristic	_	
174-25	31079-31083	path	_	
174-26	31084-31090	length	_	
174-27	31090-31091	.	_	

#Text=These traits yield a highly integrated and segregated networks which are efficient for information transfer.
175-1	31092-31097	These	_	
175-2	31098-31104	traits	_	
175-3	31105-31110	yield	_	
175-4	31111-31112	a	_	
175-5	31113-31119	highly	_	
175-6	31120-31130	integrated	_	
175-7	31131-31134	and	_	
175-8	31135-31145	segregated	_	
175-9	31146-31154	networks	_	
175-10	31155-31160	which	_	
175-11	31161-31164	are	_	
175-12	31165-31174	efficient	_	
175-13	31175-31178	for	_	
175-14	31179-31190	information	_	
175-15	31191-31199	transfer	_	
175-16	31199-31200	.	_	

#Text=The source level results revealed that IWMD had significantly increased SWI and S with decreased L at the gamma band compared to NCs.
176-1	31201-31204	The	_	
176-2	31205-31211	source	_	
176-3	31212-31217	level	_	
176-4	31218-31225	results	_	
176-5	31226-31234	revealed	_	
176-6	31235-31239	that	_	
176-7	31240-31244	IWMD	_	
176-8	31245-31248	had	_	
176-9	31249-31262	significantly	_	
176-10	31263-31272	increased	_	
176-11	31273-31276	SWI	_	
176-12	31277-31280	and	_	
176-13	31281-31282	S	_	
176-14	31283-31287	with	_	
176-15	31288-31297	decreased	_	
176-16	31298-31299	L	_	
176-17	31300-31302	at	_	
176-18	31303-31306	the	_	
176-19	31307-31312	gamma	_	
176-20	31313-31317	band	_	
176-21	31318-31326	compared	_	
176-22	31327-31329	to	_	
176-23	31330-31333	NCs	_	
176-24	31333-31334	.	_	

#Text=These results are in line with those of Ahmadlou et al..
177-1	31335-31340	These	_	
177-2	31341-31348	results	_	
177-3	31349-31352	are	_	
177-4	31353-31355	in	_	
177-5	31356-31360	line	_	
177-6	31361-31365	with	_	
177-7	31366-31371	those	_	
177-8	31372-31374	of	_	
177-9	31375-31383	Ahmadlou	_	
177-10	31384-31386	et	_	
177-11	31387-31389	al	_	
177-12	31389-31390	.	_	
177-13	31390-31391	.	_	

#Text=This implies enhanced integration and segregation of FCN among IWMUD at the expense of increased node strength at the gamma frequencies.
178-1	31392-31396	This	_	
178-2	31397-31404	implies	_	
178-3	31405-31413	enhanced	_	
178-4	31414-31425	integration	_	
178-5	31426-31429	and	_	
178-6	31430-31441	segregation	_	
178-7	31442-31444	of	_	
178-8	31445-31448	FCN	_	
178-9	31449-31454	among	_	
178-10	31455-31460	IWMUD	_	
178-11	31461-31463	at	_	
178-12	31464-31467	the	_	
178-13	31468-31475	expense	_	
178-14	31476-31478	of	_	
178-15	31479-31488	increased	_	
178-16	31489-31493	node	_	
178-17	31494-31502	strength	_	
178-18	31503-31505	at	_	
178-19	31506-31509	the	_	
178-20	31510-31515	gamma	_	
178-21	31516-31527	frequencies	_	
178-22	31527-31528	.	_	

#Text=The majority of connectivity changes at the gamma band are attributed to DMN network.
179-1	31529-31532	The	_	
179-2	31533-31541	majority	_	
179-3	31542-31544	of	_	
179-4	31545-31557	connectivity	_	
179-5	31558-31565	changes	_	
179-6	31566-31568	at	_	
179-7	31569-31572	the	_	
179-8	31573-31578	gamma	_	
179-9	31579-31583	band	_	
179-10	31584-31587	are	_	
179-11	31588-31598	attributed	_	
179-12	31599-31601	to	_	
179-13	31602-31605	DMN	_	
179-14	31606-31613	network	_	
179-15	31613-31614	.	_	

#Text=Hence, one may speculate that the gamma-dependent small-worldness may reflect an alteration in the brain functional topology of IWMUD to be more efficient in an inter-modal dysfunctional network associated with rumination or other maladaptive self-referential propensities.
180-1	31615-31620	Hence	_	
180-2	31620-31621	,	_	
180-3	31622-31625	one	_	
180-4	31626-31629	may	_	
180-5	31630-31639	speculate	_	
180-6	31640-31644	that	_	
180-7	31645-31648	the	_	
180-8	31649-31664	gamma-dependent	_	
180-9	31665-31680	small-worldness	_	
180-10	31681-31684	may	_	
180-11	31685-31692	reflect	_	
180-12	31693-31695	an	_	
180-13	31696-31706	alteration	_	
180-14	31707-31709	in	_	
180-15	31710-31713	the	_	
180-16	31714-31719	brain	_	
180-17	31720-31730	functional	_	
180-18	31731-31739	topology	_	
180-19	31740-31742	of	_	
180-20	31743-31748	IWMUD	_	
180-21	31749-31751	to	_	
180-22	31752-31754	be	_	
180-23	31755-31759	more	_	
180-24	31760-31769	efficient	_	
180-25	31770-31772	in	_	
180-26	31773-31775	an	_	
180-27	31776-31787	inter-modal	_	
180-28	31788-31801	dysfunctional	_	
180-29	31802-31809	network	_	
180-30	31810-31820	associated	_	
180-31	31821-31825	with	_	
180-32	31826-31836	rumination	_	
180-33	31837-31839	or	_	
180-34	31840-31845	other	_	
180-35	31846-31857	maladaptive	_	
180-36	31858-31874	self-referential	_	
180-37	31875-31887	propensities	_	
180-38	31887-31888	.	_	

#Text=Similar differences were also revealed in the delta band: significantly increased C, increased L and SWI.
181-1	31889-31896	Similar	_	
181-2	31897-31908	differences	_	
181-3	31909-31913	were	_	
181-4	31914-31918	also	_	
181-5	31919-31927	revealed	_	
181-6	31928-31930	in	_	
181-7	31931-31934	the	_	
181-8	31935-31940	delta	_	
181-9	31941-31945	band	_	
181-10	31945-31946	:	_	
181-11	31947-31960	significantly	_	
181-12	31961-31970	increased	_	
181-13	31971-31972	C	_	
181-14	31972-31973	,	_	
181-15	31974-31983	increased	_	
181-16	31984-31985	L	_	
181-17	31986-31989	and	_	
181-18	31990-31993	SWI	_	
181-19	31993-31994	.	_	

#Text=Ahmadlou et al. also found a small difference in C at this frequency band.
182-1	31995-32003	Ahmadlou	_	
182-2	32004-32006	et	_	
182-3	32007-32009	al	_	
182-4	32009-32010	.	_	
182-5	32011-32015	also	_	
182-6	32016-32021	found	_	
182-7	32022-32023	a	_	
182-8	32024-32029	small	_	
182-9	32030-32040	difference	_	
182-10	32041-32043	in	_	
182-11	32044-32045	C	_	
182-12	32046-32048	at	_	
182-13	32049-32053	this	_	
182-14	32054-32063	frequency	_	
182-15	32064-32068	band	_	
182-16	32068-32069	.	_	

#Text=Therefore, it could be concluded that brain dysfunction at the delta and gamma frequency band in IWMUD is expected.
183-1	32070-32079	Therefore	_	
183-2	32079-32080	,	_	
183-3	32081-32083	it	_	
183-4	32084-32089	could	_	
183-5	32090-32092	be	_	
183-6	32093-32102	concluded	_	
183-7	32103-32107	that	_	
183-8	32108-32113	brain	_	
183-9	32114-32125	dysfunction	_	
183-10	32126-32128	at	_	
183-11	32129-32132	the	_	
183-12	32133-32138	delta	_	
183-13	32139-32142	and	_	
183-14	32143-32148	gamma	_	
183-15	32149-32158	frequency	_	
183-16	32159-32163	band	_	
183-17	32164-32166	in	_	
183-18	32167-32172	IWMUD	_	
183-19	32173-32175	is	_	
183-20	32176-32184	expected	_	
183-21	32184-32185	.	_	

#Text=Balcony et al. suggested that the delta frequencies may be responsive-relevant rewarding cues and their modulation may be related to a reward bias.
184-1	32186-32193	Balcony	_	
184-2	32194-32196	et	_	
184-3	32197-32199	al	_	
184-4	32199-32200	.	_	
184-5	32201-32210	suggested	_	
184-6	32211-32215	that	_	
184-7	32216-32219	the	_	
184-8	32220-32225	delta	_	
184-9	32226-32237	frequencies	_	
184-10	32238-32241	may	_	
184-11	32242-32244	be	_	
184-12	32245-32264	responsive-relevant	_	
184-13	32265-32274	rewarding	_	
184-14	32275-32279	cues	_	
184-15	32280-32283	and	_	
184-16	32284-32289	their	_	
184-17	32290-32300	modulation	_	
184-18	32301-32304	may	_	
184-19	32305-32307	be	_	
184-20	32308-32315	related	_	
184-21	32316-32318	to	_	
184-22	32319-32320	a	_	
184-23	32321-32327	reward	_	
184-24	32328-32332	bias	_	
184-25	32332-32333	.	_	

#Text=A meta-analysis on fMRI studies suggested that the visual cortex consistently discriminates drug cues from neutral cues in substance-dependent populations.
185-1	32334-32335	A	_	
185-2	32336-32349	meta-analysis	_	
185-3	32350-32352	on	_	
185-4	32353-32357	fMRI	_	
185-5	32358-32365	studies	_	
185-6	32366-32375	suggested	_	
185-7	32376-32380	that	_	
185-8	32381-32384	the	_	
185-9	32385-32391	visual	_	
185-10	32392-32398	cortex	_	
185-11	32399-32411	consistently	_	
185-12	32412-32425	discriminates	_	
185-13	32426-32430	drug	_	
185-14	32431-32435	cues	_	
185-15	32436-32440	from	_	
185-16	32441-32448	neutral	_	
185-17	32449-32453	cues	_	
185-18	32454-32456	in	_	
185-19	32457-32476	substance-dependent	_	
185-20	32477-32488	populations	_	
185-21	32488-32489	.	_	

#Text=The result of delta band revealed increased connectivity between visual cortex (Occipital_Inf_L) and executive network (Frontal_Med_Orb_L).
186-1	32490-32493	The	_	
186-2	32494-32500	result	_	
186-3	32501-32503	of	_	
186-4	32504-32509	delta	_	
186-5	32510-32514	band	_	
186-6	32515-32523	revealed	_	
186-7	32524-32533	increased	_	
186-8	32534-32546	connectivity	_	
186-9	32547-32554	between	_	
186-10	32555-32561	visual	_	
186-11	32562-32568	cortex	_	
186-12	32569-32570	(	_	
186-13	32570-32585	Occipital_Inf_L	_	
186-14	32585-32586	)	_	
186-15	32587-32590	and	_	
186-16	32591-32600	executive	_	
186-17	32601-32608	network	_	
186-18	32609-32610	(	_	
186-19	32610-32627	Frontal_Med_Orb_L	_	
186-20	32627-32628	)	_	
186-21	32628-32629	.	_	

#Text=Hence, it may be related to the attribution of incentive salience to drugs and drug-associated cues in IWMUD.
187-1	32630-32635	Hence	_	
187-2	32635-32636	,	_	
187-3	32637-32639	it	_	
187-4	32640-32643	may	_	
187-5	32644-32646	be	_	
187-6	32647-32654	related	_	
187-7	32655-32657	to	_	
187-8	32658-32661	the	_	
187-9	32662-32673	attribution	_	
187-10	32674-32676	of	_	
187-11	32677-32686	incentive	_	
187-12	32687-32695	salience	_	
187-13	32696-32698	to	_	
187-14	32699-32704	drugs	_	
187-15	32705-32708	and	_	
187-16	32709-32724	drug-associated	_	
187-17	32725-32729	cues	_	
187-18	32730-32732	in	_	
187-19	32733-32738	IWMUD	_	
187-20	32738-32739	.	_	

#Text=Despite the differences in results at sensor and source level, however, their trend is the same and it could be attributed to the fact that each EEG electrode collects the sum of the electrical activity from different sources.
188-1	32740-32747	Despite	_	
188-2	32748-32751	the	_	
188-3	32752-32763	differences	_	
188-4	32764-32766	in	_	
188-5	32767-32774	results	_	
188-6	32775-32777	at	_	
188-7	32778-32784	sensor	_	
188-8	32785-32788	and	_	
188-9	32789-32795	source	_	
188-10	32796-32801	level	_	
188-11	32801-32802	,	_	
188-12	32803-32810	however	_	
188-13	32810-32811	,	_	
188-14	32812-32817	their	_	
188-15	32818-32823	trend	_	
188-16	32824-32826	is	_	
188-17	32827-32830	the	_	
188-18	32831-32835	same	_	
188-19	32836-32839	and	_	
188-20	32840-32842	it	_	
188-21	32843-32848	could	_	
188-22	32849-32851	be	_	
188-23	32852-32862	attributed	_	
188-24	32863-32865	to	_	
188-25	32866-32869	the	_	
188-26	32870-32874	fact	_	
188-27	32875-32879	that	_	
188-28	32880-32884	each	_	
188-29	32885-32888	EEG	_	
188-30	32889-32898	electrode	_	
188-31	32899-32907	collects	_	
188-32	32908-32911	the	_	
188-33	32912-32915	sum	_	
188-34	32916-32918	of	_	
188-35	32919-32922	the	_	
188-36	32923-32933	electrical	_	
188-37	32934-32942	activity	_	
188-38	32943-32947	from	_	
188-39	32948-32957	different	_	
188-40	32958-32965	sources	_	
188-41	32965-32966	.	_	

#Text=Also, the source-localization is a statistical estimation of the sources and, therefore, is subject to technical limitations for accurate estimation.
189-1	32967-32971	Also	_	
189-2	32971-32972	,	_	
189-3	32973-32976	the	_	
189-4	32977-32996	source-localization	_	
189-5	32997-32999	is	_	
189-6	33000-33001	a	_	
189-7	33002-33013	statistical	_	
189-8	33014-33024	estimation	_	
189-9	33025-33027	of	_	
189-10	33028-33031	the	_	
189-11	33032-33039	sources	_	
189-12	33040-33043	and	_	
189-13	33043-33044	,	_	
189-14	33045-33054	therefore	_	
189-15	33054-33055	,	_	
189-16	33056-33058	is	_	
189-17	33059-33066	subject	_	
189-18	33067-33069	to	_	
189-19	33070-33079	technical	_	
189-20	33080-33091	limitations	_	
189-21	33092-33095	for	_	
189-22	33096-33104	accurate	_	
189-23	33105-33115	estimation	_	
189-24	33115-33116	.	_	

#Text=Filtering may cause some other aberrant differences between connectivity values of the two groups.
190-1	33117-33126	Filtering	_	
190-2	33127-33130	may	_	
190-3	33131-33136	cause	_	
190-4	33137-33141	some	_	
190-5	33142-33147	other	_	
190-6	33148-33156	aberrant	_	
190-7	33157-33168	differences	_	
190-8	33169-33176	between	_	
190-9	33177-33189	connectivity	_	
190-10	33190-33196	values	_	
190-11	33197-33199	of	_	
190-12	33200-33203	the	_	
190-13	33204-33207	two	_	
190-14	33208-33214	groups	_	
190-15	33214-33215	.	_	

#Text=To decrease the notch filtering influence at the gamma band, we examined two frequency ranges, 30-45Hz by following previous studies and 30-60Hz similar to the work presented at.
191-1	33216-33218	To	_	
191-2	33219-33227	decrease	_	
191-3	33228-33231	the	_	
191-4	33232-33237	notch	_	
191-5	33238-33247	filtering	_	
191-6	33248-33257	influence	_	
191-7	33258-33260	at	_	
191-8	33261-33264	the	_	
191-9	33265-33270	gamma	_	
191-10	33271-33275	band	_	
191-11	33275-33276	,	_	
191-12	33277-33279	we	_	
191-13	33280-33288	examined	_	
191-14	33289-33292	two	_	
191-15	33293-33302	frequency	_	
191-16	33303-33309	ranges	_	
191-17	33309-33310	,	_	
191-18	33311-33313	30	_	
191-19	33313-33314	-	_	
191-20	33314-33318	45Hz	_	
191-21	33319-33321	by	_	
191-22	33322-33331	following	_	
191-23	33332-33340	previous	_	
191-24	33341-33348	studies	_	
191-25	33349-33352	and	_	
191-26	33353-33355	30	_	
191-27	33355-33356	-	_	
191-28	33356-33360	60Hz	_	
191-29	33361-33368	similar	_	
191-30	33369-33371	to	_	
191-31	33372-33375	the	_	
191-32	33376-33380	work	_	
191-33	33381-33390	presented	_	
191-34	33391-33393	at	_	
191-35	33393-33394	.	_	

#Text=The first range that is preserved from notch filtering effect yielded no significant differences by the sensor space analysis, while the second range (30–60 Hz) led to significant results at the gamma band that may be due to notch filtering influence.
192-1	33395-33398	The	_	
192-2	33399-33404	first	_	
192-3	33405-33410	range	_	
192-4	33411-33415	that	_	
192-5	33416-33418	is	_	
192-6	33419-33428	preserved	_	
192-7	33429-33433	from	_	
192-8	33434-33439	notch	_	
192-9	33440-33449	filtering	_	
192-10	33450-33456	effect	_	
192-11	33457-33464	yielded	_	
192-12	33465-33467	no	_	
192-13	33468-33479	significant	_	
192-14	33480-33491	differences	_	
192-15	33492-33494	by	_	
192-16	33495-33498	the	_	
192-17	33499-33505	sensor	_	
192-18	33506-33511	space	_	
192-19	33512-33520	analysis	_	
192-20	33520-33521	,	_	
192-21	33522-33527	while	_	
192-22	33528-33531	the	_	
192-23	33532-33538	second	_	
192-24	33539-33544	range	_	
192-25	33545-33546	(	_	
192-26	33546-33548	30	_	
192-27	33548-33549	–	_	
192-28	33549-33551	60	_	
192-29	33552-33554	Hz	_	
192-30	33554-33555	)	_	
192-31	33556-33559	led	_	
192-32	33560-33562	to	_	
192-33	33563-33574	significant	_	
192-34	33575-33582	results	_	
192-35	33583-33585	at	_	
192-36	33586-33589	the	_	
192-37	33590-33595	gamma	_	
192-38	33596-33600	band	_	
192-39	33601-33605	that	_	
192-40	33606-33609	may	_	
192-41	33610-33612	be	_	
192-42	33613-33616	due	_	
192-43	33617-33619	to	_	
192-44	33620-33625	notch	_	
192-45	33626-33635	filtering	_	
192-46	33636-33645	influence	_	
192-47	33645-33646	.	_	

#Text=Hence, here, the range of 30–45 Hz was selected to attenuate the likely disruptive effect of notch filtering on connectivity.
193-1	33647-33652	Hence	_	
193-2	33652-33653	,	_	
193-3	33654-33658	here	_	
193-4	33658-33659	,	_	
193-5	33660-33663	the	_	
193-6	33664-33669	range	_	
193-7	33670-33672	of	_	
193-8	33673-33675	30	_	
193-9	33675-33676	–	_	
193-10	33676-33678	45	_	
193-11	33679-33681	Hz	_	
193-12	33682-33685	was	_	
193-13	33686-33694	selected	_	
193-14	33695-33697	to	_	
193-15	33698-33707	attenuate	_	
193-16	33708-33711	the	_	
193-17	33712-33718	likely	_	
193-18	33719-33729	disruptive	_	
193-19	33730-33736	effect	_	
193-20	33737-33739	of	_	
193-21	33740-33745	notch	_	
193-22	33746-33755	filtering	_	
193-23	33756-33758	on	_	
193-24	33759-33771	connectivity	_	
193-25	33771-33772	.	_	

#Text=Brain disorders are related to altered brain coupling that reflects either as a complete variation in the network topology by the replacement of hubs or by alteration of their inter connectivity.
194-1	33773-33778	Brain	_	
194-2	33779-33788	disorders	_	
194-3	33789-33792	are	_	
194-4	33793-33800	related	_	
194-5	33801-33803	to	_	
194-6	33804-33811	altered	_	
194-7	33812-33817	brain	_	
194-8	33818-33826	coupling	_	
194-9	33827-33831	that	_	
194-10	33832-33840	reflects	_	
194-11	33841-33847	either	_	
194-12	33848-33850	as	_	
194-13	33851-33852	a	_	
194-14	33853-33861	complete	_	
194-15	33862-33871	variation	_	
194-16	33872-33874	in	_	
194-17	33875-33878	the	_	
194-18	33879-33886	network	_	
194-19	33887-33895	topology	_	
194-20	33896-33898	by	_	
194-21	33899-33902	the	_	
194-22	33903-33914	replacement	_	
194-23	33915-33917	of	_	
194-24	33918-33922	hubs	_	
194-25	33923-33925	or	_	
194-26	33926-33928	by	_	
194-27	33929-33939	alteration	_	
194-28	33940-33942	of	_	
194-29	33943-33948	their	_	
194-30	33949-33954	inter	_	
194-31	33955-33967	connectivity	_	
194-32	33967-33968	.	_	

#Text=According to the hub-associated findings, it appears that the brain FCN of IWMUD and NCs could be considerably distinct, not only at the delta and gamma band but also at the other oscillatory bands because of having few common hubs in all the oscillatory bands between IWMUD and NCs.
195-1	33969-33978	According	_	
195-2	33979-33981	to	_	
195-3	33982-33985	the	_	
195-4	33986-34000	hub-associated	_	
195-5	34001-34009	findings	_	
195-6	34009-34010	,	_	
195-7	34011-34013	it	_	
195-8	34014-34021	appears	_	
195-9	34022-34026	that	_	
195-10	34027-34030	the	_	
195-11	34031-34036	brain	_	
195-12	34037-34040	FCN	_	
195-13	34041-34043	of	_	
195-14	34044-34049	IWMUD	_	
195-15	34050-34053	and	_	
195-16	34054-34057	NCs	_	
195-17	34058-34063	could	_	
195-18	34064-34066	be	_	
195-19	34067-34079	considerably	_	
195-20	34080-34088	distinct	_	
195-21	34088-34089	,	_	
195-22	34090-34093	not	_	
195-23	34094-34098	only	_	
195-24	34099-34101	at	_	
195-25	34102-34105	the	_	
195-26	34106-34111	delta	_	
195-27	34112-34115	and	_	
195-28	34116-34121	gamma	_	
195-29	34122-34126	band	_	
195-30	34127-34130	but	_	
195-31	34131-34135	also	_	
195-32	34136-34138	at	_	
195-33	34139-34142	the	_	
195-34	34143-34148	other	_	
195-35	34149-34160	oscillatory	_	
195-36	34161-34166	bands	_	
195-37	34167-34174	because	_	
195-38	34175-34177	of	_	
195-39	34178-34184	having	_	
195-40	34185-34188	few	_	
195-41	34189-34195	common	_	
195-42	34196-34200	hubs	_	
195-43	34201-34203	in	_	
195-44	34204-34207	all	_	
195-45	34208-34211	the	_	
195-46	34212-34223	oscillatory	_	
195-47	34224-34229	bands	_	
195-48	34230-34237	between	_	
195-49	34238-34243	IWMUD	_	
195-50	34244-34247	and	_	
195-51	34248-34251	NCs	_	
195-52	34251-34252	.	_	

#Text=Gamma-related hubs of IWMUD are mostly attributed to reward (Frontal_Inf_Orb_R), salience (Cingulum_Ant_R), DMN (Frontal_Sup_R, Temporal_Inf_L), visual and auditory (Calcarine_R and Temporal_Sup_L), and the delta-associated hubs are mostly located in reward (Frontal_Mid_Orb_L, Frontal_Med_Orb_L), DMN (Frontal_Sup_Medial_R) and sensorimotor network.
196-1	34253-34266	Gamma-related	_	
196-2	34267-34271	hubs	_	
196-3	34272-34274	of	_	
196-4	34275-34280	IWMUD	_	
196-5	34281-34284	are	_	
196-6	34285-34291	mostly	_	
196-7	34292-34302	attributed	_	
196-8	34303-34305	to	_	
196-9	34306-34312	reward	_	
196-10	34313-34314	(	_	
196-11	34314-34331	Frontal_Inf_Orb_R	_	
196-12	34331-34332	)	_	
196-13	34332-34333	,	_	
196-14	34334-34342	salience	_	
196-15	34343-34344	(	_	
196-16	34344-34358	Cingulum_Ant_R	_	
196-17	34358-34359	)	_	
196-18	34359-34360	,	_	
196-19	34361-34364	DMN	_	
196-20	34365-34366	(	_	
196-21	34366-34379	Frontal_Sup_R	_	
196-22	34379-34380	,	_	
196-23	34381-34395	Temporal_Inf_L	_	
196-24	34395-34396	)	_	
196-25	34396-34397	,	_	
196-26	34398-34404	visual	_	
196-27	34405-34408	and	_	
196-28	34409-34417	auditory	_	
196-29	34418-34419	(	_	
196-30	34419-34430	Calcarine_R	_	
196-31	34431-34434	and	_	
196-32	34435-34449	Temporal_Sup_L	_	
196-33	34449-34450	)	_	
196-34	34450-34451	,	_	
196-35	34452-34455	and	_	
196-36	34456-34459	the	_	
196-37	34460-34476	delta-associated	_	
196-38	34477-34481	hubs	_	
196-39	34482-34485	are	_	
196-40	34486-34492	mostly	_	
196-41	34493-34500	located	_	
196-42	34501-34503	in	_	
196-43	34504-34510	reward	_	
196-44	34511-34512	(	_	
196-45	34512-34529	Frontal_Mid_Orb_L	_	
196-46	34529-34530	,	_	
196-47	34531-34548	Frontal_Med_Orb_L	_	
196-48	34548-34549	)	_	
196-49	34549-34550	,	_	
196-50	34551-34554	DMN	_	
196-51	34555-34556	(	_	
196-52	34556-34576	Frontal_Sup_Medial_R	_	
196-53	34576-34577	)	_	
196-54	34578-34581	and	_	
196-55	34582-34594	sensorimotor	_	
196-56	34595-34602	network	_	
196-57	34602-34603	.	_	

#Text=Activations of sensorimotor areas in response to drug stimuli are correlated to craving, the severity of dependence and automatized behavioral reactions towards drug-related stimuli.
197-1	34604-34615	Activations	_	
197-2	34616-34618	of	_	
197-3	34619-34631	sensorimotor	_	
197-4	34632-34637	areas	_	
197-5	34638-34640	in	_	
197-6	34641-34649	response	_	
197-7	34650-34652	to	_	
197-8	34653-34657	drug	_	
197-9	34658-34665	stimuli	_	
197-10	34666-34669	are	_	
197-11	34670-34680	correlated	_	
197-12	34681-34683	to	_	
197-13	34684-34691	craving	_	
197-14	34691-34692	,	_	
197-15	34693-34696	the	_	
197-16	34697-34705	severity	_	
197-17	34706-34708	of	_	
197-18	34709-34719	dependence	_	
197-19	34720-34723	and	_	
197-20	34724-34735	automatized	_	
197-21	34736-34746	behavioral	_	
197-22	34747-34756	reactions	_	
197-23	34757-34764	towards	_	
197-24	34765-34777	drug-related	_	
197-25	34778-34785	stimuli	_	
197-26	34785-34786	.	_	

#Text=Salience and reward networks are also important in this regard.
198-1	34787-34795	Salience	_	
198-2	34796-34799	and	_	
198-3	34800-34806	reward	_	
198-4	34807-34815	networks	_	
198-5	34816-34819	are	_	
198-6	34820-34824	also	_	
198-7	34825-34834	important	_	
198-8	34835-34837	in	_	
198-9	34838-34842	this	_	
198-10	34843-34849	regard	_	
198-11	34849-34850	.	_	

#Text=In sum, it may be speculated that hub replacement and connectivity alterations in the gamma and delta frequency bands are associated with regions that have an important role in disability of substance-dependent individuals to control their addiction-related behaviors.
199-1	34851-34853	In	_	
199-2	34854-34857	sum	_	
199-3	34857-34858	,	_	
199-4	34859-34861	it	_	
199-5	34862-34865	may	_	
199-6	34866-34868	be	_	
199-7	34869-34879	speculated	_	
199-8	34880-34884	that	_	
199-9	34885-34888	hub	_	
199-10	34889-34900	replacement	_	
199-11	34901-34904	and	_	
199-12	34905-34917	connectivity	_	
199-13	34918-34929	alterations	_	
199-14	34930-34932	in	_	
199-15	34933-34936	the	_	
199-16	34937-34942	gamma	_	
199-17	34943-34946	and	_	
199-18	34947-34952	delta	_	
199-19	34953-34962	frequency	_	
199-20	34963-34968	bands	_	
199-21	34969-34972	are	_	
199-22	34973-34983	associated	_	
199-23	34984-34988	with	_	
199-24	34989-34996	regions	_	
199-25	34997-35001	that	_	
199-26	35002-35006	have	_	
199-27	35007-35009	an	_	
199-28	35010-35019	important	_	
199-29	35020-35024	role	_	
199-30	35025-35027	in	_	
199-31	35028-35038	disability	_	
199-32	35039-35041	of	_	
199-33	35042-35061	substance-dependent	_	
199-34	35062-35073	individuals	_	
199-35	35074-35076	to	_	
199-36	35077-35084	control	_	
199-37	35085-35090	their	_	
199-38	35091-35108	addiction-related	_	
199-39	35109-35118	behaviors	_	
199-40	35118-35119	.	_	

#Text=The delta and gamma related topology and connectivity changes could facilitate the development of new treatment strategies and serves as a predictive biomarker of disease severity and treatment outcome for IWMUD.
200-1	35120-35123	The	_	
200-2	35124-35129	delta	_	
200-3	35130-35133	and	_	
200-4	35134-35139	gamma	_	
200-5	35140-35147	related	_	
200-6	35148-35156	topology	_	
200-7	35157-35160	and	_	
200-8	35161-35173	connectivity	_	
200-9	35174-35181	changes	_	
200-10	35182-35187	could	_	
200-11	35188-35198	facilitate	_	
200-12	35199-35202	the	_	
200-13	35203-35214	development	_	
200-14	35215-35217	of	_	
200-15	35218-35221	new	_	
200-16	35222-35231	treatment	_	
200-17	35232-35242	strategies	_	
200-18	35243-35246	and	_	
200-19	35247-35253	serves	_	
200-20	35254-35256	as	_	
200-21	35257-35258	a	_	
200-22	35259-35269	predictive	_	
200-23	35270-35279	biomarker	_	
200-24	35280-35282	of	_	
200-25	35283-35290	disease	_	
200-26	35291-35299	severity	_	
200-27	35300-35303	and	_	
200-28	35304-35313	treatment	_	
200-29	35314-35321	outcome	_	
200-30	35322-35325	for	_	
200-31	35326-35331	IWMUD	_	
200-32	35331-35332	.	_	

#Text=The recruited IWMUD of the current study were in their middle stages of abstinence (1–6 months) and they did not experience considerable withdrawal effects.
201-1	35333-35336	The	_	
201-2	35337-35346	recruited	_	
201-3	35347-35352	IWMUD	_	
201-4	35353-35355	of	_	
201-5	35356-35359	the	_	
201-6	35360-35367	current	_	
201-7	35368-35373	study	_	
201-8	35374-35378	were	_	
201-9	35379-35381	in	_	
201-10	35382-35387	their	_	
201-11	35388-35394	middle	_	
201-12	35395-35401	stages	_	
201-13	35402-35404	of	_	
201-14	35405-35415	abstinence	_	
201-15	35416-35417	(	_	
201-16	35417-35418	1	_	
201-17	35418-35419	–	_	
201-18	35419-35420	6	_	
201-19	35421-35427	months	_	
201-20	35427-35428	)	_	
201-21	35429-35432	and	_	
201-22	35433-35437	they	_	
201-23	35438-35441	did	_	
201-24	35442-35445	not	_	
201-25	35446-35456	experience	_	
201-26	35457-35469	considerable	_	
201-27	35470-35480	withdrawal	_	
201-28	35481-35488	effects	_	
201-29	35488-35489	.	_	

#Text=Therefore compared to participants of Ahmadlou’s study who were in early withdrawal stage (< 3 weeks), probability of this hypothesis is reinforced that the dysfunctional organization of the gamma frequency band indexed by abnormal small-world properties of the brain FCN may be associated with chronic exposure to MA and not to the abstinence.
#Text=5.3.
202-1	35490-35499	Therefore	_	
202-2	35500-35508	compared	_	
202-3	35509-35511	to	_	
202-4	35512-35524	participants	_	
202-5	35525-35527	of	_	
202-6	35528-35536	Ahmadlou	_	
202-7	35536-35537	’	_	
202-8	35537-35538	s	_	
202-9	35539-35544	study	_	
202-10	35545-35548	who	_	
202-11	35549-35553	were	_	
202-12	35554-35556	in	_	
202-13	35557-35562	early	_	
202-14	35563-35573	withdrawal	_	
202-15	35574-35579	stage	_	
202-16	35580-35581	(	_	
202-17	35581-35582	<	_	
202-18	35583-35584	3	_	
202-19	35585-35590	weeks	_	
202-20	35590-35591	)	_	
202-21	35591-35592	,	_	
202-22	35593-35604	probability	_	
202-23	35605-35607	of	_	
202-24	35608-35612	this	_	
202-25	35613-35623	hypothesis	_	
202-26	35624-35626	is	_	
202-27	35627-35637	reinforced	_	
202-28	35638-35642	that	_	
202-29	35643-35646	the	_	
202-30	35647-35660	dysfunctional	_	
202-31	35661-35673	organization	_	
202-32	35674-35676	of	_	
202-33	35677-35680	the	_	
202-34	35681-35686	gamma	_	
202-35	35687-35696	frequency	_	
202-36	35697-35701	band	_	
202-37	35702-35709	indexed	_	
202-38	35710-35712	by	_	
202-39	35713-35721	abnormal	_	
202-40	35722-35733	small-world	_	
202-41	35734-35744	properties	_	
202-42	35745-35747	of	_	
202-43	35748-35751	the	_	
202-44	35752-35757	brain	_	
202-45	35758-35761	FCN	_	
202-46	35762-35765	may	_	
202-47	35766-35768	be	_	
202-48	35769-35779	associated	_	
202-49	35780-35784	with	_	
202-50	35785-35792	chronic	_	
202-51	35793-35801	exposure	_	
202-52	35802-35804	to	_	
202-53	35805-35807	MA	_	
202-54	35808-35811	and	_	
202-55	35812-35815	not	_	
202-56	35816-35818	to	_	
202-57	35819-35822	the	_	
202-58	35823-35833	abstinence	_	
202-59	35833-35834	.	_	
202-60	35835-35838	5.3	_	
202-61	35838-35839	.	_	

#Text=EEG activity and impulsiveness, depression, anxiety and stress scales
#Text=According to a study among individuals with gambling disorder, high impulsivity (25th percentile of BIS-11 scale) has the potential to affect EEG power spectrum in different frequency bands except for the gamma band.
203-1	35840-35843	EEG	_	
203-2	35844-35852	activity	_	
203-3	35853-35856	and	_	
203-4	35857-35870	impulsiveness	_	
203-5	35870-35871	,	_	
203-6	35872-35882	depression	_	
203-7	35882-35883	,	_	
203-8	35884-35891	anxiety	_	
203-9	35892-35895	and	_	
203-10	35896-35902	stress	_	
203-11	35903-35909	scales	_	
203-12	35910-35919	According	_	
203-13	35920-35922	to	_	
203-14	35923-35924	a	_	
203-15	35925-35930	study	_	
203-16	35931-35936	among	_	
203-17	35937-35948	individuals	_	
203-18	35949-35953	with	_	
203-19	35954-35962	gambling	_	
203-20	35963-35971	disorder	_	
203-21	35971-35972	,	_	
203-22	35973-35977	high	_	
203-23	35978-35989	impulsivity	_	
203-24	35990-35991	(	_	
203-25	35991-35995	25th	_	
203-26	35996-36006	percentile	_	
203-27	36007-36009	of	_	
203-28	36010-36013	BIS	_	
203-29	36013-36014	-	_	
203-30	36014-36016	11	_	
203-31	36017-36022	scale	_	
203-32	36022-36023	)	_	
203-33	36024-36027	has	_	
203-34	36028-36031	the	_	
203-35	36032-36041	potential	_	
203-36	36042-36044	to	_	
203-37	36045-36051	affect	_	
203-38	36052-36055	EEG	_	
203-39	36056-36061	power	_	
203-40	36062-36070	spectrum	_	
203-41	36071-36073	in	_	
203-42	36074-36083	different	_	
203-43	36084-36093	frequency	_	
203-44	36094-36099	bands	_	
203-45	36100-36106	except	_	
203-46	36107-36110	for	_	
203-47	36111-36114	the	_	
203-48	36115-36120	gamma	_	
203-49	36121-36125	band	_	
203-50	36125-36126	.	_	

#Text=Stress may alter EEG waves so that the baseline rhythms in individuals with mild and moderate stress is alpha wave and in those with high stress is beta wave.
204-1	36127-36133	Stress	_	
204-2	36134-36137	may	_	
204-3	36138-36143	alter	_	
204-4	36144-36147	EEG	_	
204-5	36148-36153	waves	_	
204-6	36154-36156	so	_	
204-7	36157-36161	that	_	
204-8	36162-36165	the	_	
204-9	36166-36174	baseline	_	
204-10	36175-36182	rhythms	_	
204-11	36183-36185	in	_	
204-12	36186-36197	individuals	_	
204-13	36198-36202	with	_	
204-14	36203-36207	mild	_	
204-15	36208-36211	and	_	
204-16	36212-36220	moderate	_	
204-17	36221-36227	stress	_	
204-18	36228-36230	is	_	
204-19	36231-36236	alpha	_	
204-20	36237-36241	wave	_	
204-21	36242-36245	and	_	
204-22	36246-36248	in	_	
204-23	36249-36254	those	_	
204-24	36255-36259	with	_	
204-25	36260-36264	high	_	
204-26	36265-36271	stress	_	
204-27	36272-36274	is	_	
204-28	36275-36279	beta	_	
204-29	36280-36284	wave	_	
204-30	36284-36285	.	_	

#Text=Our recruited subjects were mostly in normal, mild or moderate levels of impulsivity, stress, anxiety, and depression (Table 10).
205-1	36286-36289	Our	_	
205-2	36290-36299	recruited	_	
205-3	36300-36308	subjects	_	
205-4	36309-36313	were	_	
205-5	36314-36320	mostly	_	
205-6	36321-36323	in	_	
205-7	36324-36330	normal	_	
205-8	36330-36331	,	_	
205-9	36332-36336	mild	_	
205-10	36337-36339	or	_	
205-11	36340-36348	moderate	_	
205-12	36349-36355	levels	_	
205-13	36356-36358	of	_	
205-14	36359-36370	impulsivity	_	
205-15	36370-36371	,	_	
205-16	36372-36378	stress	_	
205-17	36378-36379	,	_	
205-18	36380-36387	anxiety	_	
205-19	36387-36388	,	_	
205-20	36389-36392	and	_	
205-21	36393-36403	depression	_	
205-22	36404-36405	(	_	
205-23	36405-36410	Table	_	
205-24	36411-36413	10	_	
205-25	36413-36414	)	_	
205-26	36414-36415	.	_	

#Text=The correlation analysis revealed no significant correlation between the gamma SWI and impulsivity or DASS scales; further, the DASS score showed no significant effect in the MANOVA model.
206-1	36416-36419	The	_	
206-2	36420-36431	correlation	_	
206-3	36432-36440	analysis	_	
206-4	36441-36449	revealed	_	
206-5	36450-36452	no	_	
206-6	36453-36464	significant	_	
206-7	36465-36476	correlation	_	
206-8	36477-36484	between	_	
206-9	36485-36488	the	_	
206-10	36489-36494	gamma	_	
206-11	36495-36498	SWI	_	
206-12	36499-36502	and	_	
206-13	36503-36514	impulsivity	_	
206-14	36515-36517	or	_	
206-15	36518-36522	DASS	_	
206-16	36523-36529	scales	_	
206-17	36529-36530	;	_	
206-18	36531-36538	further	_	
206-19	36538-36539	,	_	
206-20	36540-36543	the	_	
206-21	36544-36548	DASS	_	
206-22	36549-36554	score	_	
206-23	36555-36561	showed	_	
206-24	36562-36564	no	_	
206-25	36565-36576	significant	_	
206-26	36577-36583	effect	_	
206-27	36584-36586	in	_	
206-28	36587-36590	the	_	
206-29	36591-36597	MANOVA	_	
206-30	36598-36603	model	_	
206-31	36603-36604	.	_	

#Text=Moreover, previous related study also reported abnormal alteration of brain topology metrics in this frequency band.
207-1	36605-36613	Moreover	_	
207-2	36613-36614	,	_	
207-3	36615-36623	previous	_	
207-4	36624-36631	related	_	
207-5	36632-36637	study	_	
207-6	36638-36642	also	_	
207-7	36643-36651	reported	_	
207-8	36652-36660	abnormal	_	
207-9	36661-36671	alteration	_	
207-10	36672-36674	of	_	
207-11	36675-36680	brain	_	
207-12	36681-36689	topology	_	
207-13	36690-36697	metrics	_	
207-14	36698-36700	in	_	
207-15	36701-36705	this	_	
207-16	36706-36715	frequency	_	
207-17	36716-36720	band	_	
207-18	36720-36721	.	_	

#Text=Accordingly, it may be concluded that the findings in the gamma frequency band are probably due to methamphetamine dependence and its effect on brain resting-state networks, not withdrawal effects.
208-1	36722-36733	Accordingly	_	
208-2	36733-36734	,	_	
208-3	36735-36737	it	_	
208-4	36738-36741	may	_	
208-5	36742-36744	be	_	
208-6	36745-36754	concluded	_	
208-7	36755-36759	that	_	
208-8	36760-36763	the	_	
208-9	36764-36772	findings	_	
208-10	36773-36775	in	_	
208-11	36776-36779	the	_	
208-12	36780-36785	gamma	_	
208-13	36786-36795	frequency	_	
208-14	36796-36800	band	_	
208-15	36801-36804	are	_	
208-16	36805-36813	probably	_	
208-17	36814-36817	due	_	
208-18	36818-36820	to	_	
208-19	36821-36836	methamphetamine	_	
208-20	36837-36847	dependence	_	
208-21	36848-36851	and	_	
208-22	36852-36855	its	_	
208-23	36856-36862	effect	_	
208-24	36863-36865	on	_	
208-25	36866-36871	brain	_	
208-26	36872-36885	resting-state	_	
208-27	36886-36894	networks	_	
208-28	36894-36895	,	_	
208-29	36896-36899	not	_	
208-30	36900-36910	withdrawal	_	
208-31	36911-36918	effects	_	
208-32	36918-36919	.	_	

#Text=Nevertheless, the findings of other frequency bands may be affected by the impulsivity and stress levels and also the power of brain activity is not directly associated with its functional connectivity.
209-1	36920-36932	Nevertheless	_	
209-2	36932-36933	,	_	
209-3	36934-36937	the	_	
209-4	36938-36946	findings	_	
209-5	36947-36949	of	_	
209-6	36950-36955	other	_	
209-7	36956-36965	frequency	_	
209-8	36966-36971	bands	_	
209-9	36972-36975	may	_	
209-10	36976-36978	be	_	
209-11	36979-36987	affected	_	
209-12	36988-36990	by	_	
209-13	36991-36994	the	_	
209-14	36995-37006	impulsivity	_	
209-15	37007-37010	and	_	
209-16	37011-37017	stress	_	
209-17	37018-37024	levels	_	
209-18	37025-37028	and	_	
209-19	37029-37033	also	_	
209-20	37034-37037	the	_	
209-21	37038-37043	power	_	
209-22	37044-37046	of	_	
209-23	37047-37052	brain	_	
209-24	37053-37061	activity	_	
209-25	37062-37064	is	_	
209-26	37065-37068	not	_	
209-27	37069-37077	directly	_	
209-28	37078-37088	associated	_	
209-29	37089-37093	with	_	
209-30	37094-37097	its	_	
209-31	37098-37108	functional	_	
209-32	37109-37121	connectivity	_	
209-33	37121-37122	.	_	

#Text=We could not asses these undesired effects because the sample size was low and just a few variables had the eligibility to be included in the MANOVA.
210-1	37123-37125	We	_	
210-2	37126-37131	could	_	
210-3	37132-37135	not	_	
210-4	37136-37141	asses	_	
210-5	37142-37147	these	_	
210-6	37148-37157	undesired	_	
210-7	37158-37165	effects	_	
210-8	37166-37173	because	_	
210-9	37174-37177	the	_	
210-10	37178-37184	sample	_	
210-11	37185-37189	size	_	
210-12	37190-37193	was	_	
210-13	37194-37197	low	_	
210-14	37198-37201	and	_	
210-15	37202-37206	just	_	
210-16	37207-37208	a	_	
210-17	37209-37212	few	_	
210-18	37213-37222	variables	_	
210-19	37223-37226	had	_	
210-20	37227-37230	the	_	
210-21	37231-37242	eligibility	_	
210-22	37243-37245	to	_	
210-23	37246-37248	be	_	
210-24	37249-37257	included	_	
210-25	37258-37260	in	_	
210-26	37261-37264	the	_	
210-27	37265-37271	MANOVA	_	
210-28	37271-37272	.	_	

#Text=Conducting a related research with large sample size is therefore suggested to confirm the functional alterations found in the alpha and theta frequency bands.
211-1	37273-37283	Conducting	_	
211-2	37284-37285	a	_	
211-3	37286-37293	related	_	
211-4	37294-37302	research	_	
211-5	37303-37307	with	_	
211-6	37308-37313	large	_	
211-7	37314-37320	sample	_	
211-8	37321-37325	size	_	
211-9	37326-37328	is	_	
211-10	37329-37338	therefore	_	
211-11	37339-37348	suggested	_	
211-12	37349-37351	to	_	
211-13	37352-37359	confirm	_	
211-14	37360-37363	the	_	
211-15	37364-37374	functional	_	
211-16	37375-37386	alterations	_	
211-17	37387-37392	found	_	
211-18	37393-37395	in	_	
211-19	37396-37399	the	_	
211-20	37400-37405	alpha	_	
211-21	37406-37409	and	_	
211-22	37410-37415	theta	_	
211-23	37416-37425	frequency	_	
211-24	37426-37431	bands	_	
211-25	37431-37432	.	_	

#Text=Number of subjects in different stress, anxiety, and depression levels.
212-1	37433-37439	Number	_	
212-2	37440-37442	of	_	
212-3	37443-37451	subjects	_	
212-4	37452-37454	in	_	
212-5	37455-37464	different	_	
212-6	37465-37471	stress	_	
212-7	37471-37472	,	_	
212-8	37473-37480	anxiety	_	
212-9	37480-37481	,	_	
212-10	37482-37485	and	_	
212-11	37486-37496	depression	_	
212-12	37497-37503	levels	_	
212-13	37503-37504	.	_	

#Text=Normal\tMild\tModerate\tHigh\tSever\t \tIWMD\tStress\t12\t2\t8\t3\t5\t \tAnxiety\t9\t3\t8\t4\t7\t \tDepression\t5\t6\t7\t4\t7\t \tNCs\tStress\t21\t0\t-\t-\t-\t \tAnxiety\t16\t4\t1\t1\t1\t \tDepression\t3\t8\t10\t0\t2\t \t
#Text=5.4 Limitations
#Text=The present study had several limitations.
213-1	37506-37512	Normal	_	
213-2	37513-37517	Mild	_	
213-3	37518-37526	Moderate	_	
213-4	37527-37531	High	_	
213-5	37532-37537	Sever	_	
213-6	37540-37544	IWMD	_	
213-7	37545-37551	Stress	_	
213-8	37552-37554	12	_	
213-9	37555-37556	2	_	
213-10	37557-37558	8	_	
213-11	37559-37560	3	_	
213-12	37561-37562	5	_	
213-13	37565-37572	Anxiety	_	
213-14	37573-37574	9	_	
213-15	37575-37576	3	_	
213-16	37577-37578	8	_	
213-17	37579-37580	4	_	
213-18	37581-37582	7	_	
213-19	37585-37595	Depression	_	
213-20	37596-37597	5	_	
213-21	37598-37599	6	_	
213-22	37600-37601	7	_	
213-23	37602-37603	4	_	
213-24	37604-37605	7	_	
213-25	37608-37611	NCs	_	
213-26	37612-37618	Stress	_	
213-27	37619-37621	21	_	
213-28	37622-37623	0	_	
213-29	37624-37625	-	_	
213-30	37626-37627	-	_	
213-31	37628-37629	-	_	
213-32	37632-37639	Anxiety	_	
213-33	37640-37642	16	_	
213-34	37643-37644	4	_	
213-35	37645-37646	1	_	
213-36	37647-37648	1	_	
213-37	37649-37650	1	_	
213-38	37653-37663	Depression	_	
213-39	37664-37665	3	_	
213-40	37666-37667	8	_	
213-41	37668-37670	10	_	
213-42	37671-37672	0	_	
213-43	37673-37674	2	_	
213-44	37678-37681	5.4	_	
213-45	37682-37693	Limitations	_	
213-46	37694-37697	The	_	
213-47	37698-37705	present	_	
213-48	37706-37711	study	_	
213-49	37712-37715	had	_	
213-50	37716-37723	several	_	
213-51	37724-37735	limitations	_	
213-52	37735-37736	.	_	

#Text=First, as a human study, there were some intrinsic limitations from matching the behavioral and demographic characteristics of IWMUD and NCs because of inaccessibility of backgrounds of the participants.
214-1	37737-37742	First	_	
214-2	37742-37743	,	_	
214-3	37744-37746	as	_	
214-4	37747-37748	a	_	
214-5	37749-37754	human	_	
214-6	37755-37760	study	_	
214-7	37760-37761	,	_	
214-8	37762-37767	there	_	
214-9	37768-37772	were	_	
214-10	37773-37777	some	_	
214-11	37778-37787	intrinsic	_	
214-12	37788-37799	limitations	_	
214-13	37800-37804	from	_	
214-14	37805-37813	matching	_	
214-15	37814-37817	the	_	
214-16	37818-37828	behavioral	_	
214-17	37829-37832	and	_	
214-18	37833-37844	demographic	_	
214-19	37845-37860	characteristics	_	
214-20	37861-37863	of	_	
214-21	37864-37869	IWMUD	_	
214-22	37870-37873	and	_	
214-23	37874-37877	NCs	_	
214-24	37878-37885	because	_	
214-25	37886-37888	of	_	
214-26	37889-37904	inaccessibility	_	
214-27	37905-37907	of	_	
214-28	37908-37919	backgrounds	_	
214-29	37920-37922	of	_	
214-30	37923-37926	the	_	
214-31	37927-37939	participants	_	
214-32	37939-37940	.	_	

#Text=Therefore, more accurate research using genetically modified animals with better control matching are required to support the obtained results of this study.
215-1	37941-37950	Therefore	_	
215-2	37950-37951	,	_	
215-3	37952-37956	more	_	
215-4	37957-37965	accurate	_	
215-5	37966-37974	research	_	
215-6	37975-37980	using	_	
215-7	37981-37992	genetically	_	
215-8	37993-38001	modified	_	
215-9	38002-38009	animals	_	
215-10	38010-38014	with	_	
215-11	38015-38021	better	_	
215-12	38022-38029	control	_	
215-13	38030-38038	matching	_	
215-14	38039-38042	are	_	
215-15	38043-38051	required	_	
215-16	38052-38054	to	_	
215-17	38055-38062	support	_	
215-18	38063-38066	the	_	
215-19	38067-38075	obtained	_	
215-20	38076-38083	results	_	
215-21	38084-38086	of	_	
215-22	38087-38091	this	_	
215-23	38092-38097	study	_	
215-24	38097-38098	.	_	

#Text=Second, as some factors could probably vary the developmental period of vulnerability to methamphetamine toxicity in different genders, we recruited only male participants to remove the confounding factor of gender variations.
216-1	38099-38105	Second	_	
216-2	38105-38106	,	_	
216-3	38107-38109	as	_	
216-4	38110-38114	some	_	
216-5	38115-38122	factors	_	
216-6	38123-38128	could	_	
216-7	38129-38137	probably	_	
216-8	38138-38142	vary	_	
216-9	38143-38146	the	_	
216-10	38147-38160	developmental	_	
216-11	38161-38167	period	_	
216-12	38168-38170	of	_	
216-13	38171-38184	vulnerability	_	
216-14	38185-38187	to	_	
216-15	38188-38203	methamphetamine	_	
216-16	38204-38212	toxicity	_	
216-17	38213-38215	in	_	
216-18	38216-38225	different	_	
216-19	38226-38233	genders	_	
216-20	38233-38234	,	_	
216-21	38235-38237	we	_	
216-22	38238-38247	recruited	_	
216-23	38248-38252	only	_	
216-24	38253-38257	male	_	
216-25	38258-38270	participants	_	
216-26	38271-38273	to	_	
216-27	38274-38280	remove	_	
216-28	38281-38284	the	_	
216-29	38285-38296	confounding	_	
216-30	38297-38303	factor	_	
216-31	38304-38306	of	_	
216-32	38307-38313	gender	_	
216-33	38314-38324	variations	_	
216-34	38324-38325	.	_	

#Text=Research including both genders is needed.
217-1	38326-38334	Research	_	
217-2	38335-38344	including	_	
217-3	38345-38349	both	_	
217-4	38350-38357	genders	_	
217-5	38358-38360	is	_	
217-6	38361-38367	needed	_	
217-7	38367-38368	.	_	

#Text=Third, we managed to scan the IWMUD during substance withdrawal, while the NCs were not, so we were not able to absolutely exclude the influence of smoking, drinking or caffeine.
218-1	38369-38374	Third	_	
218-2	38374-38375	,	_	
218-3	38376-38378	we	_	
218-4	38379-38386	managed	_	
218-5	38387-38389	to	_	
218-6	38390-38394	scan	_	
218-7	38395-38398	the	_	
218-8	38399-38404	IWMUD	_	
218-9	38405-38411	during	_	
218-10	38412-38421	substance	_	
218-11	38422-38432	withdrawal	_	
218-12	38432-38433	,	_	
218-13	38434-38439	while	_	
218-14	38440-38443	the	_	
218-15	38444-38447	NCs	_	
218-16	38448-38452	were	_	
218-17	38453-38456	not	_	
218-18	38456-38457	,	_	
218-19	38458-38460	so	_	
218-20	38461-38463	we	_	
218-21	38464-38468	were	_	
218-22	38469-38472	not	_	
218-23	38473-38477	able	_	
218-24	38478-38480	to	_	
218-25	38481-38491	absolutely	_	
218-26	38492-38499	exclude	_	
218-27	38500-38503	the	_	
218-28	38504-38513	influence	_	
218-29	38514-38516	of	_	
218-30	38517-38524	smoking	_	
218-31	38524-38525	,	_	
218-32	38526-38534	drinking	_	
218-33	38535-38537	or	_	
218-34	38538-38546	caffeine	_	
218-35	38546-38547	.	_	

#Text=Forth, the numbers of subjects were moderate because of practical difficulties in recruitment of IWMUD.
219-1	38548-38553	Forth	_	
219-2	38553-38554	,	_	
219-3	38555-38558	the	_	
219-4	38559-38566	numbers	_	
219-5	38567-38569	of	_	
219-6	38570-38578	subjects	_	
219-7	38579-38583	were	_	
219-8	38584-38592	moderate	_	
219-9	38593-38600	because	_	
219-10	38601-38603	of	_	
219-11	38604-38613	practical	_	
219-12	38614-38626	difficulties	_	
219-13	38627-38629	in	_	
219-14	38630-38641	recruitment	_	
219-15	38642-38644	of	_	
219-16	38645-38650	IWMUD	_	
219-17	38650-38651	.	_	

#Text=Fifth, subcortical network (Putamen, palladium, thalamus, caudate) cannot be properly reconstructed by EEG.
#Text=6.
220-1	38652-38657	Fifth	_	
220-2	38657-38658	,	_	
220-3	38659-38670	subcortical	_	
220-4	38671-38678	network	_	
220-5	38679-38680	(	_	
220-6	38680-38687	Putamen	_	
220-7	38687-38688	,	_	
220-8	38689-38698	palladium	_	
220-9	38698-38699	,	_	
220-10	38700-38708	thalamus	_	
220-11	38708-38709	,	_	
220-12	38710-38717	caudate	_	
220-13	38717-38718	)	_	
220-14	38719-38725	cannot	_	
220-15	38726-38728	be	_	
220-16	38729-38737	properly	_	
220-17	38738-38751	reconstructed	_	
220-18	38752-38754	by	_	
220-19	38755-38758	EEG	_	
220-20	38758-38759	.	_	
220-21	38760-38761	6	_	
220-22	38761-38762	.	_	

#Text=Conclusion
#Text=Inter-regional functional connectivity and topological characteristics of brain FCN in IWMUD are abnormally changed in the delta and gamma oscillatory bands.
221-1	38763-38773	Conclusion	_	
221-2	38774-38788	Inter-regional	_	
221-3	38789-38799	functional	_	
221-4	38800-38812	connectivity	_	
221-5	38813-38816	and	_	
221-6	38817-38828	topological	_	
221-7	38829-38844	characteristics	_	
221-8	38845-38847	of	_	
221-9	38848-38853	brain	_	
221-10	38854-38857	FCN	_	
221-11	38858-38860	in	_	
221-12	38861-38866	IWMUD	_	
221-13	38867-38870	are	_	
221-14	38871-38881	abnormally	_	
221-15	38882-38889	changed	_	
221-16	38890-38892	in	_	
221-17	38893-38896	the	_	
221-18	38897-38902	delta	_	
221-19	38903-38906	and	_	
221-20	38907-38912	gamma	_	
221-21	38913-38924	oscillatory	_	
221-22	38925-38930	bands	_	
221-23	38930-38931	.	_	

#Text=Nevertheless, it seems that brain dysfunction of IWMUD is not limited to these frequency bands, as altered hub patterns are extended to all the oscillatory rhythms.
222-1	38932-38944	Nevertheless	_	
222-2	38944-38945	,	_	
222-3	38946-38948	it	_	
222-4	38949-38954	seems	_	
222-5	38955-38959	that	_	
222-6	38960-38965	brain	_	
222-7	38966-38977	dysfunction	_	
222-8	38978-38980	of	_	
222-9	38981-38986	IWMUD	_	
222-10	38987-38989	is	_	
222-11	38990-38993	not	_	
222-12	38994-39001	limited	_	
222-13	39002-39004	to	_	
222-14	39005-39010	these	_	
222-15	39011-39020	frequency	_	
222-16	39021-39026	bands	_	
222-17	39026-39027	,	_	
222-18	39028-39030	as	_	
222-19	39031-39038	altered	_	
222-20	39039-39042	hub	_	
222-21	39043-39051	patterns	_	
222-22	39052-39055	are	_	
222-23	39056-39064	extended	_	
222-24	39065-39067	to	_	
222-25	39068-39071	all	_	
222-26	39072-39075	the	_	
222-27	39076-39087	oscillatory	_	
222-28	39088-39095	rhythms	_	
222-29	39095-39096	.	_	

#Text=These findings may help provide predictive biomarkers of disease severity and treatment outcome for IWMUD.
223-1	39097-39102	These	_	
223-2	39103-39111	findings	_	
223-3	39112-39115	may	_	
223-4	39116-39120	help	_	
223-5	39121-39128	provide	_	
223-6	39129-39139	predictive	_	
223-7	39140-39150	biomarkers	_	
223-8	39151-39153	of	_	
223-9	39154-39161	disease	_	
223-10	39162-39170	severity	_	
223-11	39171-39174	and	_	
223-12	39175-39184	treatment	_	
223-13	39185-39192	outcome	_	
223-14	39193-39196	for	_	
223-15	39197-39202	IWMUD	_	
223-16	39202-39203	.	_	

#Text=Supporting information
#Text=References
#Text=Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study
#Text=United Nations Office on Drugs and Crime, World Drug Report 2016 (United Nations publication, Sales No.
224-1	39204-39214	Supporting	_	
224-2	39215-39226	information	_	
224-3	39227-39237	References	_	
224-4	39238-39245	Factors	_	
224-5	39246-39257	Influencing	_	
224-6	39258-39268	Transition	_	
224-7	39269-39271	to	_	
224-8	39272-39279	Shisheh	_	
224-9	39280-39281	(	_	
224-10	39281-39296	Methamphetamine	_	
224-11	39296-39297	)	_	
224-12	39298-39303	among	_	
224-13	39304-39309	Young	_	
224-14	39310-39316	People	_	
224-15	39317-39320	Who	_	
224-16	39321-39324	Use	_	
224-17	39325-39330	Drugs	_	
224-18	39331-39333	in	_	
224-19	39334-39340	Tehran	_	
224-20	39340-39341	:	_	
224-21	39342-39343	A	_	
224-22	39344-39355	Qualitative	_	
224-23	39356-39361	Study	_	
224-24	39362-39368	United	_	
224-25	39369-39376	Nations	_	
224-26	39377-39383	Office	_	
224-27	39384-39386	on	_	
224-28	39387-39392	Drugs	_	
224-29	39393-39396	and	_	
224-30	39397-39402	Crime	_	
224-31	39402-39403	,	_	
224-32	39404-39409	World	_	
224-33	39410-39414	Drug	_	
224-34	39415-39421	Report	_	
224-35	39422-39426	2016	_	
224-36	39427-39428	(	_	
224-37	39428-39434	United	_	
224-38	39435-39442	Nations	_	
224-39	39443-39454	publication	_	
224-40	39454-39455	,	_	
224-41	39456-39461	Sales	_	
224-42	39462-39464	No	_	
224-43	39464-39465	.	_	

#Text=E.16.XI.7).
225-1	39466-39467	E	_	
225-2	39467-39470	.16	_	
225-3	39470-39471	.	_	
225-4	39471-39473	XI	_	
225-5	39473-39475	.7	_	
225-6	39475-39476	)	_	
225-7	39476-39477	.	_	

#Text=Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
#Text=Disrupted topological organization in whole-brain functional networks of heroin-dependent individuals: a resting-state FMRI study
#Text=Addiction related alteration in resting-state brain connectivity
#Text=What does the broken brain say to the neuroscientist?
226-1	39478-39489	Dysfunction	_	
226-2	39490-39492	of	_	
226-3	39493-39496	the	_	
226-4	39497-39507	prefrontal	_	
226-5	39508-39514	cortex	_	
226-6	39515-39517	in	_	
226-7	39518-39527	addiction	_	
226-8	39527-39528	:	_	
226-9	39529-39541	neuroimaging	_	
226-10	39542-39550	findings	_	
226-11	39551-39554	and	_	
226-12	39555-39563	clinical	_	
226-13	39564-39576	implications	_	
226-14	39577-39586	Disrupted	_	
226-15	39587-39598	topological	_	
226-16	39599-39611	organization	_	
226-17	39612-39614	in	_	
226-18	39615-39626	whole-brain	_	
226-19	39627-39637	functional	_	
226-20	39638-39646	networks	_	
226-21	39647-39649	of	_	
226-22	39650-39666	heroin-dependent	_	
226-23	39667-39678	individuals	_	
226-24	39678-39679	:	_	
226-25	39680-39681	a	_	
226-26	39682-39695	resting-state	_	
226-27	39696-39700	FMRI	_	
226-28	39701-39706	study	_	
226-29	39707-39716	Addiction	_	
226-30	39717-39724	related	_	
226-31	39725-39735	alteration	_	
226-32	39736-39738	in	_	
226-33	39739-39752	resting-state	_	
226-34	39753-39758	brain	_	
226-35	39759-39771	connectivity	_	
226-36	39772-39776	What	_	
226-37	39777-39781	does	_	
226-38	39782-39785	the	_	
226-39	39786-39792	broken	_	
226-40	39793-39798	brain	_	
226-41	39799-39802	say	_	
226-42	39803-39805	to	_	
226-43	39806-39809	the	_	
226-44	39810-39824	neuroscientist	_	
226-45	39824-39825	?	_	

#Text=Oscillations and connectivity in schizophrenia, Alzheimer's disease, and bipolar disorder
#Text=Resting state functional connectivity in addiction: lessons learned and a road ahead
#Text=Graph theoretical analysis of brain connectivity in phantom sound perception
#Text=A hyper-connected but less efficient small-world network in the substance-dependent brain
#Text=Mahmoodi M, Abadi BM, Khajepur H, Harirchian MH, editors.
227-1	39826-39838	Oscillations	_	
227-2	39839-39842	and	_	
227-3	39843-39855	connectivity	_	
227-4	39856-39858	in	_	
227-5	39859-39872	schizophrenia	_	
227-6	39872-39873	,	_	
227-7	39874-39885	Alzheimer's	_	
227-8	39886-39893	disease	_	
227-9	39893-39894	,	_	
227-10	39895-39898	and	_	
227-11	39899-39906	bipolar	_	
227-12	39907-39915	disorder	_	
227-13	39916-39923	Resting	_	
227-14	39924-39929	state	_	
227-15	39930-39940	functional	_	
227-16	39941-39953	connectivity	_	
227-17	39954-39956	in	_	
227-18	39957-39966	addiction	_	
227-19	39966-39967	:	_	
227-20	39968-39975	lessons	_	
227-21	39976-39983	learned	_	
227-22	39984-39987	and	_	
227-23	39988-39989	a	_	
227-24	39990-39994	road	_	
227-25	39995-40000	ahead	_	
227-26	40001-40006	Graph	_	
227-27	40007-40018	theoretical	_	
227-28	40019-40027	analysis	_	
227-29	40028-40030	of	_	
227-30	40031-40036	brain	_	
227-31	40037-40049	connectivity	_	
227-32	40050-40052	in	_	
227-33	40053-40060	phantom	_	
227-34	40061-40066	sound	_	
227-35	40067-40077	perception	_	
227-36	40078-40079	A	_	
227-37	40080-40095	hyper-connected	_	
227-38	40096-40099	but	_	
227-39	40100-40104	less	_	
227-40	40105-40114	efficient	_	
227-41	40115-40126	small-world	_	
227-42	40127-40134	network	_	
227-43	40135-40137	in	_	
227-44	40138-40141	the	_	
227-45	40142-40161	substance-dependent	_	
227-46	40162-40167	brain	_	
227-47	40168-40176	Mahmoodi	_	
227-48	40177-40178	M	_	
227-49	40178-40179	,	_	
227-50	40180-40185	Abadi	_	
227-51	40186-40188	BM	_	
227-52	40188-40189	,	_	
227-53	40190-40198	Khajepur	_	
227-54	40199-40200	H	_	
227-55	40200-40201	,	_	
227-56	40202-40212	Harirchian	_	
227-57	40213-40215	MH	_	
227-58	40215-40216	,	_	
227-59	40217-40224	editors	_	
227-60	40224-40225	.	_	

#Text=A robust beamforming approach for early detection of readiness potential with application to brain-computer interface systems. 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 2017: IEEE.
228-1	40226-40227	A	_	
228-2	40228-40234	robust	_	
228-3	40235-40246	beamforming	_	
228-4	40247-40255	approach	_	
228-5	40256-40259	for	_	
228-6	40260-40265	early	_	
228-7	40266-40275	detection	_	
228-8	40276-40278	of	_	
228-9	40279-40288	readiness	_	
228-10	40289-40298	potential	_	
228-11	40299-40303	with	_	
228-12	40304-40315	application	_	
228-13	40316-40318	to	_	
228-14	40319-40333	brain-computer	_	
228-15	40334-40343	interface	_	
228-16	40344-40351	systems	_	
228-17	40351-40352	.	_	
228-18	40353-40357	2017	_	
228-19	40358-40362	39th	_	
228-20	40363-40369	Annual	_	
228-21	40370-40383	International	_	
228-22	40384-40394	Conference	_	
228-23	40395-40397	of	_	
228-24	40398-40401	the	_	
228-25	40402-40406	IEEE	_	
228-26	40407-40418	Engineering	_	
228-27	40419-40421	in	_	
228-28	40422-40430	Medicine	_	
228-29	40431-40434	and	_	
228-30	40435-40442	Biology	_	
228-31	40443-40450	Society	_	
228-32	40451-40452	(	_	
228-33	40452-40456	EMBC	_	
228-34	40456-40457	)	_	
228-35	40457-40458	;	_	
228-36	40459-40463	2017	_	
228-37	40463-40464	:	_	
228-38	40465-40469	IEEE	_	
228-39	40469-40470	.	_	

#Text=Neuroimaging Findings in Methamphetamine Abusers
#Text=Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals
#Text=Global organization of functional brain connectivity in methamphetamine abusers
#Text=Complex network measures of brain connectivity: uses and interpretations
#Text=Small worlds inside big brains
#Text=Adaptive reconfiguration of fractal small-world human brain functional networks
#Text=Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder
#Text=Impaired topological architecture of brain structural networks in idiopathic Parkinson’s disease: a DTI study
#Text=Disrupted functional brain connectome in individuals at risk for Alzheimer's disease
#Text=Modulations of functional connectivity in the healthy and schizophrenia groups during task and rest
#Text=Computer-aided tinnitus detection based on brain network analysis of EEG functional connectivity
#Text=Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals
#Text=Impaired small-world network efficiency and dynamic functional distribution in patients with cirrhosis
#Text=Efficiency and cost of economical brain functional networks
#Text=Age-related changes in modular organization of human brain functional networks
#Text=EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis
#Text=An improved index of phase-synchronization for electrophysiological data in the presence of volume-conduction, noise and sample-size bias
#Text=Graph analysis of EEG resting state functional networks in dyslexic readers
#Text=Reproducibility of functional connectivity and graph measures based on the phase lag index (PLI) and weighted phase lag index (wPLI) derived from high resolution EEG
#Text=Resting-state theta band connectivity and graph analysis in generalized social anxiety disorder
#Text=Brain oscillations and functional connectivity during overt language production
#Text=A critical assessment of connectivity measures for EEG data: a simulation study
#Text=An on-line transformation of EEG scalp potentials into orthogonal source derivations
#Text=Effective brain network analysis with resting-state EEG data: a comparison between heroin abstinent and non-addicted subjects
#Text=Collective dynamics of ‘small-world’networks
#Text=Complex brain networks: graph theoretical analysis of structural and functional systems
#Text=Small-world characteristics of EEG patterns in post-anoxic encephalopathy
#Text=Emerging hubs in phantom perception connectomics
#Text=Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details
#Text=Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
#Text=Assessing interactions in the brain with exact low-resolution electromagnetic tomography
#Text=Default Mode Network alterations in alexithymia: an EEG power spectra and connectivity study
#Text=BrainNet Viewer: a network visualization tool for human brain connectomics
#Text=Decreased cortical complexity in methamphetamine abusers
#Text=Computer-aided classifying and characterizing of methamphetamine use disorder using resting-state EEG
#Text=Emerging roles of the brain’s default network
#Text=Dynamic predictions: oscillations and synchrony in top–down processing
#Text=Temporal coding in the visual cortex: new vistas on integration in the nervous system
#Text=A mechanism for cognitive dynamics: neuronal communication through neuronal coherence
#Text=Neuronal gamma-band synchronization as a fundamental process in cortical computation
#Text=Human gamma-frequency oscillations associated with attention and memory
#Text=The default mode network and EEG regional spectral power: a simultaneous fMRI-EEG study
#Text=Short duration synchronization of human theta rhythm during recognition memory
#Text=Motivation, emotion, and their inhibitory control mirrored in brain oscillations
#Text=Thalamocortical oscillations in the sleeping and aroused brain
#Text=Multiple oscillatory rhythms determine the temporal organization of perception
#Text=Beta-band oscillations—signalling the status quo?
229-1	40471-40483	Neuroimaging	_	
229-2	40484-40492	Findings	_	
229-3	40493-40495	in	_	
229-4	40496-40511	Methamphetamine	_	
229-5	40512-40519	Abusers	_	
229-6	40520-40532	Quantitative	_	
229-7	40533-40536	EEG	_	
229-8	40537-40550	abnormalities	_	
229-9	40551-40553	in	_	
229-10	40554-40562	recently	_	
229-11	40563-40572	abstinent	_	
229-12	40573-40588	methamphetamine	_	
229-13	40589-40598	dependent	_	
229-14	40599-40610	individuals	_	
229-15	40611-40617	Global	_	
229-16	40618-40630	organization	_	
229-17	40631-40633	of	_	
229-18	40634-40644	functional	_	
229-19	40645-40650	brain	_	
229-20	40651-40663	connectivity	_	
229-21	40664-40666	in	_	
229-22	40667-40682	methamphetamine	_	
229-23	40683-40690	abusers	_	
229-24	40691-40698	Complex	_	
229-25	40699-40706	network	_	
229-26	40707-40715	measures	_	
229-27	40716-40718	of	_	
229-28	40719-40724	brain	_	
229-29	40725-40737	connectivity	_	
229-30	40737-40738	:	_	
229-31	40739-40743	uses	_	
229-32	40744-40747	and	_	
229-33	40748-40763	interpretations	_	
229-34	40764-40769	Small	_	
229-35	40770-40776	worlds	_	
229-36	40777-40783	inside	_	
229-37	40784-40787	big	_	
229-38	40788-40794	brains	_	
229-39	40795-40803	Adaptive	_	
229-40	40804-40819	reconfiguration	_	
229-41	40820-40822	of	_	
229-42	40823-40830	fractal	_	
229-43	40831-40842	small-world	_	
229-44	40843-40848	human	_	
229-45	40849-40854	brain	_	
229-46	40855-40865	functional	_	
229-47	40866-40874	networks	_	
229-48	40875-40884	Disrupted	_	
229-49	40885-40890	brain	_	
229-50	40891-40903	connectivity	_	
229-51	40904-40912	networks	_	
229-52	40913-40915	in	_	
229-53	40916-40926	drug-naive	_	
229-54	40926-40927	,	_	
229-55	40928-40941	first-episode	_	
229-56	40942-40947	major	_	
229-57	40948-40958	depressive	_	
229-58	40959-40967	disorder	_	
229-59	40968-40976	Impaired	_	
229-60	40977-40988	topological	_	
229-61	40989-41001	architecture	_	
229-62	41002-41004	of	_	
229-63	41005-41010	brain	_	
229-64	41011-41021	structural	_	
229-65	41022-41030	networks	_	
229-66	41031-41033	in	_	
229-67	41034-41044	idiopathic	_	
229-68	41045-41054	Parkinson	_	
229-69	41054-41055	’	_	
229-70	41055-41056	s	_	
229-71	41057-41064	disease	_	
229-72	41064-41065	:	_	
229-73	41066-41067	a	_	
229-74	41068-41071	DTI	_	
229-75	41072-41077	study	_	
229-76	41078-41087	Disrupted	_	
229-77	41088-41098	functional	_	
229-78	41099-41104	brain	_	
229-79	41105-41115	connectome	_	
229-80	41116-41118	in	_	
229-81	41119-41130	individuals	_	
229-82	41131-41133	at	_	
229-83	41134-41138	risk	_	
229-84	41139-41142	for	_	
229-85	41143-41154	Alzheimer's	_	
229-86	41155-41162	disease	_	
229-87	41163-41174	Modulations	_	
229-88	41175-41177	of	_	
229-89	41178-41188	functional	_	
229-90	41189-41201	connectivity	_	
229-91	41202-41204	in	_	
229-92	41205-41208	the	_	
229-93	41209-41216	healthy	_	
229-94	41217-41220	and	_	
229-95	41221-41234	schizophrenia	_	
229-96	41235-41241	groups	_	
229-97	41242-41248	during	_	
229-98	41249-41253	task	_	
229-99	41254-41257	and	_	
229-100	41258-41262	rest	_	
229-101	41263-41277	Computer-aided	_	
229-102	41278-41286	tinnitus	_	
229-103	41287-41296	detection	_	
229-104	41297-41302	based	_	
229-105	41303-41305	on	_	
229-106	41306-41311	brain	_	
229-107	41312-41319	network	_	
229-108	41320-41328	analysis	_	
229-109	41329-41331	of	_	
229-110	41332-41335	EEG	_	
229-111	41336-41346	functional	_	
229-112	41347-41359	connectivity	_	
229-113	41360-41367	Altered	_	
229-114	41368-41379	small-world	_	
229-115	41380-41385	brain	_	
229-116	41386-41396	functional	_	
229-117	41397-41405	networks	_	
229-118	41406-41409	and	_	
229-119	41410-41418	duration	_	
229-120	41419-41421	of	_	
229-121	41422-41428	heroin	_	
229-122	41429-41432	use	_	
229-123	41433-41435	in	_	
229-124	41436-41440	male	_	
229-125	41441-41450	abstinent	_	
229-126	41451-41467	heroin-dependent	_	
229-127	41468-41479	individuals	_	
229-128	41480-41488	Impaired	_	
229-129	41489-41500	small-world	_	
229-130	41501-41508	network	_	
229-131	41509-41519	efficiency	_	
229-132	41520-41523	and	_	
229-133	41524-41531	dynamic	_	
229-134	41532-41542	functional	_	
229-135	41543-41555	distribution	_	
229-136	41556-41558	in	_	
229-137	41559-41567	patients	_	
229-138	41568-41572	with	_	
229-139	41573-41582	cirrhosis	_	
229-140	41583-41593	Efficiency	_	
229-141	41594-41597	and	_	
229-142	41598-41602	cost	_	
229-143	41603-41605	of	_	
229-144	41606-41616	economical	_	
229-145	41617-41622	brain	_	
229-146	41623-41633	functional	_	
229-147	41634-41642	networks	_	
229-148	41643-41654	Age-related	_	
229-149	41655-41662	changes	_	
229-150	41663-41665	in	_	
229-151	41666-41673	modular	_	
229-152	41674-41686	organization	_	
229-153	41687-41689	of	_	
229-154	41690-41695	human	_	
229-155	41696-41701	brain	_	
229-156	41702-41712	functional	_	
229-157	41713-41721	networks	_	
229-158	41722-41728	EEGLAB	_	
229-159	41728-41729	:	_	
229-160	41730-41732	an	_	
229-161	41733-41737	open	_	
229-162	41738-41744	source	_	
229-163	41745-41752	toolbox	_	
229-164	41753-41756	for	_	
229-165	41757-41765	analysis	_	
229-166	41766-41768	of	_	
229-167	41769-41781	single-trial	_	
229-168	41782-41785	EEG	_	
229-169	41786-41794	dynamics	_	
229-170	41795-41804	including	_	
229-171	41805-41816	independent	_	
229-172	41817-41826	component	_	
229-173	41827-41835	analysis	_	
229-174	41836-41838	An	_	
229-175	41839-41847	improved	_	
229-176	41848-41853	index	_	
229-177	41854-41856	of	_	
229-178	41857-41878	phase-synchronization	_	
229-179	41879-41882	for	_	
229-180	41883-41903	electrophysiological	_	
229-181	41904-41908	data	_	
229-182	41909-41911	in	_	
229-183	41912-41915	the	_	
229-184	41916-41924	presence	_	
229-185	41925-41927	of	_	
229-186	41928-41945	volume-conduction	_	
229-187	41945-41946	,	_	
229-188	41947-41952	noise	_	
229-189	41953-41956	and	_	
229-190	41957-41968	sample-size	_	
229-191	41969-41973	bias	_	
229-192	41974-41979	Graph	_	
229-193	41980-41988	analysis	_	
229-194	41989-41991	of	_	
229-195	41992-41995	EEG	_	
229-196	41996-42003	resting	_	
229-197	42004-42009	state	_	
229-198	42010-42020	functional	_	
229-199	42021-42029	networks	_	
229-200	42030-42032	in	_	
229-201	42033-42041	dyslexic	_	
229-202	42042-42049	readers	_	
229-203	42050-42065	Reproducibility	_	
229-204	42066-42068	of	_	
229-205	42069-42079	functional	_	
229-206	42080-42092	connectivity	_	
229-207	42093-42096	and	_	
229-208	42097-42102	graph	_	
229-209	42103-42111	measures	_	
229-210	42112-42117	based	_	
229-211	42118-42120	on	_	
229-212	42121-42124	the	_	
229-213	42125-42130	phase	_	
229-214	42131-42134	lag	_	
229-215	42135-42140	index	_	
229-216	42141-42142	(	_	
229-217	42142-42145	PLI	_	
229-218	42145-42146	)	_	
229-219	42147-42150	and	_	
229-220	42151-42159	weighted	_	
229-221	42160-42165	phase	_	
229-222	42166-42169	lag	_	
229-223	42170-42175	index	_	
229-224	42176-42177	(	_	
229-225	42177-42181	wPLI	_	
229-226	42181-42182	)	_	
229-227	42183-42190	derived	_	
229-228	42191-42195	from	_	
229-229	42196-42200	high	_	
229-230	42201-42211	resolution	_	
229-231	42212-42215	EEG	_	
229-232	42216-42229	Resting-state	_	
229-233	42230-42235	theta	_	
229-234	42236-42240	band	_	
229-235	42241-42253	connectivity	_	
229-236	42254-42257	and	_	
229-237	42258-42263	graph	_	
229-238	42264-42272	analysis	_	
229-239	42273-42275	in	_	
229-240	42276-42287	generalized	_	
229-241	42288-42294	social	_	
229-242	42295-42302	anxiety	_	
229-243	42303-42311	disorder	_	
229-244	42312-42317	Brain	_	
229-245	42318-42330	oscillations	_	
229-246	42331-42334	and	_	
229-247	42335-42345	functional	_	
229-248	42346-42358	connectivity	_	
229-249	42359-42365	during	_	
229-250	42366-42371	overt	_	
229-251	42372-42380	language	_	
229-252	42381-42391	production	_	
229-253	42392-42393	A	_	
229-254	42394-42402	critical	_	
229-255	42403-42413	assessment	_	
229-256	42414-42416	of	_	
229-257	42417-42429	connectivity	_	
229-258	42430-42438	measures	_	
229-259	42439-42442	for	_	
229-260	42443-42446	EEG	_	
229-261	42447-42451	data	_	
229-262	42451-42452	:	_	
229-263	42453-42454	a	_	
229-264	42455-42465	simulation	_	
229-265	42466-42471	study	_	
229-266	42472-42474	An	_	
229-267	42475-42482	on-line	_	
229-268	42483-42497	transformation	_	
229-269	42498-42500	of	_	
229-270	42501-42504	EEG	_	
229-271	42505-42510	scalp	_	
229-272	42511-42521	potentials	_	
229-273	42522-42526	into	_	
229-274	42527-42537	orthogonal	_	
229-275	42538-42544	source	_	
229-276	42545-42556	derivations	_	
229-277	42557-42566	Effective	_	
229-278	42567-42572	brain	_	
229-279	42573-42580	network	_	
229-280	42581-42589	analysis	_	
229-281	42590-42594	with	_	
229-282	42595-42608	resting-state	_	
229-283	42609-42612	EEG	_	
229-284	42613-42617	data	_	
229-285	42617-42618	:	_	
229-286	42619-42620	a	_	
229-287	42621-42631	comparison	_	
229-288	42632-42639	between	_	
229-289	42640-42646	heroin	_	
229-290	42647-42656	abstinent	_	
229-291	42657-42660	and	_	
229-292	42661-42673	non-addicted	_	
229-293	42674-42682	subjects	_	
229-294	42683-42693	Collective	_	
229-295	42694-42702	dynamics	_	
229-296	42703-42705	of	_	
229-297	42706-42707	‘	_	
229-298	42707-42718	small-world	_	
229-299	42718-42719	’	_	
229-300	42719-42727	networks	_	
229-301	42728-42735	Complex	_	
229-302	42736-42741	brain	_	
229-303	42742-42750	networks	_	
229-304	42750-42751	:	_	
229-305	42752-42757	graph	_	
229-306	42758-42769	theoretical	_	
229-307	42770-42778	analysis	_	
229-308	42779-42781	of	_	
229-309	42782-42792	structural	_	
229-310	42793-42796	and	_	
229-311	42797-42807	functional	_	
229-312	42808-42815	systems	_	
229-313	42816-42827	Small-world	_	
229-314	42828-42843	characteristics	_	
229-315	42844-42846	of	_	
229-316	42847-42850	EEG	_	
229-317	42851-42859	patterns	_	
229-318	42860-42862	in	_	
229-319	42863-42874	post-anoxic	_	
229-320	42875-42889	encephalopathy	_	
229-321	42890-42898	Emerging	_	
229-322	42899-42903	hubs	_	
229-323	42904-42906	in	_	
229-324	42907-42914	phantom	_	
229-325	42915-42925	perception	_	
229-326	42926-42938	connectomics	_	
229-327	42939-42951	Standardized	_	
229-328	42952-42966	low-resolution	_	
229-329	42967-42972	brain	_	
229-330	42973-42988	electromagnetic	_	
229-331	42989-42999	tomography	_	
229-332	43000-43001	(	_	
229-333	43001-43008	sLORETA	_	
229-334	43008-43009	)	_	
229-335	43009-43010	:	_	
229-336	43011-43020	technical	_	
229-337	43021-43028	details	_	
229-338	43029-43038	Automated	_	
229-339	43039-43049	anatomical	_	
229-340	43050-43058	labeling	_	
229-341	43059-43061	of	_	
229-342	43062-43073	activations	_	
229-343	43074-43076	in	_	
229-344	43077-43080	SPM	_	
229-345	43081-43086	using	_	
229-346	43087-43088	a	_	
229-347	43089-43100	macroscopic	_	
229-348	43101-43111	anatomical	_	
229-349	43112-43124	parcellation	_	
229-350	43125-43127	of	_	
229-351	43128-43131	the	_	
229-352	43132-43135	MNI	_	
229-353	43136-43139	MRI	_	
229-354	43140-43154	single-subject	_	
229-355	43155-43160	brain	_	
229-356	43161-43170	Assessing	_	
229-357	43171-43183	interactions	_	
229-358	43184-43186	in	_	
229-359	43187-43190	the	_	
229-360	43191-43196	brain	_	
229-361	43197-43201	with	_	
229-362	43202-43207	exact	_	
229-363	43208-43222	low-resolution	_	
229-364	43223-43238	electromagnetic	_	
229-365	43239-43249	tomography	_	
229-366	43250-43257	Default	_	
229-367	43258-43262	Mode	_	
229-368	43263-43270	Network	_	
229-369	43271-43282	alterations	_	
229-370	43283-43285	in	_	
229-371	43286-43297	alexithymia	_	
229-372	43297-43298	:	_	
229-373	43299-43301	an	_	
229-374	43302-43305	EEG	_	
229-375	43306-43311	power	_	
229-376	43312-43319	spectra	_	
229-377	43320-43323	and	_	
229-378	43324-43336	connectivity	_	
229-379	43337-43342	study	_	
229-380	43343-43351	BrainNet	_	
229-381	43352-43358	Viewer	_	
229-382	43358-43359	:	_	
229-383	43360-43361	a	_	
229-384	43362-43369	network	_	
229-385	43370-43383	visualization	_	
229-386	43384-43388	tool	_	
229-387	43389-43392	for	_	
229-388	43393-43398	human	_	
229-389	43399-43404	brain	_	
229-390	43405-43417	connectomics	_	
229-391	43418-43427	Decreased	_	
229-392	43428-43436	cortical	_	
229-393	43437-43447	complexity	_	
229-394	43448-43450	in	_	
229-395	43451-43466	methamphetamine	_	
229-396	43467-43474	abusers	_	
229-397	43475-43489	Computer-aided	_	
229-398	43490-43501	classifying	_	
229-399	43502-43505	and	_	
229-400	43506-43520	characterizing	_	
229-401	43521-43523	of	_	
229-402	43524-43539	methamphetamine	_	
229-403	43540-43543	use	_	
229-404	43544-43552	disorder	_	
229-405	43553-43558	using	_	
229-406	43559-43572	resting-state	_	
229-407	43573-43576	EEG	_	
229-408	43577-43585	Emerging	_	
229-409	43586-43591	roles	_	
229-410	43592-43594	of	_	
229-411	43595-43598	the	_	
229-412	43599-43604	brain	_	
229-413	43604-43605	’	_	
229-414	43605-43606	s	_	
229-415	43607-43614	default	_	
229-416	43615-43622	network	_	
229-417	43623-43630	Dynamic	_	
229-418	43631-43642	predictions	_	
229-419	43642-43643	:	_	
229-420	43644-43656	oscillations	_	
229-421	43657-43660	and	_	
229-422	43661-43670	synchrony	_	
229-423	43671-43673	in	_	
229-424	43674-43682	top–down	_	
229-425	43683-43693	processing	_	
229-426	43694-43702	Temporal	_	
229-427	43703-43709	coding	_	
229-428	43710-43712	in	_	
229-429	43713-43716	the	_	
229-430	43717-43723	visual	_	
229-431	43724-43730	cortex	_	
229-432	43730-43731	:	_	
229-433	43732-43735	new	_	
229-434	43736-43742	vistas	_	
229-435	43743-43745	on	_	
229-436	43746-43757	integration	_	
229-437	43758-43760	in	_	
229-438	43761-43764	the	_	
229-439	43765-43772	nervous	_	
229-440	43773-43779	system	_	
229-441	43780-43781	A	_	
229-442	43782-43791	mechanism	_	
229-443	43792-43795	for	_	
229-444	43796-43805	cognitive	_	
229-445	43806-43814	dynamics	_	
229-446	43814-43815	:	_	
229-447	43816-43824	neuronal	_	
229-448	43825-43838	communication	_	
229-449	43839-43846	through	_	
229-450	43847-43855	neuronal	_	
229-451	43856-43865	coherence	_	
229-452	43866-43874	Neuronal	_	
229-453	43875-43885	gamma-band	_	
229-454	43886-43901	synchronization	_	
229-455	43902-43904	as	_	
229-456	43905-43906	a	_	
229-457	43907-43918	fundamental	_	
229-458	43919-43926	process	_	
229-459	43927-43929	in	_	
229-460	43930-43938	cortical	_	
229-461	43939-43950	computation	_	
229-462	43951-43956	Human	_	
229-463	43957-43972	gamma-frequency	_	
229-464	43973-43985	oscillations	_	
229-465	43986-43996	associated	_	
229-466	43997-44001	with	_	
229-467	44002-44011	attention	_	
229-468	44012-44015	and	_	
229-469	44016-44022	memory	_	
229-470	44023-44026	The	_	
229-471	44027-44034	default	_	
229-472	44035-44039	mode	_	
229-473	44040-44047	network	_	
229-474	44048-44051	and	_	
229-475	44052-44055	EEG	_	
229-476	44056-44064	regional	_	
229-477	44065-44073	spectral	_	
229-478	44074-44079	power	_	
229-479	44079-44080	:	_	
229-480	44081-44082	a	_	
229-481	44083-44095	simultaneous	_	
229-482	44096-44104	fMRI-EEG	_	
229-483	44105-44110	study	_	
229-484	44111-44116	Short	_	
229-485	44117-44125	duration	_	
229-486	44126-44141	synchronization	_	
229-487	44142-44144	of	_	
229-488	44145-44150	human	_	
229-489	44151-44156	theta	_	
229-490	44157-44163	rhythm	_	
229-491	44164-44170	during	_	
229-492	44171-44182	recognition	_	
229-493	44183-44189	memory	_	
229-494	44190-44200	Motivation	_	
229-495	44200-44201	,	_	
229-496	44202-44209	emotion	_	
229-497	44209-44210	,	_	
229-498	44211-44214	and	_	
229-499	44215-44220	their	_	
229-500	44221-44231	inhibitory	_	
229-501	44232-44239	control	_	
229-502	44240-44248	mirrored	_	
229-503	44249-44251	in	_	
229-504	44252-44257	brain	_	
229-505	44258-44270	oscillations	_	
229-506	44271-44286	Thalamocortical	_	
229-507	44287-44299	oscillations	_	
229-508	44300-44302	in	_	
229-509	44303-44306	the	_	
229-510	44307-44315	sleeping	_	
229-511	44316-44319	and	_	
229-512	44320-44327	aroused	_	
229-513	44328-44333	brain	_	
229-514	44334-44342	Multiple	_	
229-515	44343-44354	oscillatory	_	
229-516	44355-44362	rhythms	_	
229-517	44363-44372	determine	_	
229-518	44373-44376	the	_	
229-519	44377-44385	temporal	_	
229-520	44386-44398	organization	_	
229-521	44399-44401	of	_	
229-522	44402-44412	perception	_	
229-523	44413-44422	Beta-band	_	
229-524	44423-44446	oscillations—signalling	_	
229-525	44447-44450	the	_	
229-526	44451-44457	status	_	
229-527	44458-44461	quo	_	
229-528	44461-44462	?	_	

#Text=Mechanisms of gamma oscillations in the hippocampus of the behaving rat
#Text=The SEEKING mind: primal neuro-affective substrates for appetitive incentive states and their pathological dynamics in addictions and depression
#Text=The role of beta-gamma oscillations in unexpected rewards processing
#Text=Neuroimaging Impaired Response Inhibition and Salience Attribution in Human Drug Addiction: A Systematic Review
#Text=Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex
#Text=Interacting outcome retrieval, anticipation, and feedback processes in the human brain
#Text=Distributed representation of objects in the human ventral visual pathway
#Text=Visual recognition: evidence for two distinctive mechanisms from a PET study
#Text=fMRI BOLD response in high-risk college students (part 1): during exposure to alcohol, marijuana, polydrug and emotional picture cues
#Text=Neural correlates of reward-based spatial learning in persons with cocaine dependence
#Text=Disrupted Resting-State Brain Functional Architecture in Amphetamine-Type Stimulant Abusers
#Text=Humanbrainnetworksinhealthanddi ⋅ sease
#Text=Web addiction in the brain: Cortical oscillations, autonomic activity, and behavioral measures
#Text=Visual cortex activation to drug cues: a meta-analysis of functional neuroimaging papers in addiction and substance abuse literature
#Text=The effect of filtering on Granger causality based multivariate causality measures
#Text=Neural connectivity in Internet gaming disorder and alcohol use disorder: a resting-state EEG coherence study
#Text=Network medicine: a network-based approach to human disease
#Text=The Action Representation Elicited by Different Types of Drug-Related Cues in Heroin-Abstinent Individuals
#Text=Resting-state EEG activity related to impulsivity in gambling disorder
#Text=Examination stress and its effect on EEG
#Text=Gender differences in methamphetamine use and responses: a review
#Text=Abuse of amphetamines and structural abnormalities in the brain
230-1	44463-44473	Mechanisms	_	
230-2	44474-44476	of	_	
230-3	44477-44482	gamma	_	
230-4	44483-44495	oscillations	_	
230-5	44496-44498	in	_	
230-6	44499-44502	the	_	
230-7	44503-44514	hippocampus	_	
230-8	44515-44517	of	_	
230-9	44518-44521	the	_	
230-10	44522-44530	behaving	_	
230-11	44531-44534	rat	_	
230-12	44535-44538	The	_	
230-13	44539-44546	SEEKING	_	
230-14	44547-44551	mind	_	
230-15	44551-44552	:	_	
230-16	44553-44559	primal	_	
230-17	44560-44575	neuro-affective	_	
230-18	44576-44586	substrates	_	
230-19	44587-44590	for	_	
230-20	44591-44601	appetitive	_	
230-21	44602-44611	incentive	_	
230-22	44612-44618	states	_	
230-23	44619-44622	and	_	
230-24	44623-44628	their	_	
230-25	44629-44641	pathological	_	
230-26	44642-44650	dynamics	_	
230-27	44651-44653	in	_	
230-28	44654-44664	addictions	_	
230-29	44665-44668	and	_	
230-30	44669-44679	depression	_	
230-31	44680-44683	The	_	
230-32	44684-44688	role	_	
230-33	44689-44691	of	_	
230-34	44692-44702	beta-gamma	_	
230-35	44703-44715	oscillations	_	
230-36	44716-44718	in	_	
230-37	44719-44729	unexpected	_	
230-38	44730-44737	rewards	_	
230-39	44738-44748	processing	_	
230-40	44749-44761	Neuroimaging	_	
230-41	44762-44770	Impaired	_	
230-42	44771-44779	Response	_	
230-43	44780-44790	Inhibition	_	
230-44	44791-44794	and	_	
230-45	44795-44803	Salience	_	
230-46	44804-44815	Attribution	_	
230-47	44816-44818	in	_	
230-48	44819-44824	Human	_	
230-49	44825-44829	Drug	_	
230-50	44830-44839	Addiction	_	
230-51	44839-44840	:	_	
230-52	44841-44842	A	_	
230-53	44843-44853	Systematic	_	
230-54	44854-44860	Review	_	
230-55	44861-44865	Drug	_	
230-56	44866-44875	addiction	_	
230-57	44876-44879	and	_	
230-58	44880-44883	its	_	
230-59	44884-44894	underlying	_	
230-60	44895-44910	neurobiological	_	
230-61	44911-44916	basis	_	
230-62	44916-44917	:	_	
230-63	44918-44930	neuroimaging	_	
230-64	44931-44939	evidence	_	
230-65	44940-44943	for	_	
230-66	44944-44947	the	_	
230-67	44948-44959	involvement	_	
230-68	44960-44962	of	_	
230-69	44963-44966	the	_	
230-70	44967-44974	frontal	_	
230-71	44975-44981	cortex	_	
230-72	44982-44993	Interacting	_	
230-73	44994-45001	outcome	_	
230-74	45002-45011	retrieval	_	
230-75	45011-45012	,	_	
230-76	45013-45025	anticipation	_	
230-77	45025-45026	,	_	
230-78	45027-45030	and	_	
230-79	45031-45039	feedback	_	
230-80	45040-45049	processes	_	
230-81	45050-45052	in	_	
230-82	45053-45056	the	_	
230-83	45057-45062	human	_	
230-84	45063-45068	brain	_	
230-85	45069-45080	Distributed	_	
230-86	45081-45095	representation	_	
230-87	45096-45098	of	_	
230-88	45099-45106	objects	_	
230-89	45107-45109	in	_	
230-90	45110-45113	the	_	
230-91	45114-45119	human	_	
230-92	45120-45127	ventral	_	
230-93	45128-45134	visual	_	
230-94	45135-45142	pathway	_	
230-95	45143-45149	Visual	_	
230-96	45150-45161	recognition	_	
230-97	45161-45162	:	_	
230-98	45163-45171	evidence	_	
230-99	45172-45175	for	_	
230-100	45176-45179	two	_	
230-101	45180-45191	distinctive	_	
230-102	45192-45202	mechanisms	_	
230-103	45203-45207	from	_	
230-104	45208-45209	a	_	
230-105	45210-45213	PET	_	
230-106	45214-45219	study	_	
230-107	45220-45224	fMRI	_	
230-108	45225-45229	BOLD	_	
230-109	45230-45238	response	_	
230-110	45239-45241	in	_	
230-111	45242-45251	high-risk	_	
230-112	45252-45259	college	_	
230-113	45260-45268	students	_	
230-114	45269-45270	(	_	
230-115	45270-45274	part	_	
230-116	45275-45276	1	_	
230-117	45276-45277	)	_	
230-118	45277-45278	:	_	
230-119	45279-45285	during	_	
230-120	45286-45294	exposure	_	
230-121	45295-45297	to	_	
230-122	45298-45305	alcohol	_	
230-123	45305-45306	,	_	
230-124	45307-45316	marijuana	_	
230-125	45316-45317	,	_	
230-126	45318-45326	polydrug	_	
230-127	45327-45330	and	_	
230-128	45331-45340	emotional	_	
230-129	45341-45348	picture	_	
230-130	45349-45353	cues	_	
230-131	45354-45360	Neural	_	
230-132	45361-45371	correlates	_	
230-133	45372-45374	of	_	
230-134	45375-45387	reward-based	_	
230-135	45388-45395	spatial	_	
230-136	45396-45404	learning	_	
230-137	45405-45407	in	_	
230-138	45408-45415	persons	_	
230-139	45416-45420	with	_	
230-140	45421-45428	cocaine	_	
230-141	45429-45439	dependence	_	
230-142	45440-45449	Disrupted	_	
230-143	45450-45463	Resting-State	_	
230-144	45464-45469	Brain	_	
230-145	45470-45480	Functional	_	
230-146	45481-45493	Architecture	_	
230-147	45494-45496	in	_	
230-148	45497-45513	Amphetamine-Type	_	
230-149	45514-45523	Stimulant	_	
230-150	45524-45531	Abusers	_	
230-151	45532-45563	Humanbrainnetworksinhealthanddi	_	
230-152	45564-45565	⋅	_	
230-153	45566-45571	sease	_	
230-154	45572-45575	Web	_	
230-155	45576-45585	addiction	_	
230-156	45586-45588	in	_	
230-157	45589-45592	the	_	
230-158	45593-45598	brain	_	
230-159	45598-45599	:	_	
230-160	45600-45608	Cortical	_	
230-161	45609-45621	oscillations	_	
230-162	45621-45622	,	_	
230-163	45623-45632	autonomic	_	
230-164	45633-45641	activity	_	
230-165	45641-45642	,	_	
230-166	45643-45646	and	_	
230-167	45647-45657	behavioral	_	
230-168	45658-45666	measures	_	
230-169	45667-45673	Visual	_	
230-170	45674-45680	cortex	_	
230-171	45681-45691	activation	_	
230-172	45692-45694	to	_	
230-173	45695-45699	drug	_	
230-174	45700-45704	cues	_	
230-175	45704-45705	:	_	
230-176	45706-45707	a	_	
230-177	45708-45721	meta-analysis	_	
230-178	45722-45724	of	_	
230-179	45725-45735	functional	_	
230-180	45736-45748	neuroimaging	_	
230-181	45749-45755	papers	_	
230-182	45756-45758	in	_	
230-183	45759-45768	addiction	_	
230-184	45769-45772	and	_	
230-185	45773-45782	substance	_	
230-186	45783-45788	abuse	_	
230-187	45789-45799	literature	_	
230-188	45800-45803	The	_	
230-189	45804-45810	effect	_	
230-190	45811-45813	of	_	
230-191	45814-45823	filtering	_	
230-192	45824-45826	on	_	
230-193	45827-45834	Granger	_	
230-194	45835-45844	causality	_	
230-195	45845-45850	based	_	
230-196	45851-45863	multivariate	_	
230-197	45864-45873	causality	_	
230-198	45874-45882	measures	_	
230-199	45883-45889	Neural	_	
230-200	45890-45902	connectivity	_	
230-201	45903-45905	in	_	
230-202	45906-45914	Internet	_	
230-203	45915-45921	gaming	_	
230-204	45922-45930	disorder	_	
230-205	45931-45934	and	_	
230-206	45935-45942	alcohol	_	
230-207	45943-45946	use	_	
230-208	45947-45955	disorder	_	
230-209	45955-45956	:	_	
230-210	45957-45958	a	_	
230-211	45959-45972	resting-state	_	
230-212	45973-45976	EEG	_	
230-213	45977-45986	coherence	_	
230-214	45987-45992	study	_	
230-215	45993-46000	Network	_	
230-216	46001-46009	medicine	_	
230-217	46009-46010	:	_	
230-218	46011-46012	a	_	
230-219	46013-46026	network-based	_	
230-220	46027-46035	approach	_	
230-221	46036-46038	to	_	
230-222	46039-46044	human	_	
230-223	46045-46052	disease	_	
230-224	46053-46056	The	_	
230-225	46057-46063	Action	_	
230-226	46064-46078	Representation	_	
230-227	46079-46087	Elicited	_	
230-228	46088-46090	by	_	
230-229	46091-46100	Different	_	
230-230	46101-46106	Types	_	
230-231	46107-46109	of	_	
230-232	46110-46122	Drug-Related	_	
230-233	46123-46127	Cues	_	
230-234	46128-46130	in	_	
230-235	46131-46147	Heroin-Abstinent	_	
230-236	46148-46159	Individuals	_	
230-237	46160-46173	Resting-state	_	
230-238	46174-46177	EEG	_	
230-239	46178-46186	activity	_	
230-240	46187-46194	related	_	
230-241	46195-46197	to	_	
230-242	46198-46209	impulsivity	_	
230-243	46210-46212	in	_	
230-244	46213-46221	gambling	_	
230-245	46222-46230	disorder	_	
230-246	46231-46242	Examination	_	
230-247	46243-46249	stress	_	
230-248	46250-46253	and	_	
230-249	46254-46257	its	_	
230-250	46258-46264	effect	_	
230-251	46265-46267	on	_	
230-252	46268-46271	EEG	_	
230-253	46272-46278	Gender	_	
230-254	46279-46290	differences	_	
230-255	46291-46293	in	_	
230-256	46294-46309	methamphetamine	_	
230-257	46310-46313	use	_	
230-258	46314-46317	and	_	
230-259	46318-46327	responses	_	
230-260	46327-46328	:	_	
230-261	46329-46330	a	_	
230-262	46331-46337	review	_	
230-263	46338-46343	Abuse	_	
230-264	46344-46346	of	_	
230-265	46347-46359	amphetamines	_	
230-266	46360-46363	and	_	
230-267	46364-46374	structural	_	
230-268	46375-46388	abnormalities	_	
230-269	46389-46391	in	_	
230-270	46392-46395	the	_	
230-271	46396-46401	brain	_	
